<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">92755</article-id><article-id pub-id-type="doi">10.7554/eLife.92755</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.92755.3</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Rho GTPase signaling and mDia facilitate endocytosis via presynaptic actin</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-335993"><name><surname>Oevel</surname><given-names>Kristine</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0009-0003-3671-5411</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-335994"><name><surname>Hohensee</surname><given-names>Svea</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-335995"><name><surname>Kumar</surname><given-names>Atul</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-335996" deceased="yes"><name><surname>Rosas-Brugada</surname><given-names>Irving</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="fn1"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-232411"><name><surname>Bartolini</surname><given-names>Francesca</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-335997"><name><surname>Soykan</surname><given-names>Tolga</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1324-9601</contrib-id><email>soykan@fmp-berlin.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-7125"><name><surname>Haucke</surname><given-names>Volker</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-3119-6993</contrib-id><email>haucke@fmp-berlin.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/010s54n03</institution-id><institution>Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)</institution></institution-wrap><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03et1qs84</institution-id><institution>Department of Pathology and Cell Biology, Columbia University Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">New York City</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03v4gjf40</institution-id><institution>Faculty of Biology, Chemistry, Pharmacy, Freie Universität Berlin</institution></institution-wrap><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/001w7jn25</institution-id><institution>NeuroCure Cluster of Excellence, Charité Universitätsmedizin Berlin</institution></institution-wrap><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Dötsch</surname><given-names>Volker</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04cvxnb49</institution-id><institution>Goethe University</institution></institution-wrap><country>Germany</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Dötsch</surname><given-names>Volker</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04cvxnb49</institution-id><institution>Goethe University</institution></institution-wrap><country>Germany</country></aff></contrib></contrib-group><author-notes><fn fn-type="fn" id="fn1"><label>†</label><p>Deceased</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>19</day><month>03</month><year>2024</year></pub-date><volume>12</volume><elocation-id>RP92755</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2023-10-12"><day>12</day><month>10</month><year>2023</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2023-10-16"><day>16</day><month>10</month><year>2023</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2023.10.12.561997"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2023-12-05"><day>05</day><month>12</month><year>2023</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.92755.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-02-28"><day>28</day><month>02</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.92755.2"/></event></pub-history><permissions><copyright-statement>© 2023, Oevel et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Oevel et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-92755-v1.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-92755-figures-v1.pdf"/><abstract><p>Neurotransmission at synapses is mediated by the fusion and subsequent endocytosis of synaptic vesicle membranes. Actin has been suggested to be required for presynaptic endocytosis but the mechanisms that control actin polymerization and its mode of action within presynaptic nerve terminals remain poorly understood. We combine optical recordings of presynaptic membrane dynamics and ultrastructural analysis with genetic and pharmacological manipulations to demonstrate that presynaptic endocytosis is controlled by actin regulatory diaphanous-related formins mDia1/3 and Rho family GTPase signaling in mouse hippocampal neurons. We show that impaired presynaptic actin assembly in the near absence of mDia1/3 and reduced RhoA activity is partly compensated by hyperactivation of Rac1. Inhibition of Rac1 signaling further aggravates impaired presynaptic endocytosis elicited by loss of mDia1/3. Our data suggest that interdependent mDia1/3-Rho and Rac1 signaling pathways cooperatively act to facilitate synaptic vesicle endocytosis by controlling presynaptic F-actin.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>hippocampus</kwd><kwd>synaptic transmission</kwd><kwd>synaptic vesicles</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>SFB 958/ A01</award-id><principal-award-recipient><name><surname>Haucke</surname><given-names>Volker</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Genetic and pharmacological tools are used to dissect the mechanisms by which the presynaptic actin cytoskeleton facilitates membrane internalization at synapses and, thereby, neurotransmission.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Synaptic transmission relies on the release of neurotransmitters by calcium-triggered exocytic fusion of synaptic vesicles (SVs) at specialized active zone release sites within presynaptic nerve terminals. Following fusion, compensatory endocytosis retrieves SV proteins and lipids from the presynaptic plasma membrane and SVs are reformed (<xref ref-type="bibr" rid="bib10">Chanaday et al., 2019</xref>; <xref ref-type="bibr" rid="bib26">Gan and Watanabe, 2018</xref>; <xref ref-type="bibr" rid="bib43">Kononenko and Haucke, 2015</xref>; <xref ref-type="bibr" rid="bib70">Saheki and De Camilli, 2012</xref>; <xref ref-type="bibr" rid="bib77">Soykan et al., 2016</xref>), e.g., by clathrin-mediated vesicle budding (<xref ref-type="bibr" rid="bib42">Kononenko et al., 2014</xref>; <xref ref-type="bibr" rid="bib81">Watanabe et al., 2014</xref>) (but see <xref ref-type="bibr" rid="bib84">Wu et al., 2014</xref> for evidence in favor of clathrin-independent SV reformation). Endocytosis relies on mechanical forces to enable membrane deformation and eventually fission (<xref ref-type="bibr" rid="bib23">Engqvist-Goldstein and Drubin, 2003</xref>). In many biological systems, actin and actin-associated myosin motors appear to provide such mechanical force to facilitate vesicle formation (<xref ref-type="bibr" rid="bib1">Anes et al., 2003</xref>; <xref ref-type="bibr" rid="bib49">Marston et al., 2003</xref>). For example, the function of actin for endocytosis is well-established in yeast, whereas differential requirements for actin in distinct forms of endocytosis have been described in various types of mammalian cells including neurons (<xref ref-type="bibr" rid="bib8">Boulant et al., 2011</xref>; <xref ref-type="bibr" rid="bib52">Merrifield et al., 2005</xref>; <xref ref-type="bibr" rid="bib69">Saffarian et al., 2009</xref>; <xref ref-type="bibr" rid="bib70">Saheki and De Camilli, 2012</xref>). Pharmacological inhibition of actin assembly by latrunculin has been shown to cause the accumulation of endocytic intermediates at lamprey giant synapses (<xref ref-type="bibr" rid="bib76">Shupliakov et al., 2002</xref>) and interfere with ultrafast endocytosis in response to single optical action potentials (APs) at hippocampal synapses (<xref ref-type="bibr" rid="bib80">Watanabe et al., 2013</xref>; <xref ref-type="bibr" rid="bib81">Watanabe et al., 2014</xref>; <xref ref-type="bibr" rid="bib86">Wu and Chan, 2022</xref>) and with fast endocytosis at cerebellar mossy fiber boutons (<xref ref-type="bibr" rid="bib21">Delvendahl et al., 2016</xref>). The same treatment does not hamper endocytosis of SV proteins at hippocampal synapses stimulated with trains of APs (<xref ref-type="bibr" rid="bib73">Sankaranarayanan et al., 2003</xref>; <xref ref-type="bibr" rid="bib78">Soykan et al., 2017</xref>). Interference with actin function by conditional knockout (KO) of <italic>Actb</italic> or <italic>Actg1</italic> genes, encoding β- or γ-actin, respectively, has suggested a crucial role for actin in all kinetically distinguishable forms of endocytosis (<xref ref-type="bibr" rid="bib85">Wu et al., 2016</xref>) at hippocampal synapses and the calyx of Held, a fast giant synapse in the auditory brain stem (<xref ref-type="bibr" rid="bib6">Borst and Soria van Hoeve, 2012</xref>). However, in the same preparations, actin loss also affected SV exocytosis (<xref ref-type="bibr" rid="bib85">Wu et al., 2016</xref>), suggesting a more general requirement of actin for presynaptic function. Consistently, actin has been shown to surround clusters of reserve pool SVs in lamprey (<xref ref-type="bibr" rid="bib4">Bloom et al., 2003</xref>), to facilitate the replenishment of fast-releasing vesicles in various models (<xref ref-type="bibr" rid="bib72">Sakaba et al., 2013</xref>; <xref ref-type="bibr" rid="bib71">Sakaba and Neher, 2003</xref>), to be involved in Tau pathology (<xref ref-type="bibr" rid="bib88">Zhou et al., 2017</xref>), to induce spine growth and plasticity, (<xref ref-type="bibr" rid="bib14">Cingolani and Goda, 2008</xref>) and to steer neuronal migration (<xref ref-type="bibr" rid="bib75">Shinohara et al., 2012</xref>) among various other roles.</p><p>We have previously demonstrated that pharmacological interference with the function of formins, a group of Rho family-associated proteins that nucleate linear filamentous (F) actin, kinetically delays SV endocytosis at hippocampal boutons and blocks compensatory endocytosis at the calyx of Held in pre-hearing rats (<xref ref-type="bibr" rid="bib78">Soykan et al., 2017</xref>). Capacitance measurements at the calyx of Held in post-hearing rodents suggest a less stringent requirement for formin-mediated actin assembly for endocytosis (<xref ref-type="bibr" rid="bib36">Hori et al., 2022</xref>). The latter observation may reflect the operation of compensatory pathways for actin assembly, e.g., via Rac1 or Cdc42 Rho-family GTPases that promote branched actin networks (<xref ref-type="bibr" rid="bib22">Eisenmann et al., 2005</xref>; <xref ref-type="bibr" rid="bib30">Goode and Eck, 2007</xref>; <xref ref-type="bibr" rid="bib35">Hodge and Ridley, 2016</xref>).</p><p>In contrast to the vast body of literature regarding the role of actin and actin-associated proteins at the postsynapse (<xref ref-type="bibr" rid="bib14">Cingolani and Goda, 2008</xref>; <xref ref-type="bibr" rid="bib16">Colgan and Yasuda, 2014</xref>) and references therein, most notably the actin-rich mesh of the postsynaptic density of glutamatergic synapses, comparably little is known about the signaling pathways e.g., via guanine nucleotide exchange factors and GTPase activating proteins for Rho family small GTPases (<xref ref-type="bibr" rid="bib54">Müller et al., 2020</xref>) that mediate actin assembly at the presynapse. Recent work has suggested that presynaptic Rac1 negatively regulates synaptic strength and release probability by altering SV priming and replenishment at central synapses (<xref ref-type="bibr" rid="bib56">O’Neil et al., 2021</xref>) including the calyx of Held (<xref ref-type="bibr" rid="bib39">Keine et al., 2022</xref>). These data suggest a negative regulatory role for Rac1 in SV exocytosis. The abundance of postsynaptic actin (<xref ref-type="bibr" rid="bib13">Chen et al., 2020</xref>; <xref ref-type="bibr" rid="bib14">Cingolani and Goda, 2008</xref>; <xref ref-type="bibr" rid="bib16">Colgan and Yasuda, 2014</xref>) has hampered the analysis of the nanoscale localization of actin at presynaptic nerve terminals and of the actin-regulatory proteins that control its dynamics. Loss of dynamin isoforms Dynamin1 and Dynamin3, the main enzymes for endocytic membrane fission (<xref ref-type="bibr" rid="bib24">Ferguson et al., 2007</xref>; <xref ref-type="bibr" rid="bib38">Imoto et al., 2022</xref>; <xref ref-type="bibr" rid="bib62">Raimondi et al., 2011</xref>), has been shown to cause the accumulation of F-actin at and around stalled endocytic intermediates in non-neuronal cells (<xref ref-type="bibr" rid="bib25">Ferguson et al., 2009</xref>) but this phenotype seems less overt at hippocampal synapses (<xref ref-type="bibr" rid="bib62">Raimondi et al., 2011</xref>). Hence, actin in addition to a possible local role at endocytic invaginations might serve a more general function in endocytosis at synapses, for example by modulating plasma membrane tension or contractility, by providing a restrictive membrane scaffold that promotes membrane fission by keeping endocytic invaginations under longitudinal tension (<xref ref-type="bibr" rid="bib8">Boulant et al., 2011</xref>; <xref ref-type="bibr" rid="bib68">Roux et al., 2006</xref>; <xref ref-type="bibr" rid="bib86">Wu and Chan, 2022</xref>), or via formation of an F-actin ring around the active zone that mechanically couples exocytic membrane compression to endocytic pit formation (<xref ref-type="bibr" rid="bib55">Ogunmowo et al., 2023</xref>).</p><p>Here, we combine optical recordings of SV exo-/endocytosis and ultrastructural analysis with genetic and pharmacological manipulations to show that interdependent mDia1/3-Rho and Rac1 signaling pathways cooperate to facilitate SV endocytosis by controlling presynaptic F-actin.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Actin dynamics and actin nucleating mDia1/3 proteins facilitate presynaptic endocytosis and SV recycling</title><p>Previous studies using pharmacological inhibitors of actin polymerization and depolymerization have yielded inconclusive, often conflicting data regarding the function of actin in SV endocytosis and recycling in different models (<xref ref-type="bibr" rid="bib3">Bleckert et al., 2012</xref>; <xref ref-type="bibr" rid="bib20">Del Signore et al., 2021</xref>; <xref ref-type="bibr" rid="bib61">Piriya Ananda Babu et al., 2020</xref>; <xref ref-type="bibr" rid="bib73">Sankaranarayanan et al., 2003</xref>; <xref ref-type="bibr" rid="bib76">Shupliakov et al., 2002</xref>; <xref ref-type="bibr" rid="bib86">Wu and Chan, 2022</xref>). In contrast, ablation of <italic>Actb</italic> or <italic>Actg1</italic>in mouse neurons suggests that actin is required for all forms of endocytosis at several types of synapses (<xref ref-type="bibr" rid="bib85">Wu et al., 2016</xref>). Prompted by these findings we revisited the role of actin in presynaptic endocytosis by analyzing the effects of impaired F-actin dynamics in the combined presence of the G-actin sequestering drug latrunculin A, the F-actin stabilizer jasplakinolide, and Y-27632, an inhibitor of ROCK kinase signaling. This cocktail was shown to preserve the existing cytoskeleton architecture while blocking actin assembly, disassembly, and rearrangement (<xref ref-type="bibr" rid="bib60">Peng et al., 2011</xref>). We optically recorded the stimulation-induced exo-endocytosis of the SV protein Synaptophysin (Syph) fused to a pH-sensitive super-ecliptic green fluorescent protein (pHluorin) (<xref ref-type="bibr" rid="bib53">Miesenböck et al., 1998</xref>) that is de-quenched during exocytosis and undergoes re-quenching as SVs are internalized and re-acidified in hippocampal neurons at physiological temperature. Under these conditions (i.e. trains of APs, 37 °C), SV endocytosis occurs on a timescale of &gt;10 s, e.g., a timescale that is slower than re-quenching of pHluorin due to reacidification (<xref ref-type="bibr" rid="bib47">López-Hernández et al., 2022</xref>; <xref ref-type="bibr" rid="bib78">Soykan et al., 2017</xref>). Hence, the decay of pHluorin signals can serve as a measure of the time course of SV endocytosis. Perturbation of actin dynamics in the combined presence of latrunculin A, jasplakinolide, and Y-27632 significantly slowed down the endocytic retrieval of exogenously expressed Syph-pHluorin (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref>). Application of Y-27632 alone or a combination of latrunculin A and jasplakinolide had no effect on SV endocytosis kinetics, whereas combined use of Y-27632 together with jasplakinolide displayed a mild inhibitory effect (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C–F</xref>). Impaired actin dynamics in the presence of latrunculin A, jasplakinolide, and Y-27632 did not impact the apparent level of SV exocytosis indicated by the maximal amplitude of Syph-pHluorin fluorescence (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>). As optical imaging of pHluorin reporters may lead to artifacts, we analyzed the internalization kinetics of the endogenous vesicular γ-aminobutyric acid transporter (vGAT) using antibodies directed against its luminal domain coupled to the pH-sensitive fluorophore CypHer5E (<xref ref-type="bibr" rid="bib37">Hua et al., 2011</xref>; <xref ref-type="bibr" rid="bib47">López-Hernández et al., 2022</xref>). The cyanine-based dye CypHer5E is quenched at neutral pH but exhibits bright fluorescence when present in the acidic lumen of SVs and, thus can serve as a tracer for the exo-endocytic cycling of endogenous SV proteins. Perturbation of actin dynamics significantly delayed the endocytic retrieval of endogenous vGAT in response to train stimulation with 200 APs at physiological temperature (<xref ref-type="fig" rid="fig1">Figure 1C and D</xref>), consistent with the results from exogenously expressed Syph-pHluorin. vGAT exocytosis proceeded unperturbed (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>). Hence, a dynamic actin cytoskeleton facilitates presynaptic endocytosis in hippocampal neurons.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Actin dynamics and actin-nucleating mDia1/3 proteins facilitate synaptic vesicle (SV) endocytosis.</title><p>(<bold>A</bold>) Averaged normalized Synaptophysin-pHluorin (Syph-pH) fluorescence traces from transfected hippocampal neurons stimulated with 200 action potentials (APs) (40 Hz, 5 s) at physiological temperature (37.5 °C). Neurons were treated with 0.1% dimethyl sulfoxide (DMSO) or JLY cocktail (containing 8 µM Jasplakinolide, 5 µM Latrunculin A, and 10 µM Y-27632) as indicated. Data shown represent the mean ± SEM. N=4 independent experiments from n<sub>DMSO</sub> = 23 videos; n<sub>JLY</sub> = 36 videos. (<bold>B</bold>) Endocytic decay constants (τ) of Synaptophysin-pHluorin traces in A: τ<sub>DMSO</sub> = 29.1±3.4 s; τ<sub>JLY</sub> = 55.8±7.2 s; p&lt;0.05, two-tailed student’s t-test. Data shown represent mean ± SEM. (<bold>C</bold>) Averaged normalized bleach-corrected vGAT-CypHer fluorescence traces from hippocampal neurons treated with DMSO or JLY cocktail in response to 200 AP (40 Hz, 5 s) stimulation. Data shown represent the mean ± SEM. N=4 independent experiments from n<sub>DMSO</sub> = 23 videos; n<sub>JLY</sub> = 29 videos. (<bold>D</bold>) Endocytic decay constants of vGAT-CypHer traces in C: τ<sub>DMSO</sub> = 10.9±0.7 s, τ<sub>JLY</sub> = 24.6±2.0 s; p&lt;0.001, two-tailed unpaired student’s t-test. Data shown represent the mean ± SEM. (<bold>E</bold>) Averaged normalized Synaptophysin-pHluorin fluorescence traces from hippocampal neurons transfected with shRNA-encoding plasmids against no mammalian target (<italic>shCTR</italic>) or <italic>Diaph1</italic> (<italic>shmDia1</italic>) in response to 200 AP (40 Hz, 5 s) stimulation. Neurons were co-transfected with mDia1-mCherry (mDia1-WT) or mCherry alone (<italic>shCTR</italic> &amp; <italic>shmDia1</italic>) to exclude artifacts from overexpression. Data shown represent the mean ± SEM. N=3 independent experiments from n<sub>shCTR</sub> = 28 videos, n<sub>shmDia1</sub>=21 videos, n<sub>shmDia1 + mDia1-WT</sub>=21 videos. (<bold>F</bold>) Endocytic decay constants of Synaptophysin-pHluorin traces in E: τ<sub>shCTR</sub> = 29.7±1.9 s; τ<sub>shmDia1</sub> = 64.7 ± 3.9 s; τ<sub>shmDia1 + mDia1-WT</sub> = 30.6±3.7 s; p<sub>shCTR vs shmDia1</sub> &lt;0.001, p<sub>shmDia1 vs shmDia1 + mDia1-WT</sub>&lt;0.001, one-way ANOVA with Tukey’s post-test. Data shown represent mean ± SEM. (<bold>G</bold>) Endocytic decay constants of averaged normalized vesicular glutamate transporter 1 (vGLUT1)-pHluorin fluorescence traces (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1I</xref>) from hippocampal neurons transduced with <italic>shCTR</italic> (τ<sub>shCTR</sub> = 9.1±0.8 s), <italic>shmDia1</italic> (τ<sub>shmDia1</sub> = 14.3±1.5 s), or <italic>shmDia1 +3</italic> (τ<sub>shmDia1+3</sub> = 16.4±1.3 s) in response to 40 AP (20 Hz, 2 s) stimulation (p<sub>shCTR vs shmDia1</sub> &lt;0.05, p<sub>shCTR vs shmDia1+3</sub> &lt; 0.01, one-way ANOVA with Tukey’s post-test). Data shown represent mean ± SEM. N=4 independent experiments from n<sub>shCTR</sub> = 17 videos; n<sub>shmDia1</sub>=19 videos; n<sub>shmDia1+3</sub> = 18 videos. (<bold>H</bold>) Endocytic decay constants of averaged normalized vGLUT1-pHluorin fluorescence traces (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1K</xref>) of neurons transduced with lentiviral vectors encoding <italic>shCTR</italic> (τ<sub>shCTR</sub> = 13.6±1.6 s), <italic>shmDia1</italic> (τ<sub>shmDia1</sub> = 22.0±3.2 s) or <italic>shmDia1 +3</italic> (τ<sub>shmDia1+3</sub> = 26.9±3.6 s) in response to 80 AP (40 Hz, 2 s) stimulation (p<sub>shCTR vs shmDia1+3</sub> &lt; 0.05, one-way ANOVA with Tukey’s post-test). Data shown represent mean ± SEM. N=4 independent experiments from n<sub>shCTR</sub> = 12 videos, n<sub>shmDia1</sub>=15 videos, n<sub>shmDia1+3</sub> = 18 videos. (<bold>I</bold>) Averaged normalized bleach-corrected vGAT-CypHer fluorescence traces from hippocampal neurons transduced with <italic>shCTR</italic> or <italic>shmDia1 +3</italic> in response to 200 AP (40 Hz, 5 s) stimulation. Data shown represent the mean ± SEM. N=8 independent experiments from n<sub>shCTR</sub> = 37 videos, n<sub>shmDia1+3</sub> = 35 videos. (<bold>J</bold>) Endocytic decay constants of vesicular γ aminobutyric acid transporter (vGAT)-CypHer traces in I: τ<sub>shCTR</sub> = 14.1±1.3 s; τ<sub>shmDia1+3</sub> = 27.3±2.6 s; p&lt;0.001, two-tailed unpaired student’s t-test. Data shown represent the mean ± SEM. (<bold>K</bold>) Averaged normalized vGLUT1-pHluorin fluorescence traces from transduced neurons in response to 80 AP (40 Hz, 2 s) stimulation. Cells were treated with 0.1% DMSO or 10 µM mDia activator (IMM) in the imaging buffer. Data shown represent mean ± SEM. N=3 independent experiments from n<sub>DMSO</sub> = 18 videos; n<sub>IMM</sub> = 16 videos. (<bold>L</bold>) Endocytic decay constants of vGLUT1-pHluorin traces in K: τ<sub>DMSO</sub> = 14.9±0.8 s; τ<sub>IMM</sub> = 9.8±0.5 s; p&lt;0.05, two-tailed unpaired student’s t-test. Data shown represent mean ± SEM.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig1">Figure 1A–L</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92755-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Role of formins and mDia1/3 in synaptic vesicle (SV) endocytosis.</title><p>(<bold>A</bold>) Maxima of background-corrected Synaptophysin-pHluorin (Syph-pHluorin) fluorescence traces (surface normalized) for neurons treated with 0.1% dimethyl sulfoxide (DMSO) (1.7 ± 0.1) or JLY cocktail (1.8 ± 0.2) in response to 200 action potential (AP) stimulation (40 Hz, 5 s). Data represent mean ± SEM. N=4 independent experiments from n<sub>DMSO</sub> = 23 videos; n<sub>JLY</sub> = 36 videos. (<bold>B</bold>) Minima of background-corrected vesicular glutamate transporter 1 (vGAT)-CypHer fluorescence traces (surface normalization) for neurons treated with 0.1% DMSO or JLY cocktail (1.0± 0.1) in response to 200 AP stimulation (40 Hz, 5 s). Data represent mean ± SEM. Values for DMSO were set to 1. N=4 independent experiments from n<sub>DMSO</sub> = 23 videos; n<sub>JLY</sub> = 29 videos. (<bold>C</bold>) Averaged normalized Syph-pH fluorescence traces from transfected hippocampal neurons treated with 0.1% DMSO, JY or JL combinations (containing 8 µM Jasplakinolide, 5 µM Latrunculin A, and 10 µM Y-27632) stimulated with 200 APs (40 Hz, 5 s). Data shown represent the mean ± SEM. N=4 independent experiments from n<sub>DMSO</sub> = 24 videos; n<sub>JY</sub> = 19 videos; n<sub>JL</sub> = 21 videos. (<bold>D</bold>) Endocytic decay constants of fluorescence traces in C: τ<sub>DMSO</sub> = 19.0±1.9 s; τ<sub>JY</sub> = 28.5±1.6 s; τ<sub>JL</sub> = 18.2 ± 1.6 s; p<sub>DMSO vs JY</sub> &lt;0.01, one-way ANOVA with Tukey’s post-test. Data shown represent mean ± SEM. (<bold>E</bold>) Averaged normalized Syph-pH fluorescence traces from transfected hippocampal neurons treated with 0.1% DMSO or 10 µM Y-27632 following 200 AP (40 Hz, 5 s) stimulation. Data shown represent the mean ± SEM. N=4 independent experiments from n<sub>DMSO</sub> = 25 videos; n<sub>Y</sub> = 18 videos. (<bold>F</bold>) Endocytic decay constants of fluorescence traces in E: τ<sub>DMSO</sub> = 17.0±2.2 s; τ<sub>Y</sub> = 20.2±4.3 s. Data shown represent mean ± SEM. (<bold>G</bold>) Maxima of background-corrected Syph-pHluorin fluorescence traces (surface normalized) for neurons transfected with <italic>shCTR</italic> (1.8±0.1) or <italic>shmDia1</italic> (1.8 ± 0.1) in response to 200 AP stimulation (40 Hz, 5 s). Data represent mean ± SEM. N=9 independent experiments from n<sub>shCTR</sub> = 49 videos; n<sub>shmDia1</sub>=42 videos. (<bold>H</bold>) Analysis of knockdown efficiency of lentiviral particles carrying shRNA against no mammalian target (<italic>shCTR</italic>) or <italic>Diaph1</italic> and <italic>Diaph2</italic> genes (<italic>shmDia1 +3</italic>) in mouse hippocampal cultures harvested 12 days after transduction. Protein abundance of mDia1, mDia3, and Tubulin were immunoblotted with specific antibodies. (<bold>I</bold>) Averaged normalized vGLUT1-pHluorin fluorescence traces from stimulated (40 APs; 20 Hz, 2 s) hippocampal neurons transduced with lentiviruses encoding <italic>shCTR</italic>, <italic>shmDia1,</italic> or both <italic>shmDia1</italic> and <italic>shmDia3</italic> combined (<italic>shmDia1 +3</italic>). Data represent mean ± SEM. N=4 independent experiments from n<sub>shCTR</sub> = 17 videos, n<sub>shmDia1</sub>=19 videos, n<sub>shmDia1+3</sub> = 18 videos. The corresponding endocytic decay constants are shown in <xref ref-type="fig" rid="fig1">Figure 1G</xref>. (<bold>J</bold>) Maxima of background-corrected vGLUT1-pHluorin fluorescence traces (surface normalized) for neurons transduced with <italic>shCTR</italic> (1.9±0.1) or <italic>shmDia1 +3</italic> (1.9±0.1) in response to 40 AP stimulation (20 Hz, 2 s). Data represent mean ± SEM. N=22 independent experiments from n<sub>shCTR</sub> = 105 videos and n<sub>shmDia1+3</sub> = 128 videos. (<bold>K</bold>) Averaged normalized vGLUT1-pHluorin fluorescence traces for neurons transduced with <italic>shCTR, shmDia1,</italic> or <italic>shmDia1 +3</italic> in response to 80 AP stimulation (40 Hz, 2 s). Data represent mean ± SEM. N=4 independent experiments from n<sub>shCTR</sub> = 12 videos; n<sub>shmDia1</sub>=15 videos; n<sub>shmDia1+3</sub> = 18 videos. Corresponding endocytic decay constants are shown in <xref ref-type="fig" rid="fig1">Figure 1H</xref>. (<bold>L</bold>) Maxima of background-corrected vGLUT1-pHluorin fluorescence traces (surface normalized) for neurons transduced with <italic>shCTR</italic> (2.8±0.2), <italic>shmDia1</italic> (2.6±0.2), or <italic>shmDia1 +3</italic> (2.4±0.1) in response to 80 AP stimulation (40 Hz, 2 s). Data represent mean ± SEM. N=4 independent experiments from n<sub>shCTR</sub> = 12 videos; n<sub>shmDia1</sub>=15 videos and n<sub>shmDia1+3</sub> = 18 videos. (<bold>M</bold>) Minima of background-corrected vGAT-CypHer fluorescence traces (surface normalized) for neurons transduced with <italic>shCTR</italic> or <italic>shmDia1 +3</italic> (1.0±0.2) in response to 200 AP stimulation (40 Hz, 5 s). Data represent mean ± SEM. Values for shCTR were set to 1. N=11 independent experiments from n<sub>shCTR</sub> = 45 videos and n<sub>shmDia1+3</sub> = 42 videos. (<bold>N</bold>) Schematic representation of the regulation of mDia1. Binding of RhoA-GTP to the Rhotekin-Rho binding domain (RBD) (green) or application of mDia1 activator (IMM) competes with the intramolecular interaction of the N-terminal Diaphanous inhibitory domain (DID) (yellow) with the C-terminal Diaphanous autoinhibitory domain (DAD) (red) domain (see <xref ref-type="fig" rid="fig3">Figure 3A</xref> for domain structure). The release of autoinhibition leads to the dimerization of mDia formins in solution. (<bold>O</bold>) Maxima of background-corrected vGLUT1-pHluorin fluorescence traces (surface normalized) for neurons treated with 0.1% DMSO (1.7±0.1) or mDia activator (IMM; 1.6±0.1) in response to 80 AP stimulation (40 Hz, 2 s). Data represent mean ± SEM. N=3 independent experiments from n<sub>DMSO</sub> = 18 videos; n<sub>IMM</sub> = 16 videos.</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Numerical source data of <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>, B, C, D, E, F, G, I, J, K, L, M, O.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig1-figsupp1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata2"><label>Figure 1—figure supplement 1—source data 2.</label><caption><title>Original scan for the anti-mDia1 immunoblot from <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1H</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig1-figsupp1-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata3"><label>Figure 1—figure supplement 1—source data 3.</label><caption><title>Original scan for the anti-mDia3 immunoblot from <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1H</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig1-figsupp1-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata4"><label>Figure 1—figure supplement 1—source data 4.</label><caption><title>Original scan for the anti-tubulin immunoblot from <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1H</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig1-figsupp1-data4-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata5"><label>Figure 1—figure supplement 1—source data 5.</label><caption><title>Original scans for immunoblots from <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1H</xref> with highlighted bands and sample labels.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig1-figsupp1-data5-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92755-fig1-figsupp1-v1.tif"/></fig></fig-group><p>Previous studies have suggested that formins, in particular mDia1, promote SV endocytosis (<xref ref-type="bibr" rid="bib78">Soykan et al., 2017</xref>), likely by inducing F-actin assembly (<xref ref-type="bibr" rid="bib27">Ganguly et al., 2015</xref>). We confirmed that shRNA-mediated depletion of <italic>Diaph1</italic>, encoding mDia1 (shmDia1), from hippocampal neurons led to significantly delayed Syph-pHluorin endocytosis and re-acidification in response to stimulation with 200 APs. Re-expression of shRNA-resistant wild-type mDia1 fully restored normal endocytosis kinetics (<xref ref-type="fig" rid="fig1">Figure 1E and F</xref>). Impaired SV endocytosis in lentivirus-mediated mDia1-depleted neurons (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1H</xref>) was also observed, if SV exo-/endocytosis was triggered by stimulation with 40 APs or 80 APs and probed with vesicular glutamate transporter 1 (vGLUT1)-pHluorin (<xref ref-type="fig" rid="fig1">Figure 1G and H</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1I and K</xref>). Exocytic fusion of vGLUT1-pHluorin-containing SVs was unaffected (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1G</xref>). Co-depletion of the closely related mDia3 isoform tended to further aggravate this phenotype (<xref ref-type="fig" rid="fig1">Figure 1G and H</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1I and K</xref>) without impacting the apparent number of fused SVs (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1J and L</xref>) or vGAT exocytosis (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1M</xref>). Furthermore, mDia1/3 depletion significantly delayed the endocytic retrieval of endogenous vGAT (<xref ref-type="fig" rid="fig1">Figure 1I and J</xref>). Conversely, the application of IMM-01, a small molecule activator of mDia-related formins that acts by relieving autoinhibition (<xref ref-type="bibr" rid="bib45">Lash et al., 2013</xref>; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1N</xref>), led to a moderate but significant acceleration of SV endocytosis monitored by vGLUT1-pHluorin (<xref ref-type="fig" rid="fig1">Figure 1K and L</xref>) but no change in apparent SV fusion (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1O</xref>). Ultrastructural analysis of hippocampal synapses from mDia1/3-depleted neurons by electron microscopy revealed a reduction in SV density compared to controls (<xref ref-type="fig" rid="fig2">Figure 2A and B</xref>). This phenotype was rescued upon prior silencing of endogenous neuronal network activity in the presence of tetrodotoxin (TTX) (<xref ref-type="fig" rid="fig2">Figure 2C</xref> and <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A and B</xref>). A similar, slightly more pronounced depletion of SVs was observed in hippocampal synapses from <italic>Diaph1</italic> knockout (mDia1KO) mice (<xref ref-type="bibr" rid="bib59">Peng et al., 2007</xref>; <xref ref-type="bibr" rid="bib58">Peng et al., 2003</xref>; <xref ref-type="bibr" rid="bib75">Shinohara et al., 2012</xref>; <xref ref-type="fig" rid="fig2">Figure 2D and E</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Loss of mDia1/3 causes an activity-dependent reduction of the synaptic vesicle (SV) pool.</title><p>(<bold>A</bold>) Representative synaptic electron micrographs from hippocampal neurons transduced with lentiviruses encoding <italic>shCTR</italic> or <italic>shmDia1 +3</italic>, targeting <italic>Diaph1/2</italic> genes. Postsynapse and postsynaptic cleft are colored in green and maroon, respectively. Scale bar, 250 nm. (<bold>B</bold>) Average number of SVs per μm<sup>2</sup> in boutons from <italic>shCTR</italic> (92.2±2.5) and <italic>shmDia1 +3</italic> (81.4±2.9; p&lt;0.0001, Mann-Whitney test) treated neurons. Data shown represent mean ± SEM. N=3 independent experiments from n<sub>shCTR</sub> = 326 synapses, n<sub>shmDia1+3</sub> = 321 synapses. (<bold>C</bold>) Average number of SVs per μm<sup>2</sup> in synaptic boutons from hippocampal neurons transduced with lentiviruses encoding <italic>shmDia1 +3</italic> and treated with 0.1% Vehicle (10 µM NaOAc; 83.2±2.9) or 1 µM Tetrodotoxin (TTX; 93.8±3.1; p&lt;0.01, Mann-Whitney test) for 36 hr before chemical fixation. Data shown represent mean ± SEM from two independent experiments and n<sub>Vehicle</sub> = 225 synapses, n<sub>TTX</sub> = 221 synapses. Representative synaptic electron micrographs are shown in <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>. The dotted line represents the average SV numbers/μm<sup>2</sup> in <italic>shCTR</italic> boutons treated with dimethyl sulfoxide (DMSO) from the same experiments as a reference (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>), (<bold>B</bold>). (<bold>D</bold>) Representative electron micrographs of synapses in hippocampal neurons from wild-type (WT) or <italic>Diaph1</italic> (encoding mDia1) knockout (KO) mice. Postsynapse and postsynaptic cleft are colored in green and maroon, respectively. Scale bar, 250 nm. (<bold>E</bold>) Average number of SVs per μm<sup>2</sup> in WT (117.6±5.3) and <italic>mDia1</italic> KO (84.6±5.2; p&lt;0.0001, Mann-Whitney test) boutons. Data shown represent the mean ± SEM from n<sub>WT</sub> = 103, n<sub>mDia1KO</sub> = 96 synapses (N=1).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig2">Figure 2C, D and G</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig2-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92755-fig2-v1.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Synaptic vesicle (SV) depletion in mDia1/3-depleted neurons is activity-dependent.</title><p>(<bold>A</bold>) Representative synaptic electron micrographs from neurons transduced with <italic>shCTR</italic> or <italic>shmDia1 +3</italic> and treated with 0.1% Vehicle or 1 µM TTX for 36 hr before fixation. Postsynapse and postsynaptic cleft are colored in green and maroon, respectively. Scale bar, 250 nm. (<bold>B</bold>) Average number of SV per μm<sup>2</sup> in synaptic boutons of neurons transduced with <italic>shCTR</italic> and treated with 0.1% Vehicle (A; 90.7±3.1) or 1 µM TTX (B; 98.4±3.3) for 36 hr before chemical fixation. Data shown represent the mean ± SEM from two independent experiments and n<sub>Vehicle</sub> = 180, n<sub>TTX</sub> = 204 synapses.</p><p><supplementary-material id="fig2s1sdata1"><label>Figure 2—figure supplement 1—source data 1.</label><caption><title>Numerical source data of <xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig2-figsupp1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92755-fig2-figsupp1-v1.tif"/></fig></fig-group><p>These data are consistent with a role for actin dynamics (see <xref ref-type="fig" rid="fig1">Figure 1</xref>) and actin nucleating mDia1/3 proteins in presynaptic endocytosis and SV recycling.</p></sec><sec id="s2-2"><title>mDia facilitates SV endocytosis by regulating presynaptic F-actin</title><p>mDia1 in addition to its Rho binding domain and a C-terminal actin-assembling formin homology 2 (FH2) domain comprises an unstructured N-terminal region involved in membrane binding (<xref ref-type="bibr" rid="bib22">Eisenmann et al., 2005</xref>; <xref ref-type="bibr" rid="bib63">Ramalingam et al., 2010</xref>; <xref ref-type="fig" rid="fig3">Figure 3A</xref>). This architecture suggests that mDia specifically promotes the nucleation of unbranched actin filaments at membranes, for example, to promote endocytosis at the presynaptic plasma membrane. To test this hypothesis, we assayed the ability of mutant mDia1 lacking its N-terminal membrane-binding region (mDia1-ΔN) (<xref ref-type="bibr" rid="bib63">Ramalingam et al., 2010</xref>) to rescue defective SV endocytosis in hippocampal neurons depleted of endogenous mDia1. Mutant mDia1-ΔN displayed reduced association with membranes in transfected HEK293T cells (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A and B</xref>) and was unable to restore normal kinetics of Syph-pHluorin endocytosis in hippocampal neurons transfected with <italic>Diaph1</italic>-specific microRNA (shmDia1miR; <xref ref-type="fig" rid="fig3">Figure 3B</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>). Hence, mDia may act on SV endocytosis by specifically promoting actin assembly at presynaptic membranes. We probed this model at several levels. We analyzed the nanoscale localization and distribution of mDia1 via multicolor time-gated stimulated emission depletion (gSTED) microscopy. Hippocampal neurons were stained for mDia1, the presynaptic active zone marker Bassoon, and post-synaptic Homer1. The distributions of all three proteins along line profiles perpendicular to the synaptic cleft (i.e. the space between Bassoon and Homer1 clusters) were analyzed (<xref ref-type="bibr" rid="bib28">Gerth et al., 2017</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1H</xref>). This analysis revealed that endogenous mDia1 is primarily localized to the presynaptic compartment, where it is concentrated at or very close to the plasma membrane (<xref ref-type="fig" rid="fig3">Figure 3C and D</xref>), i.e., &lt;50 nm away from the presynaptic membrane see <xref ref-type="bibr" rid="bib17">Dani et al., 2010</xref>. Prompted by these results we dissected the interactome of mDia1 by unbiased quantitative proteomic analyses of immunoprecipiates from detergent-extracted mouse synaptosomes (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>). In addition to actin, we identified a variety of additional actin-regulatory proteins including Myosin IIB (<xref ref-type="bibr" rid="bib11">Chandrasekar et al., 2013</xref>) and the small GTPase Rac1 (<xref ref-type="fig" rid="fig3">Figure 3E</xref>). We confirmed the association of mDia1 with actin and Myosin IIB (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>) and found Myosin IIB to be concentrated at or near the presynaptic plasma membrane (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1F and G</xref>) akin to the localization of mDia1. The association of mDia1 with Myosin IIB is consistent with the inhibitory effects of the Myosin II inhibitor blebbistatin on SV endocytosis (<xref ref-type="bibr" rid="bib11">Chandrasekar et al., 2013</xref>; <xref ref-type="bibr" rid="bib78">Soykan et al., 2017</xref>). Interestingly, we also observed an enrichment of several endocytic proteins previously implicated in SV recycling in mDia1 immunoprecipitates. These include the lipid phosphatase Synaptojanin1, the bin-amphiphysin-rvs (BAR) domain proteins Amphiphysin, Endophilin A1, and PACSIN1/2 and, the GTPase Dynamin1 (<xref ref-type="bibr" rid="bib10">Chanaday et al., 2019</xref>; <xref ref-type="bibr" rid="bib26">Gan and Watanabe, 2018</xref>; <xref ref-type="bibr" rid="bib70">Saheki and De Camilli, 2012</xref>; <xref ref-type="bibr" rid="bib77">Soykan et al., 2016</xref>; <xref ref-type="fig" rid="fig3">Figure 3E</xref>) as confirmed by immunoblotting (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). Based on the association of mDia1 with endocytic proteins including Dynamin1, we hypothesized that mDia1 might get stalled at endocytic intermediates that accumulate under conditions of perturbed Dynamin function (<xref ref-type="bibr" rid="bib25">Ferguson et al., 2009</xref>; <xref ref-type="bibr" rid="bib62">Raimondi et al., 2011</xref>). Application of the partially non-selective Dynamin inhibitor Dynasore (<xref ref-type="bibr" rid="bib48">Macia et al., 2006</xref>; <xref ref-type="fig" rid="fig3">Figure 3C and H</xref>) or expression of dominant-negative mutant Dynamin1 K44A (<xref ref-type="fig" rid="fig3">Figure 3G1</xref>) led to a significant accumulation of mDia1 at presynaptic sites marked by Bassoon. mDia1 levels at the postsynapse were also increased (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1I</xref>). Dynasore did not impact the levels (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1J</xref>) or distribution of Bassoon or Homer1.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>mDia1 associates with endocytic proteins and localizes to presynaptic sites.</title><p>(<bold>A</bold>) Schematic representation of functional domains of mDia1. Rho-binding domain (RBD), Diaphanous inhibitory domain (DID), Dimerization domain (DD), Coiled coil domain (CC), Formin homology domain 1 (FH1), Formin homology domain 2 (FH2), Diaphanous autoinhibitory domain (DAD). The unstructured N-terminus (first 60 amino acids) contains three basic stretches and was truncated in the ΔN mutant. (<bold>B</bold>) Endocytic decay constants of Synaptophysin-pHluorin traces (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>) from hippocampal neurons transfected with shRNAmiR against no mammalian target (<italic>shCTRmiR</italic>) or <italic>Diaph1</italic> (<italic>shmDia1miR</italic>) in response to 200 action potential (AP) (40 Hz, 5 s) stimulation. For rescue experiments, neurons were co-transfected with plasmids encoding mDia1-WT-mCherry (τ<sub>shmDia1miR + mDia1-WT</sub>=20.0±0.8 s), mDia1-ΔN-mCherry (τ<sub>shmDia1miR + mDia1-ΔN</sub>=34.5±2.9 s), or mCherry alone (τ<sub>shCTRmiR</sub> = 21.8±1.1 s, τ<sub>shmDia1miR</sub> = 30.4±1.9 s) to exclude artifacts from overexpression (p<sub>shCTRmiR vs shmDia1miR</sub> &lt; 0.05; p<sub>shmDia1miR vs shmDia1miR + mDia1-WT</sub>&lt;0.01; p<sub>shmDia1miR + mDia1-WT vs shmDia1miR + mDia1-ΔN</sub>&lt;0.01, one-way ANOVA with Tukey’s post-test). Data shown represent mean ± SEM. N=5 independent experiments from n<sub>shCTRmiR</sub> = 41 videos, n<sub>shmDia1miR</sub> = 51 videos, n<sub>shmDia1miR + mDia1-WT</sub>=35 videos, n<sub>shmDia1miR + mDia1-ΔN</sub>=37 videos. (<bold>C</bold>) Representative three-channel time-gated stimulated emission depletion (STED) images of synapses from hippocampal cultures treated with 0.1% dimethyl sulfoxide (DMSO) or 80 μM Dynasore for 10 min before fixation and immunostained for Bassoon (presynaptic marker, magenta), mDia1 (cyan) and Homer1 (postsynaptic marker, green). Scale bar, 250 nm. (<bold>D</bold>) Averaged normalized line profiles for synaptic distribution of mDia1 and Homer1 relative to Bassoon (Maximum set to 0 nm). Data represent mean ± SEM. N=3 independent experiments from n=235 synapses. (<bold>E</bold>) Volcano plot of proteins associating with synaptic mDia1 analyzed by label-free proteomics of anti-mDia1 versus control (CTR) immunoprecipitates from detergent-extracted mouse synaptosomes (P2’ fraction). The logarithmic ratios of protein intensities are plotted against negative logarithmic p-values derived from a two-tailed student’s t-test. N=3 independent experiments. Each dot represents one protein. Selected cytoskeletal hits include: Actin, Myosin IIB (MyoIIB), and Rac1. Selected endocytic hits include Amphiphysin (p&lt;0.05), Dynamin1, Endophilin-A1, PACSIN1, PACSIN2 (p&lt;0.05), and Synaptojanin1. (<bold>F</bold>) Endogenous immunoprecipitation of mDia1 from detergent-extracted mouse synaptosomes (P2’ fraction) using mDia1-specific antibodies. Immunoprecipitates were analyzed by immunoblotting for mDia1, Dynamin1, and β-Actin. (<bold>G</bold>) Representative three-channel time-gated STED images of synapses from hippocampal cultures transduced with wild-type Dynamin1 (WT) or GTPase-deficient Dynamin1 (K44A) in response to 200 AP (40 Hz, 5 s) stimulation. Cells were immunostained for Bassoon (magenta), mDia1 (cyan), and Homer1 (green). Scale bar, 250 nm. (<bold>H</bold>) Presynaptic mDia1 levels in synapses treated with 0.1% DMSO (100±7.3) or 80 µM Dynasore (145.8±9.3; p=0.0001; one sample Wilcoxon test) for 10 min in response to 200 AP (40 Hz, 5 s) stimulation. Absolute line profiles of mDia1 overlapping with Bassoon (presynapse) distribution were integrated. Data shown are normalized to DMSO (set to 100) and expressed as mean ± SEM. N=3 independent experiments from n<sub>DMSO</sub> = 92 synapses, n<sub>Dynasore</sub> = 135 synapses. (<bold>I</bold>) Presynaptic mDia1 levels in synapses from hippocampal neurons transduced with wild-type Dynamin1 (WT; 100±6.2) or GTPase-deficient Dynamin1 (K44A; 142.9±8.3, p&lt;0.0001, one sample Wilcoxon test) in response to 200 AP (40 Hz, 5 s) stimulation. Line profiles of mDia1 overlapping with Bassoon distribution were integrated. Data shown are normalized to Dynamin1-WT (set to 100) and expressed as mean ± SEM. N=2 independent experiments from n<sub>WT</sub> = 43 synapses, n<sub>K44A</sub> = 51 synapses.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig3">Figure 3B, D, E, H and K</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig3-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata2"><label>Figure 3—source data 2.</label><caption><title>Original scan for the anti-mDia1 and anti-Dynamin1 immunoblots from <xref ref-type="fig" rid="fig3"><ext-link ext-link-type="uri" xlink:href="https://elifesciences.org/articles/75047#fig1">Figure 3F</ext-link></xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig3-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata3"><label>Figure 3—source data 3.</label><caption><title>Original scan for the anti-Actin immunoblot from <xref ref-type="fig" rid="fig3"><ext-link ext-link-type="uri" xlink:href="https://elifesciences.org/articles/75047#fig1">Figure 3F</ext-link></xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig3-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3sdata4"><label>Figure 3—source data 4.</label><caption><title>Original scans for immunoblots from <xref ref-type="fig" rid="fig3">Figure 3F</xref> with highlighted bands and sample labels.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig3-data4-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92755-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>mDia1 binds membranes and localizes to presynaptic endocytic sites.</title><p>(<bold>A</bold>) Membrane levels of mDia1-WT-mCherry versus mDia1-ΔN-mCherry proteins overexpressed in HEK293T cells. Membrane and cytosolic cellular fractions were isolated by ultracentrifugation and analyzed by immunoblotting with specific antibodies (LAMP1) and in-gel fluorescence of mCherry tags. (<bold>B</bold>) Densitometric quantification of mDia1-WT versus mDia1-ΔN (0.6±0.1; p&lt;0.05, one sample t-test) membrane-associated protein levels. Data shown are normalized to mDia1-WT (set to 1) and expressed as mean ± SEM. Representative immunoblot is shown in A. N=5 independent experiments. (<bold>C</bold>) Averaged normalized Synaptophysin-pHluorin fluorescence from stimulated (200 action potentials (APs), 40 Hz, 5 s) hippocampal neurons transfected with <italic>shCTRmiR</italic> or <italic>shmDia1miR</italic>. For rescue experiments, neurons were co-transfected with plasmids encoding mDia1-WT-mCherry, mDia1-ΔN-mCherry or mCherry alone (shCTRmiR &amp; shmDia1miR). Endocytic decay constants are shown in <xref ref-type="fig" rid="fig3">Figure 3B</xref>. (<bold>D</bold>) Full volcano plot of proteins from <xref ref-type="fig" rid="fig3">Figure 3E</xref> associating with synaptic mDia1 analyzed by label-free proteomics of anti-mDia1 versus control (CTR) immunoprecipitates from detergent-extracted mouse synaptosomes (P2’ fraction). The cyan dot shows the specific enrichment of mDia1 as the bait protein of the immunoprecipitation (p&lt;0.001, two-tailed student’s t-test). N=3 independent experiments. (<bold>E</bold>) Endogenous co-immunoprecipitation of Myosin IIB by mDia1 from detergent-extracted mouse synaptosomes (P2’ fraction). Samples were analyzed by immunoblotting using specific antibodies against mDia1, Myosin IIB (MyoIIB), and β-Actin. (<bold>F</bold>) Representative three-channel time-gated STED image of a synapse from hippocampal cultures fixed and immunostained for Bassoon (presynaptic marker, magenta), Myosin IIB (cyan), and Homer1 (postsynaptic marker, green). Scale bar, 250 nm. (<bold>G</bold>) Averaged normalized line profiles for synaptic distribution of Myosin IIB and Homer1 relative to Bassoon (Maximum set to 0 nm). Data are expressed as mean ± SEM. N=3 independent experiments from n=267 synapses. (<bold>H</bold>) Rationale for quantification of presynaptic protein levels of interest. The presynapse was defined by the normalized Bassoon distribution (purple fraction, cut off at the cross-section with the Homer1 profile), and corresponding absolute individual synaptic line profiles were integrated. (<bold>I</bold>) Postsynaptic F-Actin levels in synapses treated with 0.1% dimethyl sulfoxide (DMSO) (42.6±3.4) or 80 µM Dynasore (56.5±3.3; p&lt;0.001, Mann-Whitney test) for 10 min before fixation from <xref ref-type="fig" rid="fig3">Figure 3C and H</xref>. Data shown are normalized to presynaptic DMSO values from <xref ref-type="fig" rid="fig3">Figure 3H</xref> (set to 100) and expressed as mean ± SEM. N=3 independent experiments from n<sub>DMSO</sub> = 92 synapses, n<sub>Dynasore</sub> = 135 synapses. (<bold>J</bold>) Quantification of Bassoon and Homer1 levels in synapses treated with 0.1% DMSO (100.0±4.5 for Bassoon; 100.0±4.3 for Homer1) or 80 µM Dynasore (103.7±4.1 for Bassoon; 98.6±5.3) for 10 min before fixation. Data shown are normalized to DMSO values (set to 100) and expressed as mean ± SEM. N=3 independent experiments from n<sub>DMSO</sub> = 132 synapses, n<sub>Dynasore</sub> = 128 synapses.</p><p><supplementary-material id="fig3s1sdata1"><label>Figure 3—figure supplement 1—source data 1.</label><caption><title>Original scan for in-gel mCherry fluorescence from <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig3-figsupp1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata2"><label>Figure 3—figure supplement 1—source data 2.</label><caption><title>Original scan for the anti-LAMP1 immunoblot from <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig3-figsupp1-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata3"><label>Figure 3—figure supplement 1—source data 3.</label><caption><title>Original scans from <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref> with highlighted bands and sample labels.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig3-figsupp1-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata4"><label>Figure 3—figure supplement 1—source data 4.</label><caption><title>Numerical source data of <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>, C, D, G, I, J.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig3-figsupp1-data4-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata5"><label>Figure 3—figure supplement 1—source data 5.</label><caption><title>Original scans for mCherry fluorescence in gels used for analysis are shown in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig3-figsupp1-data5-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata6"><label>Figure 3—figure supplement 1—source data 6.</label><caption><title>Original scans for mCherry fluorescence in gels used for analysis are shown in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref> with highlighted bands and sample labels.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig3-figsupp1-data6-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata7"><label>Figure 3—figure supplement 1—source data 7.</label><caption><title>Original scan for the anti-mDia1 immunoblot from <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig3-figsupp1-data7-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata8"><label>Figure 3—figure supplement 1—source data 8.</label><caption><title>Original scan for the anti-Myosin IIB immunoblot from <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig3-figsupp1-data8-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata9"><label>Figure 3—figure supplement 1—source data 9.</label><caption><title>Original scan for the anti-Actin immunoblot from <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig3-figsupp1-data9-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig3s1sdata10"><label>Figure 3—figure supplement 1—source data 10.</label><caption><title>Original scans for immunoblots in <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref> with highlighted bands and sample labels.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig3-figsupp1-data10-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92755-fig3-figsupp1-v1.tif"/></fig></fig-group><p>Based on these results we next investigated the relationship between mDia1/3 and presynaptic actin. Multicolor gSTED imaging confirmed that F-actin labeled by phalloidin was highly abundant at the postsynaptic compartment. In addition, F-actin was also visible, albeit at reduced levels, in presynaptic boutons marked by Bassoon (<xref ref-type="fig" rid="fig4">Figure 4A and B</xref>). Inhibition of Dynamin in the presence of Dynasore (<xref ref-type="fig" rid="fig4">Figure 4C</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>) or expression of Dynamin1 K44A (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B and C</xref>) significantly elevated presynaptic F-actin levels within the Bassoon area. These data are consistent with a role of presynaptic actin in SV endocytosis. We directly tested the role of mDia in presynaptic actin nucleation and actin-dependent SV endocytosis in several ways. First, we generated a mutant version of mDia1 that lacks the ability to nucleate F-actin due to site-specific inactivation of its FH2 domain (<xref ref-type="bibr" rid="bib18">Daou et al., 2014</xref>; <xref ref-type="bibr" rid="bib33">Higashi et al., 2008</xref>; <xref ref-type="bibr" rid="bib87">Xu et al., 2004</xref>). We found that actin polymerization-defective mutant mDia1 (K994A) failed to restore delayed vGLUT1-pHluorin endocytosis in mDia1-depleted hippocampal neurons (<xref ref-type="fig" rid="fig4">Figure 4D</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1D</xref>). Second, we analyzed the effects of depleting hippocampal neurons of mDia1/3 on presynaptic F-actin. We found that loss of mDia1/3 significantly reduced the amount of detectable F-actin within the Bassoon area (<xref ref-type="fig" rid="fig4">Figure 4A and E</xref>). To unequivocally distinguish between presynaptic actin at exo-/ endocytic sites and the abundant pool of postsynaptic actin associated with the postsynaptic density, we used the ORANGE strategy for CRISPR-based genome-engineering (<xref ref-type="bibr" rid="bib83">Willems et al., 2020</xref>) to generate eGFP-<italic>Actb</italic>−knock-in (eGFP-β-actin KI) hippocampal neurons. Due to the low knock-in efficiency, this strategy allowed us to visualize endogenously tagged eGFP-β-actin by 2-color gSTED imaging exclusively in presynaptic boutons marked by vGLUT1. This assay confirmed the significant reduction in endogenous β-actin at presynapses from mDia1/3-depleted neurons (<xref ref-type="fig" rid="fig4">Figure 4F and G</xref>). Third, we reasoned that if loss of presynaptic actin in mDia-depleted neurons was causal for the observed defect in SV endocytosis, pharmacological stabilization of F-actin might rescue the endocytic phenotype. Treatment of mDia1/3-depleted neurons with jasplakinolide indeed fully restored the kinetics of SV endocytosis monitored by vGLUT1-pHluorin (<xref ref-type="fig" rid="fig4">Figure 4H</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1H</xref>) and rescued presynaptic F-actin levels to that of controls (actin levels normalized to shCTR + DMSO, set to 100: shCTR + DMSO = 100 ± 6.3; shmDia1+3 + DMSO=47.7 ± 4.3; shCTR + Jasp = 150.6 ± 11.9; shmDia1+3 + Jasp=94.3 ± 11.5) (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1G</xref>).</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>mDia facilitates synaptic vesicle (SV) endocytosis by regulating presynaptic F-actin.</title><p>(<bold>A</bold>) Representative three-channel time-gated stimulated emission depletion (STED) images of synapses from hippocampal cultures transduced with <italic>shCTR</italic> or <italic>shmDia1 +3</italic>, targeting <italic>Diaph1/2</italic> genes, fixed and immunostained for Bassoon (presynaptic marker, magenta), F-Actin (cyan) and Homer1 (postsynaptic marker, green). Scale bar, 250 nm. (<bold>B</bold>) Averaged normalized line profiles for synaptic distribution of F-Actin and Homer1 relative to Bassoon (Maximum set to 0 nm). Data are expressed as mean ± SEM. N=4 independent experiments from n=154 synapses. (<bold>C</bold>) Presynaptic F-Actin levels in synapses treated with 0.1% dimethyl sulfoxide (DMSO) (100±4.8) or 80 µM Dynasore (134.7±6.8; p=0.001, one sample Wilcoxon test) for 10 min before fixation (Representative images in <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). Cells were immunostained for Bassoon (magenta), F-Actin (cyan), and Homer1 (green). Absolute line profiles of F-Actin overlapping with Bassoon (presynapse) distribution were integrated. Data shown are normalized to DMSO (set to 100) and expressed as mean ± SEM. N=3 independent experiments from n<sub>DMSO</sub> = 207 synapses, n<sub>Dynasore</sub> = 211 synapses. (<bold>D</bold>) Endocytic decay constants of vesicular glutamate transporter 1 (vGLUT1)-pHluorin traces from hippocampal neurons transduced with lentiviral particles encoding <italic>shCTR</italic> (τ<sub>shCTR</sub> = 20.7 ± 0.9 s) or <italic>shmDia1</italic> (τ<sub>shmDia1</sub> = 26.4±2.0 s) in response to 200 action potential (AP) (40 Hz, 5 s) stimulation. For rescue experiments, neurons were co-transduced with lentiviruses encoding mDia1-WT-SNAP (τ<sub>shmDia1 + mDia1-WT</sub>=16.1±1.9 s) or mDia1-K994A-SNAP (τ<sub>shmDia1 + mDia1-K994A</sub>=29.0±1.9 s) (p<sub>shmDia1 vs shmDia1 + mDia1-WT</sub>&lt;0.01; p<sub>shmDia1 + mDia1-WT vs shmDia1 + mDia1-K994A</sub>&lt;0.001, one-way ANOVA with Tukey’s post-test). Data are expressed as mean ± SEM. N=6 independent experiments from n<sub>shCTR</sub> = 21 videos; n<sub>shmDia1</sub>=21 videos, n<sub>shmDia1 + mDia1-WT</sub>=16 videos, n<sub>shmDia1 + mDia1-K994A</sub>=19 videos. (<bold>E</bold>) Presynaptic F-Actin levels in synapses from hippocampal cultures transduced with <italic>shCTR</italic> (100±6.4) or <italic>shmDia1 +3</italic> (58.1±2.9; p&lt;0.001, one sample Wilcoxon test). Line profiles of F-Actin overlapping with Bassoon (presynapse) distribution were integrated. Data shown are normalized to shCTR (set to 100) and expressed as mean ± SEM. N=4 independent experiments from n<sub>shCTR</sub> = 155 synapses, n<sub>shmDia1+3</sub> = 158 synapses. (<bold>F</bold>) Representative confocal and two-channel time-gated STED images of endogenous β-Actin (cyan) in vGLUT1 (magenta) positive boutons from hippocampal neurons transduced with lentiviruses encoding <italic>shCTR</italic> or <italic>shmDia1 +3</italic>. Scale bar, 250 nm. (<bold>G</bold>) Analysis of presynaptic endogenous β-Actin levels in vGLUT1 positive boutons from <italic>shCTR</italic> (100±6.3) and <italic>shmDia1 +3</italic> (47.7±4.3; p&lt;0.0001 one-sample Wilcoxon test) transduced neurons. β-Actin STED mean intensity was measured using a confocal vGLUT1 signal as a mask. Data shown are normalized to shCTR (set to 100) and expressed as mean ± SEM from two independent experiments and n<sub>shCTR</sub> = 67 synapses, n<sub>shmDia1+3</sub> = 53 synapses. (<bold>H</bold>) Endocytic decay constants of vGLUT1-pHluorin traces (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1H</xref>) for neurons transduced with <italic>shCTR</italic> or <italic>shmDia1 +3</italic> in response to 40 AP (20 Hz, 2 s) stimulation. Neurons were pre-incubated with 0.1% DMSO or 1 µM Jasplakinolide (Jasp) for 30 min in the media before imaging (τ<sub>shCTR + DMSO</sub> = 13.4±1.0 s, τ<sub>shCTR + Jasp</sub> = 15.0±2.2 s, τ<sub>shmDia1+3 + DMSO</sub>=25.0±2.7 s, τ<sub>shmDia1+3 + Jasp</sub>=15.6±2.4 s; p<sub>shCTR vs shmDia1+3</sub> &lt; 0.01; p<sub>shmDia1+3 + DMSO vs shmDia1+3 + Jasp</sub>&lt;0.05, one-way ANOVA with Tukey’s post-test). Data are expressed as mean ± SEM. N=6 independent experiments from n<sub>shCTR + DMSO</sub> = 32 videos, n<sub>shmDia1+3 + DMSO</sub>=35 videos, n<sub>shCTR + Jasp</sub> = 33 videos; n<sub>shmDia1+3 + Jasp</sub>=34 videos.</p><p><supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig4">Figure 4B, C, D, E, G and H</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig4-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92755-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>mDia1 regulates presynaptic actin and synaptic vesicle (SV) endocytosis.</title><p>(<bold>A</bold>) Representative three-channel time-gated stimulated emission depletion (STED) images of synapses from hippocampal cultures treated with 0.1% dimethyl sulfoxide (DMSO) or 80 µM Dynasore for 10 min. Cells were fixed and stained for Bassoon (magenta), F-Actin (cyan), and Homer1 (green). Scale bar, 250 nm. Corresponding analysis of presynaptic F-Actin levels is shown in <xref ref-type="fig" rid="fig4">Figure 4C</xref>. (<bold>B</bold>) Representative three-channel time-gated STED images of synapses from hippocampal cultures transduced with Dynamin1-WT or Dynamin1-K44A. Cells were fixed and stained for Bassoon (magenta), F-Actin (cyan), and Homer1 (green). Scale bar, 250 nm. (<bold>C</bold>) Presynaptic F-Actin levels in synapses from neurons transduced with Dynamin1-WT (100±5.9) or Dynamin1-K44A (119.8±6.2, p&lt;0.01, one sample t-test) in B. Absolute line profiles of F-Actin overlapping with Bassoon (presynapse) distribution were integrated. Data shown are normalized to WT (set to 100) and expressed as mean ± SEM. n<sub>WT</sub> = 54 synapses, n<sub>K44A</sub> = 49 synapses. (<bold>D</bold>) Averaged normalized vesicular glutamate transporter 1 (vGLUT1)-pHluorin fluorescence traces for neurons transduced with <italic>shCTR</italic> or <italic>shmDia1</italic> in response to 200 action potential (AP) (40 Hz, 5 s) stimulation. For rescue purposes, cells were co-transduced with mDia1-WT-SNAP or mDia1-K994A-SNAP. Data are expressed as mean ± SEM. N=6 independent experiments from n<sub>shCTR</sub> = 21 videos; n<sub>shmDia1</sub>=21 videos; n<sub>shmDia1 + mDia1-WT</sub>=16 videos; n<sub>shmDia1 + mDia1-K994A</sub>=19 videos. Corresponding endocytic decay constants are shown in <xref ref-type="fig" rid="fig4">Figure 4D</xref>. (<bold>E</bold>) Postsynaptic F-Actin levels in synapses transduced with <italic>shCTR</italic> (100.0±6.4) or <italic>shmDia1 +3</italic> (89.3±6.4) from <xref ref-type="fig" rid="fig4">Figure 4A and E</xref>. Data shown are normalized to <italic>shCTR</italic> values (set to 100) and expressed as mean ± SEM. N=3 independent experiments from n<sub>shCTR</sub> = 206 synapses, n<sub>shmDia1+3</sub> = 135 synapses. (<bold>F</bold>) Quantification of Bassoon and Homer1 levels in synapses transduced with <italic>shCTR</italic> (100.0±4.7 for Bassoon; 100.0±4.5 for Homer1) or <italic>shmDia1 +3</italic> (101.4±4.8 for Bassoon; 92.4±4.0). Data shown are normalized to DMSO values (set to 100) and expressed as mean ± SEM. N=3 independent experiments from n<sub>shCTR</sub> = 158 synapses and n<sub>shmDia1+3</sub> = 159 synapses. (<bold>G</bold>) Representative STED images of endogenous β-Actin in vGLUT1 positive synapses in hippocampal neurons transduced with <italic>shCTR</italic> or <italic>shmDia1 +3</italic> and treated with 0.1% DMSO or 1 µM Jasplakinolide for 45 min. Neurons were co-transfected with pOrange-GFP-β-Actin knock-in and vGLUT1-mCherry plasmids before fixation and immunostaining. Scale bar, 2.5 µm. (<bold>H</bold>) Averaged normalized vGLUT1-pHluorin fluorescence traces for neurons transduced with <italic>shCTR</italic> or <italic>shmDia1 +3</italic> in response to 40 AP (20 Hz, 2 s) stimulation. Neurons were pre-incubated with 0.1% DMSO or 1 µM Jasplakinolide (Jasp) for 30 min in the cell media before imaging. Data are expressed as mean ± SEM. N=6 independent experiments from n<sub>shCTR + DMSO</sub> = 32 videos, n<sub>shmDia1+3 + DMSO</sub>=35 videos, n<sub>shCTR + Jasp</sub> = 33 videos; n<sub>shmDia1+3 + Jasp</sub>=34 videos. The corresponding endocytic decay constants are shown in <xref ref-type="fig" rid="fig4">Figure 4I</xref>.</p><p><supplementary-material id="fig4s1sdata1"><label>Figure 4—figure supplement 1—source data 1.</label><caption><title>Numerical source data of <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1C</xref>, D, E, F, H.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig4-figsupp1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92755-fig4-figsupp1-v1.tif"/></fig></fig-group><p>We conclude that mDia1/3 facilitates SV endocytosis by regulating presynaptic F-actin.</p></sec><sec id="s2-3"><title>mDia1/3-Rho and Rac1 signaling pathways cooperatively act to facilitate presynaptic endocytosis</title><p>In non-neuronal cells, mDia proteins have been shown to be disinhibited by active Rho family GTPases, in particular RhoA (<xref ref-type="bibr" rid="bib57">Otomo et al., 2005</xref>; <xref ref-type="fig" rid="fig5">Figure 5A</xref> and <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1N</xref>). We reasoned that Rho proteins might serve a similar function at presynaptic nerve terminals in hippocampal neurons. Multicolor gSTED imaging revealed that endogenous RhoA was mostly located within the presynaptic compartment (<xref ref-type="fig" rid="fig5">Figure 5B and C</xref>). Interference with Rho function by co-expression of dominant-negative (DN) variants of RhoA and RhoB (<xref ref-type="fig" rid="fig5">Figure 5D</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>) or co-depletion of these Rho isoforms, by shRNA-mediated targeting of <italic>Rhoa</italic> and <italic>Rhob</italic> genes (shRhoA +B; <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>), delayed SV endocytosis in response to stimulation with 200 APs without impacting the apparent levels of exocytosis (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B and D</xref>). These results are consistent with a model in which active Rho promotes mDia function and, thereby F-actin nucleation.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>RhoA/B facilitates presynaptic endocytosis and are regulated by mDia1/3.</title><p>(<bold>A</bold>) Schematic representation of activation of mDia1 by RhoA-GTP and positive feedback loop of mDia1 on RhoA-GTP levels through GEF stimulation. (<bold>B</bold>) Representative three-channel time-gated STED image of synapses from hippocampal cultures, fixed and immunostained for Bassoon (magenta), RhoA (cyan), and Homer1 (green). Scale bar, 250 nm. (<bold>C</bold>) Averaged normalized line profiles for synaptic distribution of RhoA and Homer1 relative to Bassoon (Maximum set to 0 nm). Data are expressed as mean ± SEM. N=5 independent experiments from n=230 synapses. (<bold>D</bold>) Endocytic decay constants of averaged normalized Synaptophysin-pHluorin fluorescence traces (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>) in response to 200 action potential (AP) (40 Hz, 5 s) stimulation. Neurons were transfected with the annotated combinations of plasmids encoding wild-type (WT) or dominant-negative (DN, T19N mutation) RhoA and RhoB (τ<sub>RhoA-WT + RhoB-WT</sub>=18.4±0.7 s, τ<sub>RhoA-WT + RhoB-DN</sub> = 16.0±1.0 s, τ<sub>RhoA-DN + RhoB-WT</sub>=19.8±2.4 s, τ<sub>RhoA-DN + RhoB-DN</sub>=30.1±1.0 s; p<sub>RhoA-WT + RhoB-WT vs RhoA-DN + RhoB-DN</sub>&lt;0.01, one-way ANOVA with Tukey’s post-test). Data shown represent mean ± SEM. N=3 independent experiments from n<sub>RhoA-WT + RhoB-WT</sub>=21 videos, n<sub>RhoA-DN + RhoB-WT</sub>=31 videos, n<sub>RhoA-WT + RhoB-DN</sub>=23 videos, n<sub>RhoA-DN + RhoB-DN</sub>=22 videos. (<bold>E</bold>) Analysis of RhoA activity by RhoA-GTP pulldown (PD) from whole-cell lysates (input) of mouse hippocampal neurons expressing shCTR or shmDia1 +3 using immobilized Rhotekin as a bait. Samples were analyzed by immunoblotting for mDia1, mDia3, RhoA, and Tubulin using specific antibodies. Input, 10% of material used for the pulldown. The contrast of pulldown and input blots was seperately adjusted for visualization purposes. (<bold>F</bold>) Densitometric quantification of RhoA-GTP normalized to total RhoA levels (input) in lysates from neurons transduced with shCTR or shmDia1 +3 (0.7±0.0, p&lt;0.001, one sample t-test) from immunoblots exemplified in E. Values for shCTR were set to 1. Data are expressed as mean ± SEM from N=3 independent experiments.</p><p><supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig5">Figure 5C, D and F</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig5-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5sdata2"><label>Figure 5—source data 2.</label><caption><title>Original scans for the anti-mDia1, anti-Tubulin, anti-RhoA, and anti-mDia3 immunoblots from <xref ref-type="fig" rid="fig5"><ext-link ext-link-type="uri" xlink:href="https://elifesciences.org/articles/75047#fig1">Figure 5E</ext-link></xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig5-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5sdata3"><label>Figure 5—source data 3.</label><caption><title>Original scans for immunoblots from <xref ref-type="fig" rid="fig5">Figure 5E</xref> with highlighted bands and sample labels.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig5-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5sdata4"><label>Figure 5—source data 4.</label><caption><title>Original scans for the anti-RhoA immunoblots used for analysis are shown in <xref ref-type="fig" rid="fig5"><ext-link ext-link-type="uri" xlink:href="https://elifesciences.org/articles/75047#fig1">Figure 5F</ext-link></xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig5-data4-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig5sdata5"><label>Figure 5—source data 5.</label><caption><title>Original scans for immunoblots used for analysis are shown in <xref ref-type="fig" rid="fig5">Figure 5F</xref> with highlighted bands and sample labels.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig5-data5-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92755-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>RhoA/B regulates synaptic vesicle (SV) endocytosis.</title><p>(<bold>A</bold>) Averaged normalized Synaptophysin-pHluorin fluorescence traces from stimulated (200 APs; 40 Hz, 5 s) hippocampal neurons transfected with plasmids encoding the indicated combinations of wild-type (WT) or DN RhoA and RhoB variants. Data represent mean ± SEM. N=3 independent experiments from n<sub>RhoA-WT + RhoB-WT</sub>=21 videos, n<sub>RhoA-DN + RhoB-WT</sub>=31 videos, n<sub>RhoA-WT + RhoB-DN</sub>=23 videos, n<sub>RhoA-DN + RhoB-DN</sub>=22 videos. Endocytic decay constants are shown in <xref ref-type="fig" rid="fig5">Figure 5D</xref>. (<bold>B</bold>) Maxima of background-corrected Syph-pHluorin fluorescence traces (surface normalized) for neurons transfected with indicated combinations of WT or DN RhoA and RhoB variants (1.9±0.2 for RhoA-WT+RhoB WT; 1.9±0.1 for RhoA-WT+RhoB DN; 1.8±0.1 for RhoA-DN +RhoB WT; 1.7±0.1 for RhoA-DN +RhoB DN) in response to 200 AP stimulation (40 Hz, 5 s). Data represent mean ± SEM. (<bold>C</bold>) Averaged normalized Synaptophysin-pHluorin fluorescence traces from stimulated (200 APs; 40 Hz, 5 s) hippocampal neurons transfected with shRNA against no mammalian target (<italic>shCTR</italic>) or against <italic>Rhoa</italic> and <italic>Rhob</italic> genes (<italic>shRhoA +B</italic>). Data represent mean ± SEM. N=3 independent experiments from n<sub>shCTR</sub> = 27 videos, n<sub>shRhoA+B</sub> = 25 videos. (<bold>D</bold>) Maxima of background-corrected Syph-pHluorin fluorescence traces (surface normalized) for neurons transfected with <italic>shCTR</italic> (1.6±0.2) or <italic>shRhoA +B</italic> (1.6±0.1) in response to 200 AP stimulation (40 Hz, 5 s). Data represent mean ± SEM.</p><p><supplementary-material id="fig5s1sdata1"><label>Figure 5—figure supplement 1—source data 1.</label><caption><title>Numerical source data of <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A–D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig5-figsupp1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92755-fig5-figsupp1-v1.tif"/></fig></fig-group><p>F-actin dynamics are known to be controlled by interdependent signaling networks characterized by feedback regulation between components within the same pathway and between key regulatory switches (e.g. individual Rho/Rac family members) that drive distinct forms of F-actin (see below) (<xref ref-type="bibr" rid="bib46">Lawson and Ridley, 2018</xref>). For example, active mDia is known to stimulate RhoA activation (<xref ref-type="bibr" rid="bib41">Kitzing et al., 2007</xref>; <xref ref-type="fig" rid="fig5">Figure 5A</xref>). Consistently, we found that RhoA activity was reduced in hippocampal neurons depleted of mDia1/3 (<xref ref-type="fig" rid="fig5">Figure 5E and F</xref>). Work in non-neuronal cells has further revealed that RhoA activity antagonizes activation of Rac1 (<xref ref-type="bibr" rid="bib12">Chauhan et al., 2011</xref>), a key factor for promoting the formation of branched F-actin networks at the cell cortex (<xref ref-type="bibr" rid="bib35">Hodge and Ridley, 2016</xref>; <xref ref-type="bibr" rid="bib46">Lawson and Ridley, 2018</xref>; <xref ref-type="fig" rid="fig6">Figure 6A</xref>). We hypothesized that reciprocally interdependent Rho/ Rac1 signaling might control presynaptic F-actin assembly and, thereby, SV endocytosis. In agreement with the alleged antagonistic regulation of RhoA and Rac1 function (<xref ref-type="bibr" rid="bib46">Lawson and Ridley, 2018</xref>), we found Rac1 activity to be significantly elevated in hippocampal neurons depleted of mDia1/3 (<xref ref-type="fig" rid="fig6">Figure 6B and C</xref>), e.g., under conditions of reduced Rho-GTP levels. A similar increase in active Rac1 levels was observed upon pharmacological inhibition of RhoA/B in the presence of Rhosin (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>). Multicolor gSTED imaging showed that Rac1 was equally distributed between pre- and postsynaptic compartments in unperturbed hippocampal neurons (<xref ref-type="fig" rid="fig6">Figure 6D and E</xref>). Elevated active Rac1 levels might conceivably ameliorate presynaptic endocytic phenotypes elicted by mDia1/3 loss. In support of this hypothesis, we found that selective pharmacological inhibition of Rac1 reduced presynaptic actin levels (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1B and C</xref>) and caused a delay in the endocytic retrieval of endogenous vGAT (<xref ref-type="fig" rid="fig6">Figure 6F and G</xref>). Moreover, Rac1 inhibition appeared to further aggravate impaired vGAT endocytosis in mDia1/3-depleted neurons, although the effect remained below statistical significance. Expression of constitutively active GTP-locked Rac1 (Rac1-CA) restored normal Syph-pHluorin endocytosis kinetics in mDia1/3-depleted neurons, whereas Syph-pHluorin endocytosis was delayed upon expression of dominant-negative Rac1 (Rac1-DN) and exacerbated the endocytic phenotype of mDia1/3 loss (<xref ref-type="fig" rid="fig6">Figure 6H</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1E</xref>). No overt effect of Rac1 inhibition or overexpression of either Rac1 form on SV exocytosis was observed (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1D and F</xref>). Perturbation of the related Cdc42 protein, another actin regulatory GTPase <xref ref-type="bibr" rid="bib46">Lawson and Ridley, 2018</xref> found at synapses (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1G–I</xref>), did not significantly affect the kinetics of SV endocytosis in control or mDia1/3-depleted neurons (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1J and K</xref>). These data suggest that interdependent mDia1/3 and Rac1-based pathways control SV endocytosis via presynaptic actin.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>mDia1/3-Rho and Rac1 signaling facilitates presynaptic endocytosis.</title><p>(<bold>A</bold>) Schematic of the interplay between RhoA and Rac1 signaling via GTPase regulatory proteins (e.g. GTPase activating proteins (GAPs) among others) common for RhoA and Rac1. (<bold>B</bold>) Analysis of Rac1 activity by Rac1-GTP pulldown (PD) from whole-cell lysates (input) of mouse hippocampal neurons expressing shCTR or shmDia1 +3 utilizing immobilized PAK as a bait. Samples were analyzed by immunoblotting for mDia1, mDia3, Rac1, and Tubulin using specific antibodies. Input, 10% of material used for the pulldown. The contrast of pulldown and input blots was seperately adjusted for visualization purposes. (<bold>C</bold>) Densitometric quantification of Rac1-GTP normalized to total Rac1 levels (input) in lysates from neurons transduced with shCTR or shmDia1 +3 (2.2±0.2; p&lt;0.05, one sample t-test) from immunoblots exemplified in (<bold>B</bold>). Values for shCTR were set to 1. Data are expressed as mean ± SEM from N=3 independent experiments. (<bold>D</bold>) Representative three-channel time-gated stimulated emission depletion (STED) image of synapses from hippocampal cultures, fixed and immunostained for Bassoon (magenta), Rac1 (cyan), and Homer1 (green). Scale bar, 250 nm. (<bold>E</bold>) Averaged normalized line profiles for synaptic distribution of Rac1 and Homer1 relative to Bassoon (Maximum set to 0 nm). Data represent mean ± SEM. N=3 independent experiments from n=79 synapses. (<bold>F</bold>) Averaged normalized vGAT-CypHer fluorescence traces for neurons transduced with <italic>shCTR</italic> or <italic>shmDia1 +3</italic> in response to 200 AP (40 Hz, 5 s) stimulation. Cells were acutely treated with 0.1% DMSO or 10 µM Rac1 Inhibitor (EHT 1864) in the imaging buffer. Data shown represent the mean ± SEM. N=8 independent experiments from n<sub>shCTR + DMSO</sub> = 46 videos, n<sub>shmDia1+3 + DMSO</sub> = 45 videos, n<sub>shCTR + EHT 1864</sub> = 42 videos, n<sub>shmDia1+3 + EHT 1864</sub> = 43 videos. (<bold>G</bold>) Endocytic decay constants of vGAT-CypHer traces in F: τ<sub>shCTR + DMSO</sub> = 14.7±0.9 s, τ<sub>shmDia1+3 + DMSO</sub>=27.5±2.3 s, τ<sub>shCTR + EHT 1864</sub> = 30.3±6.7 s, τ<sub>shmDia1+3 + EHT 1864</sub> = 41.0±4.3 s; p<sub>shCTR + DMSO vs shmDia1+3 + DMSO</sub>&lt;0.05, p<sub>shCTR + DMSO vs shmDia1+3 + EHT 1864</sub> &lt; 0.0001, Kruskal-Wallis test with Dunn’s post-test. Data represent mean ± SEM. (<bold>H</bold>) Endocytic decay constants of Synaptophysin-pHluorin traces (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1E</xref>) of neurons transduced with <italic>shCTR</italic> (τ<sub>shCTR</sub> = 12.0±0.7 s) or <italic>shmDia1 +3</italic> (τ<sub>shmDia1+3</sub> = 22.7±2.0 s) and transfected with constitutively active Rac1 (Rac1-CA; Q61L variant; τ<sub>shCTR + Rac1-CA</sub>=13.6±1.2 s, τ<sub>shmDia1+3 + Rac1-CA</sub>=13.3±1.4 s) or dominant negative Rac1 (Rac1-DN; T17N variant; τ<sub>shCTR + Rac1-DN</sub> = 27.8±1.3 s, τ<sub>shmDia1+3 + Rac1-DN</sub> = 33.4±1.6 s) in response to 200 AP (40 Hz, 5 s) stimulation (p<sub>shCTR vs shmDia1+3</sub> &lt; 0.01; p<sub>shCTR vs shCTR + Rac1-DN</sub>&lt;0.0001, p<sub>shCTR vs shmDia1+3 + Rac1-DN</sub>&lt;0.01, p<sub>shmDia1+3 vs shmDia1+3 + Rac1-DN</sub>&lt;0.01, one-way ANOVA with Tukey’s post-test). Data are expressed as mean ± SEM. N=3 independent experiments from n<sub>shCTR</sub> = 12 videos, n<sub>shmDia1+3</sub> = 23 videos; n<sub>shCTR + Rac1-CA</sub>=10 videos, n<sub>shmDia1+3 + Rac1-CA</sub>=14 videos, n<sub>shCTR + Rac1-DN</sub> = 9 videos; n<sub>shmDia1+3 + Rac1-DN</sub> = 13 videos.</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Original scans for the anti-mDia3, anti-Tubulin, and anti-Rac1 immunoblots from <xref ref-type="fig" rid="fig6"><ext-link ext-link-type="uri" xlink:href="https://elifesciences.org/articles/75047#fig1">Figure 6B</ext-link></xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig6-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Original scan for the anti-mDia1 immunoblot from <xref ref-type="fig" rid="fig6"><ext-link ext-link-type="uri" xlink:href="https://elifesciences.org/articles/75047#fig1">Figure 6B</ext-link></xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig6-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata3"><label>Figure 6—source data 3.</label><caption><title>Original scans for immunoblots from <xref ref-type="fig" rid="fig6">Figure 6B</xref> with highlighted bands and sample labels.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig6-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata4"><label>Figure 6—source data 4.</label><caption><title>Numerical source data for <xref ref-type="fig" rid="fig6">Figure 6C, E, F, G and H</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig6-data4-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata5"><label>Figure 6—source data 5.</label><caption><title>Original scans for the anti-Rac1 immunoblots used for analysis are shown in <xref ref-type="fig" rid="fig6"><ext-link ext-link-type="uri" xlink:href="https://elifesciences.org/articles/75047#fig1">Figure 6C</ext-link></xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig6-data5-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6sdata6"><label>Figure 6—source data 6.</label><caption><title>Original scans for immunoblots used for analysis are shown in <xref ref-type="fig" rid="fig6">Figure 6C</xref> with highlighted bands and sample labels.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig6-data6-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92755-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Cooperative action of mDia1/3 and Rac1 pathways in presynaptic endocytosis.</title><p>(<bold>A</bold>) Analysis of Rac1 activity by Rac1-GTP pulldown (PD) from whole-cell lysates (input) of mouse hippocampal cultures upon inhibition of Rho activity utilizing immobilized PAK as bait. Cells were treated with 0.1% DMSO or 10 µM Rho Inhibitor (Rhosin) for 2 hr before harvest. Samples were analyzed by immunoblotting for Rac1 and Tubulin using specific antibodies. Input, 10% of material used for the pulldown. The contrast of pulldown and input blots was seperately adjusted for visualization purposes. (<bold>B</bold>) Representative three-channel time-gated STED images of synapses from hippocampal cultures treated with 0.1% DMSO or 10 µM Rac1 Inhibitor (EHT 1864) for 2 hr. Cells were fixed and stained for Bassoon (magenta), F-Actin (cyan), and Homer1 (green). Scale bar, 250 nm. (<bold>C</bold>) Presynaptic F-Actin levels in synapses of neurons treated with 0.1% DMSO (100±8.5) or 10 µM Rac1 Inhibitor (EHT 1864; 58.6±6.5; p&lt;0.0001, one sample Wilcoxon test) for 2 hr. Line profiles of F-Actin overlapping with Bassoon (presynapse) distribution were integrated. Data shown are normalized to DMSO (set to 100) and expressed as mean ± SEM. n<sub>DMSO</sub> = 30, n<sub>EHT 1864</sub> = 46 from two independent experiments. (<bold>D</bold>) Minima of background-corrected vGAT-CypHer fluorescence traces (surface normalized) for neurons treated with 0.1% DMSO (1.0±0.2 for <italic>shmDia1 +3</italic>) or 10 µM Rac1 Inhibitor (EHT 1864; 0.8±0.1 for <italic>shCTR</italic>; 0.8±0.1 for <italic>shmDia1 +3</italic>) in response to 200 AP stimulation (40 Hz, 5 s). Data represent mean ± SEM. Values were normalized to DMSO-treated <italic>shCTR</italic> (set to 1). N=8 independent experiments from n<sub>shCTR + DMSO</sub> = 46 videos, n<sub>shmDia1+3 + DMSO</sub>=45 videos, n<sub>shCTR + EHT 1864</sub> = 42 videos, n<sub>shmDia1+3 + EHT 1864</sub> = 43 videos. (<bold>E</bold>) Averaged normalized Synaptophysin-pHluorin fluorescence traces from stimulated (200 APs; 40 Hz, 5 s) hippocampal neurons transduced with lentiviruses encoding <italic>shCTR</italic> or <italic>shmDia1 +3</italic> and transfected with plasmids for expression of constitutively-active Rac1 (Rac1-CA; Q61L variant) or dominant-negative Rac1 (Rac1-DN; T17N variant). Data represent mean ± SEM. N=3 independent experiments from n<sub>shCTR</sub> = 12 videos, n<sub>shmDia1+3</sub> = 23 videos, n<sub>shCTR + Rac1-CA</sub>=10 videos, n<sub>shmDia1+3 + Rac1-CA</sub>=14 videos, n<sub>shCTR + Rac1-DN</sub> = 9 videos; n<sub>shmDia1+3 + Rac1-DN</sub> = 13 videos. The corresponding endocytic decay constants are shown in <xref ref-type="fig" rid="fig6">Figure 6H</xref>. (<bold>F</bold>) Maxima of background-corrected Synaptophysin-pHluorin fluorescence traces (surface normalized maximum values of traces shown in E) from stimulated (200 APs; 40 Hz, 5 s) hippocampal neurons transduced with lentiviruses encoding <italic>shCTR</italic> (F<sub>max</sub>/F<sub>0</sub>=1.3±0.0) or <italic>shmDia1 +3</italic> (F<sub>max</sub>/F<sub>0</sub>=1.5±0.0) and transfected with plasmids encoding CA (F<sub>max</sub>/F<sub>0 shCTR + Rac1-CA</sub>=1.4±0.2; F<sub>max</sub>/F<sub>0 shmDia1+3 + Rac1-CA</sub>=1.5±0.1) or DN versions (F<sub>max</sub>/F<sub>0 shCTR + Rac1-DN</sub> = 1.2±0.1; F<sub>max</sub>/F<sub>0 shmDia1+3 + Rac1-DN</sub> = 1.3±0.1) of Rac1. Data represent mean ± SEM. (<bold>G</bold>) Densitometric quantification of Cdc42-GTP normalized to total Cdc42 levels in lysates from <italic>shmDia1 +3</italic> transduced neurons (2.7±0.6; p&lt;0.05, one sample t-test). Values for <italic>shCTR</italic> were set to 1. Data are expressed as mean ± SEM from N=3 independent experiments. (<bold>H</bold>) Representative three-channel time-gated stimulated emission depletion (STED) image of synapses from hippocampal mouse cultures, fixed and immunostained for Bassoon (magenta), Cdc42 (cyan), and Homer1 (green). Scale bar, 250 nm. (<bold>I</bold>) Averaged normalized line profiles for synaptic distribution of Cdc42 and Homer1 relative to Bassoon (Maximum set to 0 nm). Data are expressed as mean ± SEM (N=3; n=96 synapses). (<bold>J</bold>) Averaged normalized vesicular glutamate transporter 1 (vGAT)-CypHer fluorescence traces for neurons transduced with shCTR or shmDia1 +3 in response to 200 AP (40 Hz, 5 s) stimulation. Cells were acutely treated with 0.1% DMSO or 10 µM Cdc42 Inhibitor (ML141) in the imaging buffer. Data shown represent the mean ± SEM. N=6 independent experiments from n<sub>shCTR + DMSO</sub> = 31 videos, n<sub>shmDia1+3 + DMSO</sub>=33 videos, n<sub>shmDia1+3 + ML141</sub>=32 videos. (<bold>K</bold>) Endocytic decay constants of vGAT-CypHer traces in J: τ<sub>shCTR + DMSO</sub> = 15.6±1.0 s, τ<sub>shmDia1+3 + DMSO</sub>=28.0±3.1 s, τ<sub>shCTR + ML141</sub>=17.6±1.6 s, τ<sub>shmDia1+3 + ML141</sub>=33.1 ± 7.7 s; p<sub>shCTR + DMSO vs shmDia1+3 + DMSO</sub>&lt;0.01, Kruskal-Wallis test with Dunn’s post-test. Data shown represent the mean ± SEM. N=6 independent experiments from n<sub>shCTR + DMSO</sub> = 31 videos, n<sub>shmDia1+3 + DMSO</sub>=33 videos, n<sub>shCTR + ML141</sub>=29 videos, n<sub>shmDia1+3 + ML141</sub>=32 videos.</p><p><supplementary-material id="fig6s1sdata1"><label>Figure 6—figure supplement 1—source data 1.</label><caption><title>Original scan for the anti-Rac1 immunoblots from <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig6-figsupp1-data1-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6s1sdata2"><label>Figure 6—figure supplement 1—source data 2.</label><caption><title>Original scan for the anti-Tubulin immunoblot from <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig6-figsupp1-data2-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6s1sdata3"><label>Figure 6—figure supplement 1—source data 3.</label><caption><title>Original scans for immunoblots in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A</xref> with highlighted bands and sample labels.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig6-figsupp1-data3-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6s1sdata4"><label>Figure 6—figure supplement 1—source data 4.</label><caption><title>Numerical source data of <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C</xref>, D, E, F, G, I, J, K.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig6-figsupp1-data4-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6s1sdata5"><label>Figure 6—figure supplement 1—source data 5.</label><caption><title>Original scans for anti-Cdc42 immunoblots used for analysis are shown in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1G</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig6-figsupp1-data5-v1.zip"/></supplementary-material></p><p><supplementary-material id="fig6s1sdata6"><label>Figure 6—figure supplement 1—source data 6.</label><caption><title>Original scans for anti-Cdc42 immunoblots used for analysis are shown in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1G</xref> with highlighted bands and sample labels.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig6-figsupp1-data6-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92755-fig6-figsupp1-v1.tif"/></fig></fig-group><p>We probed this model by analyzing the ultrastructure of synapses from hippocampal neurons depleted of mDia1/3 or following inhibition of Rac1 activity. Synapses from mDia1/3-depleted neurons displayed an accumulation of non-coated plasma membrane invaginations that were found both in the vicinity of the active zone as well as distal from the synaptic contact area (<xref ref-type="fig" rid="fig7">Figure 7A and B</xref>). Moreover, we observed elevated numbers of endosome-like vacuoles (ELVs) (<xref ref-type="fig" rid="fig7">Figure 7A and C</xref>) that might serve as a donor membrane for SV reformation (<xref ref-type="bibr" rid="bib43">Kononenko and Haucke, 2015</xref>; <xref ref-type="bibr" rid="bib42">Kononenko et al., 2014</xref>; <xref ref-type="bibr" rid="bib81">Watanabe et al., 2014</xref>) as suggested by the observed reduction in SV numbers in mDia-depleted neurons (compare <xref ref-type="fig" rid="fig2">Figure 2</xref>). A prominent accumulation of plasma membrane invaginations (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A</xref>) and endosome-like vacuoles (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1B</xref>) was similarly found in hippocampal neurons from mDia1 KO mice. Inhibition of Rac1 function by EHT 1864 also led to the accumulation of non-coated plasma membrane invaginations (<xref ref-type="fig" rid="fig7">Figure 7A and D</xref>), whereas the number of endosome-like vacuoles was not significantly altered (<xref ref-type="fig" rid="fig7">Figure 7A and E</xref>). Pharmacological blockade of Rac1 activity in neurons depleted of mDia1/3 further increased the number of plasma membrane invaginations significantly, while the additional effect on the number of endosome-like vacuoles remained insignificant (<xref ref-type="fig" rid="fig7">Figure 7F, G and H</xref>). mDia1/3 loss and Rac1 perturbation exhibited similar phenotypes with respect to the length and width of tubular membrane invaginations (<xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1C and D</xref>).</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Defects in presynaptic ultrastructure induced by interference with mDia1/3-Rho and Rac1 signaling.</title><p>(<bold>A</bold>) Representative synaptic electron micrographs from hippocampal neurons transduced with lentiviruses encoding <italic>shCTR</italic> or <italic>shmDia1 +3</italic>, targeting <italic>Diaph1/2</italic> genes, and treated with 0.1% dimethyl sulfoxide (DMSO) or 10 µM Rac1 Inhibitor (EHT 1864) for 2 hr before fixation. Invaginations and endosome-like vacuoles (ELVs) are colored in blue and yellow, while postsynapse and synaptic cleft are colored in green and maroon, respectively. Scale bar, 250 nm. (<bold>B</bold>) Average number of invaginations per μm<sup>2</sup> in <italic>shCTR</italic> (0.5±0.1) and <italic>shmDia1 +3</italic> (0.9±0.1; p&lt;0.0001, Mann-Whitney test) boutons. Data represent mean ± SEM. N=3 independent experiments from n<sub>shCTR</sub> = 326 synapses, n<sub>shmDia1+3</sub> = 323 synapses. (<bold>C</bold>) Average number of ELVs per μm<sup>2</sup> in shCTR (1.4±0.1) and <italic>shmDia1 +</italic>3 (2.7±0.2; p&lt;0.0001, Mann-Whitney test) boutons. Data represent mean ± SEM. N=3 independent experiments from n<sub>shCTR</sub> = 326 synapses, n<sub>shmDia1+3</sub> = 323 synapses. (<bold>D</bold>) Average number of invaginations per μm<sup>2</sup> in <italic>shCTR</italic> and <italic>shmDia1 +3</italic> boutons treated with 0.1% DMSO (0.8±0.1 for <italic>shCTR</italic>; 1.2±0.1 for <italic>shmDia1 +3</italic>, p<sub>shCTR + DMSO vs shmDia1+3 + DMSO</sub>&lt;0.01) or 10 µM EHT 1864 (1.8±0.1 for <italic>shCTR</italic>, p<sub>shCTR + DMSO vs shCTR + EHT 1864</sub> &lt; 0.0001; 1.9±0.2 for <italic>shmDia1 +3</italic>, p<sub>shCTR + DMSO vs shmDia1+3 + EHT 1864</sub> &lt; 0.0001, p<sub>shmDia1+3 + DMSO vs shmDia1+3 + EHT 1864</sub> &lt; 0.05, Kruskal-Wallis test with Dunn’s post-test) for 2 hr before fixation. Data represent mean ± SEM from n<sub>shCTR + DMSO</sub> = 144 synapses, n<sub>shmDia1+3 + DMSO</sub>=143 synapses, n<sub>shCTR + EHT 1864</sub> = 136 synapses, n<sub>shmDia1+3 + EHT 1864</sub> = 153 synapses. (<bold>E</bold>) Average number of ELVs per μm<sup>2</sup> in <italic>shCTR</italic> and <italic>shmDia1 +3</italic> boutons treated with 0.1% DMSO (2.2±0.2 for <italic>shCTR</italic>; 3.3±0.3 for <italic>shmDia1 +3</italic>, p<sub>shCTR + DMSO vs shmDia1+3 + DMSO</sub>&lt;0.05) or 10 µM EHT 1864 (2.6±0.3 for <italic>shCTR</italic>; 4.3±0.4 for <italic>shmDia1 +3</italic>, p<sub>shCTR + DMSO vs shmDia1+3 + EHT 1864</sub> &lt; 0.001, p<sub>shCTR + EHT 1864 vs shmDia1+3 + EHT 1864</sub> &lt; 0.01, Kruskal-Wallis test with Dunn’s post-test) for 2 hr before fixation. Data represent mean ± SEM from n<sub>shCTR + DMSO</sub> = 144 synapses, n<sub>shmDia1+3 + DMSO</sub>=143 synapses, n<sub>shCTR + EHT 1864</sub> = 136 synapses, n<sub>shmDia1+3 + EHT 1864</sub> = 153 synapses.</p><p><supplementary-material id="fig7sdata1"><label>Figure 7—source data 1.</label><caption><title>Numerical source data from <xref ref-type="fig" rid="fig7">Figure 7B–E</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig7-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92755-fig7-v1.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>mDia1/3 and Rac1 cooperatively regulate the synaptic vesicle (SV) cycle and presynaptic ultrastructure.</title><p>(<bold>A</bold>) Average number of invaginations per μm<sup>2</sup> in WT (0.1±0.1) and <italic>Diaph1</italic> KO (<italic>mDia1</italic>KO; 0.4±0.1; p&lt;0.01, Mann-Whitney test) boutons. Data shown represent the mean ± SEM from n<sub>WT</sub> = 103 synapses, n<sub>mDia1KO</sub> = 96 synapses. (<bold>B</bold>) Average number of endosome-like vacuoles (ELVs) per μm<sup>2</sup> in wild-type (WT) (1.3±0.2) and <italic>mDia</italic>1KO (3.1±0.5; p&lt;0.001, Mann-Whitney test) boutons. Data shown represent the mean ± SEM from n<sub>WT</sub> = 103 synapses, n<sub>mDia1KO</sub> = 96 synapses. (<bold>C</bold>) Average invagination length in shCTR and shmDia1 +3 boutons treated with 0.1% dimethyl sulfoxide (DMSO) (97.6±4.5 nm for <italic>shCTR</italic>; 136.8±6.0 nm for <italic>shmDia1 +3</italic>, p<sub>shCTR + DMSO vs shmDia1+3 + DMSO</sub>&lt;0.0001) or 10 µM EHT 1864 (130.9±4.5 nm for shCTR, p<sub>shCTR + DMSO vs shCTR + EHT 1864</sub> &lt; 0.001; 143.1±4.9 nm for shmDia1 +3, p<sub>shCTR + DMSO vs shmDia1+3 + EHT 1864</sub> &lt; 0.0001, Kruskal-Wallis test with Dunn’s post-test) for 2 hr before chemical fixation. Data represent mean ± SEM from n<sub>shCTR + DMSO</sub> = 77 invaginations, n<sub>shmDia1+3 + DMSO</sub>=141 invaginations, n<sub>shCTR + EHT 1864</sub> = 176 invaginations, n<sub>shmDia1+3 + EHT 1864</sub> = 189 invaginations. (<bold>D</bold>) Average invagination width in shCTR and <italic>shmDia1 +3</italic> boutons treated with 0.1% DMSO (124.5±5.6 nm for <italic>shCTR</italic>; 184.1±6.6 nm for <italic>shmDia1 +3</italic>, p<sub>shCTR + DMSO vs shmDia1+3 + DMSO</sub>&lt;0.0001) or 10 µM EHT 1864 (179.0±5.8 nm for <italic>shCTR</italic>, p<sub>shCTR + DMSO vs shCTR + EHT 1864</sub> &lt; 0.0001; 191.0±5.4 nm for <italic>shmDia1 +3</italic>, p<sub>shCTR + DMSO vs shmDia1+3 + EHT 1864</sub> &lt; 0.0001, Kruskal-Wallis test with Dunn’s post-test) for 2 hr before chemical fixation. Data represent mean ± SEM from n<sub>shCTR + DMSO</sub> = 77 invaginations, n<sub>shmDia1+3 + DMSO</sub>=141 invaginations, n<sub>shCTR + EHT 1864</sub> = 176 invaginations, n<sub>shmDia1+3 + EHT 1864</sub> = 189 invaginations.</p><p><supplementary-material id="fig7s1sdata1"><label>Figure 7—figure supplement 1—source data 1.</label><caption><title>Numerical source data of <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1A–D</xref>.</title></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-92755-fig7-figsupp1-data1-v1.zip"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92755-fig7-figsupp1-v1.tif"/></fig></fig-group><p>Collectively, these findings demonstrate that mDia1/3-Rho and Rac1 signaling pathways cooperatively act to facilitate presynaptic endocytosis and SV recycling.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>We found that loss of mDia1 either alone or in conjunction with the closely related mDia3 isoform slows the kinetics of SV endocytosis of exogenous pHluorin-tagged SV proteins and of endogenous vGAT without perturbing exocytic SV fusion. These phenotypes are accompanied by the accumulation of plasma membrane invaginations and vacuolar structures as well as an activity-dependent reduction of the total SV pool (<xref ref-type="fig" rid="fig1">Figures 1</xref>, <xref ref-type="fig" rid="fig2">2</xref> and <xref ref-type="fig" rid="fig7">7</xref>). Furthermore, we observe that interdependent mDia1/3-Rho and Rac1 signaling pathways cooperatively act to facilitate presynaptic endocytosis (<xref ref-type="fig" rid="fig5">Figures 5</xref>—<xref ref-type="fig" rid="fig7">7</xref>). Several lines of evidence indicate that these endocytic phenotypes are a consequence of perturbed presynaptic actin levels or dynamics. (i) Endogenous presynaptic F-actin is reduced in mDia1/3-depleted hippocampal synapses (<xref ref-type="fig" rid="fig4">Figure 4</xref>) and (ii) actin polymerization-defective mDia1 fails to restore normal endocytosis kinetics in hippocampal neurons depleted of mDia1 (<xref ref-type="fig" rid="fig4">Figure 4</xref>). Conversely, (iii) pharmacological stabilization of F-actin by jasplakinolide (<xref ref-type="fig" rid="fig4">Figure 4</xref>) or (iv) expression of constitutively-active Rac1 to drive compensatory actin polymerization (for example via other formins and/ or ARP2/3) (<xref ref-type="fig" rid="fig6">Figure 6</xref>) rescues endocytosis in mDia1/3-KD hippocampal neurons. Moreover, (v) we find mDia1 (<xref ref-type="fig" rid="fig3">Figure 3</xref>) and F-actin (<xref ref-type="fig" rid="fig4">Figure 4</xref>) to accumulate at presynapses under conditions of impaired dynamin-dependent endocytosis. Together with the observation that inhibition of F-actin dynamics (<xref ref-type="bibr" rid="bib60">Peng et al., 2011</xref>) in the combined presence of latrunculin A, jasplakinolide, and Y-27632 (<xref ref-type="fig" rid="fig1">Figure 1</xref>) slows the kinetics of SV endocytosis, our data support the hypothesis that presynaptic actin facilitates SV endocytosis downstream of mDia/ RhoA and Rac1-based signaling pathways.</p><p>Our data extend previous studies using conditional genetics that have identified an actin requirement for SV endocytosis (<xref ref-type="bibr" rid="bib85">Wu et al., 2016</xref>). The endocytic phenotype described here for loss of mDia1/3, however, is substantially milder than that elicited by complete loss of β− or γ-actin, likely reflecting the fact that several partially redundant pathways cooperate to promote F-actin assembly at synapses (see below). In contrast to <italic>Actb</italic> or <italic>Actg1</italic> KO hippocampal neurons (<xref ref-type="bibr" rid="bib85">Wu et al., 2016</xref>) we did not observe strong exocytic depression in response to train stimulation in mDia-depleted neurons (e.g. <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A–M</xref>) although we cannot rule out mild differences in synaptic strength and/ or release probability as observed in <italic>Rac1</italic> KO hippocampal neurons and at the calyx of Held (<xref ref-type="bibr" rid="bib39">Keine et al., 2022</xref>; <xref ref-type="bibr" rid="bib56">O’Neil et al., 2021</xref>).</p><p>At the ultrastructural level, we find that genetic (KO) or lentiviral induced (KD) loss of the genes <italic>Diaph1</italic> or <italic>Diaph1/2</italic>, encoding mDia1 or mDia1/3, respectively, partially phenocopies acute perturbation of formin-mediated actin assembly (<xref ref-type="bibr" rid="bib78">Soykan et al., 2017</xref>) with respect to the accumulation of plasma membrane invaginations. Unlike acute formin inhibition (<xref ref-type="bibr" rid="bib78">Soykan et al., 2017</xref>), we find elevated numbers of post-fission endosome-like vacuoles in mDia-depleted hippocampal synapses. The latter correlates with a mild reduction of SV numbers, suggesting that mDia may have a further role in SV reformation downstream of the actual endocytosis reaction (<xref ref-type="bibr" rid="bib10">Chanaday et al., 2019</xref>; <xref ref-type="bibr" rid="bib26">Gan and Watanabe, 2018</xref>; <xref ref-type="bibr" rid="bib42">Kononenko et al., 2014</xref>). The identified function of mDia1/3-mediated presynaptic actin assembly in presynaptic endocytosis and SV recycling is consistent with the actin-binding properties of many endocytic proteins including Dynamin (<xref ref-type="bibr" rid="bib25">Ferguson et al., 2009</xref>; <xref ref-type="bibr" rid="bib32">Gu et al., 2014</xref>), PACSINs (<xref ref-type="bibr" rid="bib40">Kessels and Qualmann, 2006</xref>), or Epsins, among others (<xref ref-type="bibr" rid="bib50">McMahon and Boucrot, 2011</xref>; <xref ref-type="bibr" rid="bib52">Merrifield et al., 2005</xref>; <xref ref-type="bibr" rid="bib70">Saheki and De Camilli, 2012</xref>). How exactly actin functions to facilitate endocytosis of SV membranes remains to be fully understood. The comparably small size of the membrane invaginations that accumulate following pharmacological inhibition of formins (&lt;100 nm) or Rac1 or upon loss of mDia1 (typically &lt;150 nm, although larger ones are observed) render an actomyosin-based constriction mechanism for SV endocytosis unlikely (consistent with <xref ref-type="bibr" rid="bib73">Sankaranarayanan et al., 2003</xref>). We rather favor a - possibly indirect - function of F-actin in presynaptic endocytosis via the formation of an F-actin ring that couples exocytic membrane compression to endocytic pit formation (<xref ref-type="bibr" rid="bib55">Ogunmowo et al., 2023</xref>). Such a model is supported by the abundance of large plasma membrane invaginations distal from the active zone where SV fusion occurs at synapses following mDia1/3 and Rac1 loss of function (<xref ref-type="fig" rid="fig7">Figure 7</xref>). Consistent with this, it has been shown that mDia1 controls presynaptic membrane contractility (<xref ref-type="bibr" rid="bib19">Deguchi et al., 2016</xref>), e.g., via the recently identified presynaptic actin corrals visualized in genome-engineered rat hippocampal neurons (<xref ref-type="bibr" rid="bib2">Bingham et al., 2023</xref>).</p><p>A key result from our study is the finding that presynaptic endocytosis is regulated by interdependent, yet partially redundant signaling for F-actin assembly downstream of Rho and Rac1, e.g., pathways known to control linear and branched F-actin networks (<xref ref-type="bibr" rid="bib46">Lawson and Ridley, 2018</xref>; <xref ref-type="bibr" rid="bib54">Müller et al., 2020</xref>) that were shown to co-exist within hippocampal presynaptic boutons (<xref ref-type="bibr" rid="bib2">Bingham et al., 2023</xref>). We demonstrate that loss of mDia1/3 or inhibition of Rho causes the hyperactivation of the actin-promoting GTPase Rac1 and that dual loss of mDia1/3 loss and Rac1 function results in synergistic inhibitory effects with respect to presynaptic endocytosis and ultrastructural defects (<xref ref-type="fig" rid="fig5">Figures 5</xref>—<xref ref-type="fig" rid="fig7">7</xref>). These findings suggest that the signaling network that regulates presynaptic actin assembly may have been evolutionarily selected for plasticity and resilience. A resilient network for the control of actin dynamics at the presynapse may also help to explain the partially contradicting results from drug-based manipulations of actin and actin regulatory factors in different models of presynaptic neurotransmission reported in the past (<xref ref-type="bibr" rid="bib3">Bleckert et al., 2012</xref>; <xref ref-type="bibr" rid="bib20">Del Signore et al., 2021</xref>; <xref ref-type="bibr" rid="bib36">Hori et al., 2022</xref>; <xref ref-type="bibr" rid="bib61">Piriya Ananda Babu et al., 2020</xref>; <xref ref-type="bibr" rid="bib66">Richards et al., 2004</xref>; <xref ref-type="bibr" rid="bib73">Sankaranarayanan et al., 2003</xref>; <xref ref-type="bibr" rid="bib76">Shupliakov et al., 2002</xref>; <xref ref-type="bibr" rid="bib86">Wu and Chan, 2022</xref>; <xref ref-type="bibr" rid="bib85">Wu et al., 2016</xref>). Moreover, accumulating evidence indicates that different pools of actin might be differentially amenable to drug treatments (<xref ref-type="bibr" rid="bib3">Bleckert et al., 2012</xref>), e.g., as a consequence of the association of actin filaments with molecules such as tropomyosin (<xref ref-type="bibr" rid="bib31">Gormal et al., 2017</xref>) that render them resistant to drugs, and/ or variations in the fraction of F-actin <italic>vs</italic>. monomeric actin pools (<xref ref-type="bibr" rid="bib34">Higashida et al., 2008</xref>), providing a possible explanation for previously discrepant results.</p><p>A number of open questions remain. We predict that presynaptic actin assembly via mDia/Rho and Rac1 facilitates all forms of presynaptic endocytosis that operate on timescales of milliseconds to seconds (<xref ref-type="bibr" rid="bib9">Chanaday and Kavalali, 2018</xref>; <xref ref-type="bibr" rid="bib15">Clayton and Cousin, 2009</xref>; <xref ref-type="bibr" rid="bib82">Watanabe and Boucrot, 2017</xref>) and at many types of synapses (e.g. small central synapses, ribbon synapses, the neuromuscular junction), but further studies will be needed to test this hypothesis. We note that fast endophilin-mediated endocytosis (FEME), a process with resemblance to endocytosis at synapses (<xref ref-type="bibr" rid="bib82">Watanabe and Boucrot, 2017</xref>), has been shown to be differentially regulated by actin and Rho GTPase family members (<xref ref-type="bibr" rid="bib7">Boucrot et al., 2015</xref>; <xref ref-type="bibr" rid="bib65">Renard et al., 2015</xref>). At present we do not understand if and how RhoA/B and Rac1 GTPase activation is nested into the SV cycle and whether these GTPases operate at the same or different nanoscale sites and on the same or different membranes. Future studies will be required to tackle these questions.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Materials</title><sec id="s4-1-1"><title>Animals</title><p>Primary neurons were obtained from either wild-type C57BL/6 J (Charles River, RRID: <ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:000664">IMSR_JAX:000664</ext-link>) or <italic>Diaph1</italic> KO mice (<xref ref-type="bibr" rid="bib59">Peng et al., 2007</xref>; <xref ref-type="bibr" rid="bib58">Peng et al., 2003</xref>). All animal experiments were reviewed and approved by the ethics committee of the <italic>Landesamt für Gesundheit und Soziales</italic> (LAGeSo) Berlin or the Committee on the Ethics of Animal Experiments of Columbia University and conducted according to the committees’ guidelines (LAGeSo) or the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (for <italic>Diaph1</italic> KO mice). At the facilities, animal care officers monitored compliance with all regulations. Mice were group-housed under 12/12 hr light/dark cycle with access to food and water ad libitum. Mice from both genders were used and cultures were randomly allocated to experimental groups (e.g. different treatments). Multiple independent experiments using several biological replicates were carried out as indicated in the Figure legends.</p></sec><sec id="s4-1-2"><title>Antibodies</title><p>Antibodies and their working dilutions used in this study are denoted in the Key Resource Table (IB: Immunoblot; IC: Immunocytochemistry; IP: Immunoprecipitation). Antibodies were stored according to the manufacturer’s recommendations. All secondary antibodies are species-specific (highly cross-adsorbed).</p></sec><sec id="s4-1-3"><title>Cell lines</title><p>Human embryonic kidney 293T (HEK293T) cells were obtained from the American Type Culture Collection (Cat# CRL-3216; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0063">CVCL_0063</ext-link>). Cells were cultured in Dulbecco’s modified Eagle’s medium supplemented with glucose (DMEM; 4.5 g/L; Thermo Fisher Scientific) and 10% heat-inactivated fetal bovine serum (FBS; Gibco), penicillin (100 U/ml; Gibco), and streptomycin (100 μg/ml; Gibco) at 37 °C and 5% CO<sub>2</sub>. Cells were routinely tested for mycoplasma contamination.</p></sec><sec id="s4-1-4"><title>Chemicals</title><p>Compounds were dissolved in dimethyl sulfoxide (DMSO), unless indicated otherwise, and diluted 1: 1000 to their working concentrations (see Key Resource Table). For acute pharmacological treatment (in pHluorin/CypHer assays), drugs were added to the imaging buffer. For longer incubations, the conditioned cell media was supplemented with the chemicals (see Key Resource Table for incubation time).</p><p>For silencing neuronal network activity, sodium channels were inhibited by the addition of tetrodotoxin (TTX; in 10 mM sodium acetate, pH 5.3) to the neuronal culture medium at a day in vitro (DIV) 12 for 36 hr. As a control, cells from the same preparation were treated with equal volumes of 10 mM sodium acetate (annotated as Vehicle).</p></sec><sec id="s4-1-5"><title>Plasmids</title><p>All recombinant DNA reagents used for protein expression are listed in the Key Resource Table: Synaptophysin-pHluorin was a kind gift from Dr. L. Lagnado (Univ. of Sussex, UK), vGLUT1-pHluorin was generated in-house by Svenja Bolz as previously described, while vGLUT1-mCherry was kindly provided by Dr. Franck Polleux (New York, USA). HA-tagged RhoA-WT and RhoA-T19N were kind gifts from Dr. Theofilos Papadopoulos (Göttingen, Germany) and myc-tagged RhoB-WT and RhoB-T19N were kindly gifted by Dr. Harry Mellor (Bristol, UK). All other expression vectors were generated for this study. Plasmids based on pEGFP-C1, pmCherry-N1, pCAG, and pcDNA3 utilizing a CMV, or CAG promotor (see Key Resource table) were used for overexpression based on the transfection of neuronal cells, while pFUGW vectors carrying a human Synapsin1 promotor (hSyn1) were used for the generation of lentiviral particles for the transduction of neurons (see Key Resource Table annotated as ‘lentiviral plasmid’). In the course of this study several approaches to deplete <italic>Diaph1</italic>, encoding mDia1, have been carried out and are annotated in the Figure legends: For knockdown of <italic>Diaph1</italic>, <italic>Rhoa,</italic> and <italic>Rhob</italic> by transfection, commercially available lentiviral small hairpin RNA (shRNA) vectors based on the pLKO.1 backbone (see Key Resource Table; annotated as ‘transfected’) were purchased from Sigma-Aldrich. To reduce the amount of DNA needed for transfection to perform pHluorin assays, vectors expressing shRNA embedded into a microRNA (miRNA) context for <italic>Diaph1</italic> together with Synaptophysin-2x-pHluorin as a reporter were cloned based on pRRLsinPPT-emGFP-miR Control, a kind gift of Dr. Peter S. McPherson (Montreal, Canada). Finally, lentiviral vectors for knockdown of <italic>Diaph1</italic> and <italic>Diaph2</italic> (annotated in Key Resource Table as shmDia1 and shmDia3 ‘transduced’) were generated based on the backbone f(U6) sNLS-RFPw shCTR, a kind gift from Prof. Christian Rosenmund (Berlin, Germany). All vectors used for genetic depletion via RNA interference are listed in the Key Resource Table and express gene-specific shRNA under a U6 promotor, that either targets the coding sequence (CDS) or the 3’-untranslated region (3’-UTR).</p></sec><sec id="s4-1-6"><title>Oligonucleotides</title><p>Plasmids generated for this study were cloned using oligonucleotides (BioTez GmbH, Berlin, Germany) listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref> (lower case denotes nucleotides that do not anneal to the backbone; underlined nucleotides denote sense and antisense sequences of shRNA).</p></sec></sec><sec id="s4-2"><title>Methods</title><sec id="s4-2-1"><title>Generation of expression plasmids</title><p>Expression plasmids generated for this study were cloned by PCR amplification (Phusion High-Fidelity DNA polymerase) and restriction enzyme (Thermo Fisher Scientific; Fast digest) digest according to the manufacturers’ manual. pSNAP-N1 was generated in-house by Hannes Gonschior by sub-cloning pSNAP<sub>f</sub> (New England BioLabs Inc, Cat#N9183S) via PCR and the restriction enzymes <italic>AgeI</italic> and <italic>NotI</italic> into pmCherry-N1. pFUG_hSyn_MCS was cloned by Amirreza Ohadi to enable simple insertion of SNAP-tagged proteins by inserting a multiple cloning site (MCS) on annealed oligonucleotides into a pFUG_hSyn1 backbone (a gift from Christian Rosenmund, Berlin, Germany) cut by <italic>AgeI</italic> and <italic>EcoRI</italic>. To generate mDia1-WT-mCherry, the sequence encoding mDia1 was cut from mDia1-mEmerald-N1 (Addgene, Cat#54157) and pasted into pmCherry-N1 by <italic>AgeI</italic> and <italic>XhoI</italic> digestion. mDia1-WT-SNAP was cloned by cutting out the coding sequence of mDia1 from mDia1-mEmerald-N1 and pasting it into pSNAP-N1 by <italic>AgeI</italic> and <italic>NheI</italic> digest of both vector and insert. To subclone mDia1-SNAP into a lentiviral vector the coding sequence of mDia1-SNAP was pasted from mDia1-WT-SNAP-N1 into pFUG_hSyn1_MCS utilizing common cut sites for <italic>NheI</italic> and <italic>NotI</italic> digest. For the generation of a lentiviral vector expressing Dynamin-WT, the sequence encoding Dynamin1 was first extracted from Dynamin1-pmCherry-N1 (Addgene; Cat#27697) by <italic>EcoRI</italic> and <italic>XmaI</italic> digestion and cloned into pSNAP-N1 with the same enzymes. Subsequently, Dynamin1-SNAP was isolated by <italic>NheI</italic> and <italic>NotI</italic> digest and transformed into pFUG_hSyn1_MCS. The mDia1- ΔN truncation variant was generated by introducing a new start codon on a primer shifted by 60 amino acids (see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), PCR amplifying the truncated DNA and subcloning the template into pmCherry-N1 by <italic>BglII</italic> and <italic>AgeI</italic> digest. For introducing point mutations in mDia1 (Lysine-994 to Alanine; K994A) and Dynamin1 (Lysine-44 to Alanine; K44A), the Q5 site-directed mutagenesis kit (New England Biolabs Inc; E0552S) was used according to the manufacturer’s manual and oligonucleotides listed in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>.</p><p>All vectors were confirmed by Sanger sequencing (LGC Genomics, Berlin, Germany) and amplified by self-made chemically competent TOP10 <italic>Escherichia coli</italic> before purifying respective endotoxin-free DNA by 2-propanole precipitation.</p></sec></sec><sec id="s4-3"><title>Isolation, culture, and transfection of primary hippocampal neurons</title><p>Neuronal hippocampal cell cultures were prepared as described before (<xref ref-type="bibr" rid="bib47">López-Hernández et al., 2022</xref>; <xref ref-type="bibr" rid="bib78">Soykan et al., 2017</xref>). In short, hippocampi from postnatal mice (p0-p3) were surgically isolated and dissociated into single cells by trypsin (5 g/L, Sigma-Aldrich) digestion. Neurons (100,000 cells/ well of a six-well) were plated onto poly-L-lysine-coated coverslips and grown in modified Eagle medium (MEM; Thermo Fisher) supplemented with 5% FCS and 2% B-27 (Gibco) and maintained at 5% CO<sub>2</sub> and 37 °C in humidified incubators. In addition, 2 μM cytosine β-D-arabinofuranoside (AraC) was added to the cell culture media in the first 2 days in vitro (DIV) to limit glial proliferation. For transient protein expression, neurons were transfected on DIV 7–9 utilizing a Calcium phosphate transfection kit (Promega; Cat# E1200): In brief, 1–6 μg plasmid DNA (per well of a six-well plate) were mixed with 250 mM calcium phosphate (CaCl<sub>2</sub>) in ultrapure nuclease-free water. The resulting solution was added to equal volumes of 2x 4-(2-hydroxyethyl)–1-piperazineethanesulfonic acid buffered saline (2 x HEPES; 100 µL) and incubated at room temperature for 20 min. Resulting precipitates were added dropwise to cells that had been transferred to osmolarity-adjusted Neurobasal-A (NBA; Gibco) media to induce starvation. After incubation at 37 °C and 5% CO<sub>2</sub> for 30 min, neurons were washed thrice with osmolarity-adjusted Hank’s balanced salt solutions (HBSS; Gibco) and transferred back to their original conditioned media.</p></sec><sec id="s4-4"><title>shRNA cloning and lentivirus production</title><p>Knockdown of proteins was achieved through RNA interference either by CaCl<sub>2</sub> transfection of gene-specific shRNA encoding vectors (pLKO.1; Sigma-Aldrich or shRNAmiR) on DIV 7 or by transduction of cells with lentiviral particles harboring the gene-specific shRNA on DIV 2. The respective method is indicated in the Figure legends as <italic>transfected</italic> or <italic>transduced</italic>. To reduce the amount of DNA needed for transfection and to improve neuronal health, shRNAmiR were expressed from the 3’UTR of Synaptophysin-pHluorin based on <xref ref-type="bibr" rid="bib67">Ritter et al., 2017</xref>: The reporter protein/synthetic cassette was generated by PCR amplifying Synaptophysin-2x-pHluorin with oligos (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) harboring <italic>XbaI</italic> and <italic>SalI</italic> sites. The eGFP in the RRLsinPPT-eGFP-miRCTR plasmid (a kind gift from Dr. Peter S. McPherson, McGill University, Canada) was replaced by the PCR product through a similar restriction digest to yield shCTRmiR. miRmDia1 (start position 4892, targeting sequence matches open-reading frame) was designed with BLOCK-iT (Thermo Fisher Scientific) and subcloned into shCTRmiR to yield shmDia1miR following protocol in <xref ref-type="bibr" rid="bib67">Ritter et al., 2017</xref>.</p><p>As both transfection strategies were limited by low efficiency, lentiviral knockdown was carried out: Lentiviral particles were based on a shuttle vector (pFUGw) driving the expression of a nuclear-targeted red fluorescent protein (NLS-RFP) under a human Synapsin1 (hSyn1) promotor to monitor infection efficiency in neurons and a scrambled mouse shRNA against Clathrin without any murine targets, which was used as the control virus (f(U6) sNLS-RFPw shCTR). To prevent crosstalk between the NLS-RFP and other mCherry constructs, a similar backbone expressing the blue fluorescent protein (BFP) as a reporter was generated in-house by Klaas Ypermann: The backbone was digested by <italic>XbaI</italic> and <italic>PacI</italic>, the hSyn1 promotor and mTagBFP (Addgene; #Cat 105772) were amplified with oligos (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), gel extracted and assembled utilizing a Gibson master mix (New England BioLabs Inc; Cat#E2611L) to yield f(U6) BFP shCTR. To deplete mDia1, a shRNA sequence based on 5’-<named-content content-type="sequence">GCCTAAATGGTCAAGGAGATA</named-content>-3’ as the sense nucleotide corresponding to the 3’UTR of mouse <italic>Diaph1</italic> (NM_007858.4; Sigma-Aldrich, Cat# TRCN0000108685) was designed as an oligonucleotide with overhangs (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) and annealed into the f(U6) sNLS-RFPw shCTR backbone cut with <italic>BamHI</italic> and <italic>PacI</italic> to yield the vector f(U6) sNLS-RFPw/BFP shmDia1. For depletion of mDia3, a sense sequence based on 5’-<named-content content-type="sequence">GCCCTAATCCAGAATCTTGTA</named-content>-3’ corresponding to nucleotides 2473–2493 of mouse <italic>Diaph2</italic> (NM_172493.2; Sigma-Aldrich, Cat# TRCN0000108782) was used to construct f(U6) sNLS-RFPw/BFP shmDia3 as described above. Production of lentiviral particles was conducted using the second-generation packaging system: In brief, HEK293T were co-transfected with lentiviral shRNA constructs and the packaging plasmids psPAX2 (Addgene; Cat# 12260) and MD2.G (Addgene; Cat# 12259) using CaCl<sub>2</sub>. After 12 hr, the cell media was replaced. Virus-containing supernatants were collected at 48 and 72 hr after transfection, filtered to remove cell debris and particles were concentrated (30-fold) via low-speed centrifugation (Amicon Ultra-15, Ultracel-100; Merck Millipore; Cat# UFC9100) before aliquoting and storage at –70 °C. For all experiments, an infection rate of over 95% was achieved at DIV 14–16.</p></sec><sec id="s4-5"><title>Microscopy</title><sec id="s4-5-1"><title>Live-imaging of SV recycling</title><p>For live-imaging of Synaptophysin and vesicular glutamate transporter 1 (vGLUT1) recycling, SV proteins fused to the green-fluorescent protein-based pH-sensitive fluorescent reporter pHluorin at their luminal domain were overexpressed by plasmid transfection (Synaptophysin-pHluorin; DIV 7) or lentiviral transduction (vGLUT1-pHluorin; DIV 2).</p><p>For following endogenous vesicular gamma-aminobutyric acid transporter (vGAT) recycling, spontaneously active synaptic boutons were labeled by incubating cells with CypHer5E-conjugated antibodies against the luminal domain of vGAT (1:500 from a 1 mg/ml stock; Synaptic Systems; Cat#131,103CpH) for 2 hr in their respective conditioned culture media at 37 °C and 5% CO<sub>2</sub> prior to imaging.</p><p>To investigate the kinetics of SV recycling, neurons at DIV 14–16 were placed into an RC-47FSLP stimulation chamber (Warner Instruments) in osmolarity-adjusted imaging buffer [170 mM sodium chloride (NaCl), 20 mM N-Tris(hydroxyl-methyl)-methyl-2-aminoethane-sulphonic acid (TES), 5 mM Glucose, 5 mM sodium hydrogencabonate (NaHCO<sub>3</sub>), 3.5 mM potassium chloride (KCl), 1.3 mM CaCl<sub>2</sub>, 1.2 mM sodium sulfate (Na<sub>2</sub>SO<sub>4</sub>), 1.2 mM magnesium chloride (MgCl<sub>2</sub>), 0.4 mM potassium dihydrogenphosphate (KH<sub>2</sub>PO<sub>4</sub>), 50 μM (<italic>2 R)-</italic>amino-5-phosphonovaleric acid (AP5) and 10 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX); pH 7.4] at 37 °C (Tempcontrol 37–2 digital). Cells were subjected to electrical field-stimulation (MultiStim System-D330; Digimeter Ltd.) with annotated stimulation trains to evoke action potentials (APs) [40 Hz, 5 s (200 APs), 40 Hz, 2 s (80 APs), 20 Hz, 2 s (40 APs); at 100 mA]. Following changes in fluorescence were tracked by an inverted Zeiss Axiovert 200 M microscope, equipped with a 40 x oil-immersion EC Plan Neofluar objective (NA 1.30), an EM-CCD camera (Evolve Delta 512) and a pE-300<sup>white</sup> LED light source (CoolLED). The scanning format was set to 512x512 pixels with 16-bit sampling. eGFP (Excitation: BP470-40; Emission: BP535-50; Zeiss filter set 38) or Cy5 (Excitation: BP640-30; Emission: BP525-50; Zeiss filter set 50) filter sets were used for pHluorin or CypHer assays, respectively. Images were acquired at 0.5 Hz frame rate for 100 s with 50 (Syph-pHluorin) or 100 (vGLUT1-pH, vGAT-CypHer) ms exposure with an electron multiplying gain of 250 operated through Fiji-based MicroManager 4.11 software.</p><p>Analysis of responding boutons was performed through custom-written macros to identify regions of interest (ROIs) ( <xref ref-type="bibr" rid="bib79">Voll, 2020</xref>) in an automated manner using SynActJ (<xref ref-type="bibr" rid="bib74">Schmied et al., 2021</xref>). Such analysis averaged fluorescence for each time point in an image series (video) of at least &gt;20 responding boutons and corrected values for background fluorescence yielding raw background-corrected fluorescence (F). The fold increase of fluorescence after stimulation (F<sub>max</sub>) can serve as a measure for exocytic fusion and is calculated by normalizing F by the mean intensity of F before stimulation (Baseline/basal fluorescence (F<sub>0</sub>)=mean intensity of first five frames for pHluorin; first 10 frames for CypHer) for each time point (surface normalization = F/F<sub>0</sub> for pHluorin; F<sub>0</sub> – F<sub>min</sub> for CypHer). To account for boutons with varying pHluorin expression in one image series and to compare reacidification kinetics, the fluorescence of each time point was subtracted by the basal fluorescence (F<sub>0</sub>) to yield ΔF (F-F<sub>0</sub>), which was then normalized by its peak value (ΔF<sub>max</sub>). Resulting peak normalized curves (ΔF/ ΔF<sub>max</sub>) are annotated as a norm. ΔF. Endocytic decay constants (τ) were calculated by averaging and then fitting the norm. ΔF (ΔF/ΔF<sub>max</sub>) traces of all videos in one condition (N) to a mono-exponential decay curve [y<sub>0</sub> +A*e <sup>(-t/τ)</sup>] with the constraints of y<sub>0</sub>=1 and offset = 0 in Prism 9 (GraphPad).</p><p>CypHer traces had to be corrected for photobleaching: The decay constant of the bleaching curve was determined by fitting the data points of the first 10 frames (20 s, prior to stimulation) to a mono-exponential decay curve. The corresponding value of the photobleaching curve at a given time <italic>t</italic> was added to the raw fluorescence intensity measured at each corresponding time point to correct for the loss of intensity due to bleaching.</p></sec></sec><sec id="s4-6"><title>Immunocytochemistry</title><p>For immunostainings, neuronal cultures were chemically fixed on DIV 14–16 using 4% p-formaldehyde (PFA) and 4% sucrose in phosphate-buffered saline (PBS) for 15 min at room temperature (RT). For experiments in <xref ref-type="fig" rid="fig3">Figure 3C, G–I</xref>, cultures were stimulated with a 40 Hz train for 5 s in an imaging buffer before immediate fixation. After fixation, cells were washed thrice with PBS and incubated with permeabilization buffer (10% normal goat serum, 0.3% Triton X-100 in PBS) for 30 min at RT, followed by primary antibody incubation of proteins of interest in permeabilization buffer at indicated dilutions (see Key Resource Table) at 4 °C overnight. Subsequently, unbound antibodies were removed by three PBS washes while bound antibodies were decorated by corresponding fluorophore-coupled secondary antibodies in permeabilization buffer for 1 hr at RT. For F-Actin staining, Phalloidin-Alexa Fluor 594 (1:1000 stock; AAT Bioquest; Cat# ABD-23158) was added in the secondary incubation step. Finally, neurons were washed thrice with PBS, followed by two washes with ultra-pure water. Coverslips were dried for 2 hr before mounting in ProLong Gold Antifade (Thermo Fisher Scientific; #P36934) on glass slides (Thermo Fisher Scientific; VWR; Cat#630–1985). The slides were cured for at least 72 hr at RT before imaging.</p></sec><sec id="s4-7"><title>Multicolor time-gated STED imaging</title><p>STED images were acquired from fixed samples by a HC PL APO CS2 100 x oil objective (1.40 NA) on a Leica SP8 TCS STED 3 x microscope (Leica Microsystems) equipped with a pulsed white-light excitation laser (WLL; ∼80 ps pulse width, 80 MHz repetition rate; NKT Photonics) and a STED laser for depletion (775 nm). The scanning format was set to 1024 × 1024 pixels, with 8-bit sampling, 4 x line averaging, 4 x frame accumulation, and 6 x optical zoom, yielding a final pixel size of 18.9 nm. Three-color imaging was performed by sequentially exciting following fluorophores (excitation filter = Exf; emission filter = Emf): Atto647N (Exf: 640 nm; Emf: 650–700 nm); Alexa Fluor 594 (Exf: 590 nm; Emf: 600–640 nm) and Atto542 (Exf: 540 nm; Emf: 550–580 nm) operated by the Leica Application Suite X (Leica Microsystems, 2020). For stimulated depletion of the signal, the 775 nm STED laser was applied to all emissions. Detection of the resulting signal was time-gated by 0.3–6 ns to allow enough time for stimulated depletion and collected by two sensitive HyD detectors at appropriate spectral regions distinct from the STED laser wavelength. Settings in independent experiments were similar between conditions to allow quantification of signals. Raw data obtained from three-channel time-gated STED (gSTED) imaging were analyzed with Fiji. For analysis, only synapses oriented in the xy-plane exhibiting a clear separation of Bassoon (presynapse) and Homer1 (postsynapse) clusters were taken into account. To determine synaptic localization and presynaptic levels of proteins of interest, multicolor line profiles were measured: A line (1.0 μm length, 0.4 μm width) perpendicular to the synaptic cleft (space between Bassoon &amp; Homer1 cluster) was drawn (<xref ref-type="bibr" rid="bib28">Gerth et al., 2017</xref>) and fluorescence intensity of all three channels along this line was measured using a Fiji Macro (Macro_plot_lineprofile_multicolor; Dr. Kees Straatman, University of Leicester, UK). Resulting profiles were aligned to the maximum Bassoon intensity, which was set to 0 nm. For localization analysis, all three profiles were normalized to their maxima, which were set to 1. For quantification of presynaptic protein levels, only the fractions of the non-normalized line profiles of proteins of interest overlapping with the normalized averaged Bassoon distribution (between 151.4 and –37.8 nm; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1H</xref>) were integrated. Intensities were normalized to controls (DMSO, shCTR, WT) which were set to 100.</p></sec><sec id="s4-8"><title>Imaging of endogenous β-Actin levels</title><p>To visualize endogenous β-Actin levels, eGFP knock-in following the ORANGE method was performed (<xref ref-type="bibr" rid="bib83">Willems et al., 2020</xref>): Neurons were transfected with vGLUT1-mCherry (Franck Polleux) and pOrange GFP-β-Actin KI (Addgene; Cat#131479) by CaCl<sub>2</sub> on DIV 2. Directly following transfection, cells were transduced with shCTR or shmDia1 +3 lentiviral particles carrying BFP as a reporter to prevent crosstalk between mCherry and NLS-RFP expression. Neuronal cultures were chemically fixed on DIV 15. After fixation, endogenous GFP and overexpressed vGLUT1-mCherry intensities were enhanced by additional antibody (anti-GFP and anti-RFP; see Key Resource Table) incubation according to the immunocytochemistry protocol described above. Images of neurons were taken on the STED microscope with and without stimulated depletion (confocal) with the same settings as indicated above. For analysis, confocal images were filtered by Gaussian blur (sigma = 2 pixels) and auto-thresholded using Otsu’s method. Whenever confocal vGLUT1 signal co-localized with confocal Actin clusters, the area was chosen as a ROI. Actin intensity was then measured in the ROI applied to the STED image. The intensities of β-Actin were normalized to shCTR which was set to 100.</p></sec><sec id="s4-9"><title>Transmission electron microscopy</title><p>To investigate the synaptic effects of F-actin manipulations at the ultrastructural level, cells on coverslips were chemically fixed with 2% glutaraldehyde in cacodylate buffer (CDB; 0.1 M sodium cacodylate) for 1 hr at RT. Coverslips were washed thrice with CDB before osmification by 1% (w/v) osmium tetroxide (OsO<sub>4</sub>) and 1.5% (w/v) potassium hexacyanoferrate (K<sub>3</sub>Fe(CN)<sub>6</sub>) in CBD for 1 hr at 4 °C. After postfixation, cells were stained with 1% (w/v) uranyl acetate, dehydrated by methanol gradients and finally embedded by epoxy resin (Sigma Aldrich; Cat# 45359) infiltration. After polymerization (60 °C, 30 hr), coverslips were removed and ultra-thin (70 nm) sections were cut and contrasted with 2% (w/v) uranyl acetate and 80 mM lead citrate. Eight-bit images were obtained on a Zeiss 900 transmission electron microscope equipped with Olympus MegaViewIII or Olympus Morada G2 digital cameras at 30,000x magnification yielding a pixel size of 1.07 nm. Subsequently, morphometry (density of synaptic vesicles, endosome-like vacuoles, clathrin-coated vesicles, clathrin-coated pits, and non-coated invaginations) was analyzed from synaptic profiles with clearly distinguishable active zones and adjacent synaptic vesicles in a blinded manner.</p></sec><sec id="s4-10"><title>Biochemistry</title><sec id="s4-10-1"><title>Immunoblotting</title><p>To compare protein levels between experimental conditions, immunoblotting was performed: Protein concentrations in lysates were measured by BCA assay (Thermo Fisher Scientific; Cat#23227) and equal protein amounts were diluted in Laemmli sample buffer [final (1 x) concentration: 31.5 mM 2-Amino-2-(hydroxymethyl)propane-1,3-diol (Tris), 1% (w/v) sodium dodecyl sulfate (SDS), 10% (v/v) glycerol, 0.001% (w/v) 3,3-Bis(3,5-dibromo-4-hydroxyphenyl)–2,1λ<sup>6</sup>-benzoxathiole-1,1 (3<italic>H</italic>)-dione (bromophenol blue), 5% (v/v) 2-mercaptoethanol; pH 6.8], and denatured at 55 °C for 20 min (unless indicated otherwise). Samples were resolved by SDS-polyacrylamide gel electrophoresis (SDS-PAGE) with self-made Bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methane (BisTris; 250 mM) based 4–20% polyacrylamide (Rotiphorese Gel 30; Carl Roth) gradient gels and run (80–120 V; 90 min) in NuPAGE MOPS SDS running buffer (Thermo Fisher Scientific; Cat#NP000102) using Mini-PROTEAN Tetra Vertical Electrophoresis Cells (Bio-Rad, Cat#1658004). For membrane fractionation experiments, RFP-fluorescence of mDia1 variants in respective fractions was imaged in-gel on a ChemiDoc XRS+ (Bio-Rad) controlled by the Image Lab software (version 6.0.1) utilizing the Alexa546 preset (605/50 Filter3; Light Green Epi illumination). Separated proteins were wet-blotted (110 V; 90 min; 4 °C) on fluorescence-optimized polyvinylidene difluoride (PVDF) membranes (Immobilon-FL; Merck; IPFL00010) in transfer buffer (25  mM Tris (pH 7.6), 192  mM glycine, 20% (v/v) methanol, 0.03% (w/v) SDS). Subsequently, membranes were blocked with blocking buffer [5% bovine serum albumin (BSA), in Tris-buffered saline (TBS) containing 0.01% Tween 20 (TBS-T)] for 1 hr at RT and incubated (4°C; overnight) with primary antibodies under constant agitation at indicated dilutions (s. Key Resource Table) in blocking buffer. Membranes were washed thrice with TBS-T and incubated with corresponding pairs of IRDye 680RD- or 800CW-conjugated secondary antibodies in TBS-T for 1 hr at RT. After three washes with TBS-T, bound antibodies were visualized by the Odyssey Fc Imaging System (LI-COR Biosciences) controlled and analyzed by Image Studio Lite (Version 5.2.5). For colorimetric analysis of protein levels, the intensity of bands was measured by assigning shapes of equal size to all lanes at similar heights and subtracting the individual background for each shape. Signals were normalized to controls on the same blot. The PageRuler Prestained (Thermo Fisher Scientific; Cat#26616) was used as a ladder to control for protein size.</p></sec></sec><sec id="s4-11"><title>Immunoprecipitation from synaptosomes</title><p>To immunoprecipitate synaptic mDia1, synaptosomes (P2’) were prepared as follows: One mouse brain (p28) was homogenized (900 rpm; 12 strokes with glass-teflon homogenizer) in 7 mL of ice-cold homogenization buffer [(320 mM sucrose, 4 mM HEPES; pH 7.4) supplemented with mammalian protease inhibitor cocktail (PIC)] at 4 °C. Large cellular debris and nuclei were sedimented by centrifugation at 900 g for 10 min at 4 °C. The supernatant was further centrifuged at 12,500 g for 15 min at 4 °C. The resulting pellet (P2) was resuspended in 15 mL of homogenization buffer and pelleted at 12,500 g for 15 min at 4 °C yielding the crude synaptosomal fraction P2’. Subsequently, the pellet was resuspended in 2 mL of immunoprecipitation buffer [20 mM HEPES, 130 mM NaCl, 2 mM MgCl<sub>2</sub>, 1% (w/v) 3-[Dimethyl[3-(3α,7α,12α-trihydroxy-5β-cholan-24-amido)propyl]azaniumyl]propane-1-sulfonate (CHAPS), PIC, phosphatase inhibitor cocktail II and III (Sigma-Aldrich); pH 7.4] and lysed for 30 min at 4 °C under light agitation. The lysate was cleared by centrifugation at 15,000 g at 4 °C and protein concentration was measured using the BCA assay.</p><p>For identification of the protein environment of mDia1, P2’ lysate (2 mg; 2 g/L) was incubated with either 2 μg of anti-mDia1 antibody (BD Biosciences, Cat# 610848) or equal amounts of immunoglobulin G (IgG) isotype control mouse antibody (Thermo Fisher Scientific; Cat# 31903; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10959891">AB_10959891</ext-link>) for 1 hr at 4 °C before the addition of 25 μL of Pierce Protein A/G Magnetic Beads (Thermo Fisher Scientific) for an additional 2 h under constant rotation. Subsequently, unbound proteins were removed from the beads by three consecutive wash cycles with an immunoprecipitation buffer. Bound proteins were eluted and boiled (10 min; 95 °C) in 2 x Laemmli buffer, resolved by SDS-PAGE, and analyzed by immunoblotting.</p></sec><sec id="s4-12"><title>LC-MS analysis of the protein environment of mDia1</title><p>For the analysis of interaction partners of synaptic mDia1, mDia1 was immunoprecipitated from synaptosomes as described above. Eluted proteins were reduced (5 mM dithiothreitol; 30 min at 55 °C), alkylated (15 mM iodoacetamide; 20 min at RT in the dark), and submitted to LC-MS analysis: Proteins were subjected to SDS-PAGE following excision of three bands per lane and in-gel digestion of proteins by trypsin (1:100 (w/w); overnight at 37 °C). Resulting tryptic peptides were separated by reverse-phase high-performance liquid chromatography (RP-HPLC; Ultimate 3000 RSLCnano system; Thermo Scientific) using a 50 cm analytical column (in-house packed with Poroshell 120 EC-C18; 2.7 µm; Agilent Technologies) with a 120 min gradient. RP-HPLC was coupled on-line to an Orbitrap Elite mass spectrometer (Thermo Fisher Scientific) that performed precursor ion (MS1) scans at a mass resolution of 60,000, while fragment ion (MS2) scans were acquired with an automatic gain control (AGC) target of 5 × 10<sup>3</sup> and a maximum injection time of 50 ms. Data analysis including label-free quantification was performed with MaxQuant (version 1.6.1.0) using the following parameters: The initial maximum mass deviation of the precursor ions was set at 4.5 parts per million (ppm), and the maximum mass deviation of the fragment ions was set at 0.5  Da. Cysteine carbamidometyl and propionamide, Methionine oxidation, and N-terminal acetylation were set as variable modifications. For the identification of proteins, data were searched against the SwissProt murine database (Mouse_2016oktuniprot-proteome%3AUP000000589.fasta). False discovery rates were &lt;1% at the protein level based on matches to reversed sequences in the concatenated target-decoy database. The statistical analysis was performed utilizing Perseus software (version 1.6.7.0).</p></sec><sec id="s4-13"><title>Effector pulldown assays</title><p>To analyze the activity of small Rho GTPases, pulldowns utilizing effector protein domains which exclusively bind to their GTP-bound forms were performed: Neurons (200,000 cells) were washed with ice-cold PBS and harvested in GTPase lysis buffer (50 mM HEPES, 500 mM NaCl, 10 mM MgCl<sub>2</sub>, PIC, phosphatase Inhibitor cocktails II + III; pH 7.4). Cells were lysed for 5 min under repetitive mixing before centrifugation (15,000 g; 5 min; 4 °C). Cleared lysates were incubated with Rhotekin-Rho binding domain (RBD) beads (60 µg; Cytoskeleton Inc) or with PAK-p21 binding domain (PBD) beads (20 µg; Cytoskeleton Inc) at 4 °C under constant rotation to bind active RhoA or Cdc42 and Rac1, respectively. After 2 hr, the beads were pelleted by centrifugation (1000 g; 1 min; 4 °C) and washed with washing buffer (50 mM HEPES, 150 mM NaCl, 10 mM MgCl<sub>2</sub>; pH 7.4). After repeated centrifugation, unbound proteins were discarded with the supernatant, while bound proteins were eluted from the beads by the addition of 2x Laemmli buffer and boiling (10 min; 95 °C). Finally, the activity of small Rho GTPases was resolved by SDS-PAGE and analyzed by immunoblotting input and pulldown samples.</p></sec><sec id="s4-14"><title>Membrane fractionation</title><p>To characterize membrane association of the truncation mDia1 mutant, HEK293T cells were transfected with wild-type (mDia1-WT) or mDia1 truncation mutant (mDia1-ΔN) using CaCl<sub>2</sub>. 48 hr after transfection cells were washed with ice-cold PBS and harvested in ice-cold resuspension buffer (20 mM HEPES, 130 mM NaCl, PIC; pH 7.4). Cells were lysed by forcing the suspension through 18-gauge syringes to crack the plasma membrane in between three freeze-thaw cycles in liquid nitrogen. Nuclei were removed by centrifugation at 1000 g for 5 min at 4 °C. The supernatant (total lysate) was sedimented at 100,000 g for 30 min at 4 °C to yield the membrane fraction as the pellet and the cytosolic fraction as the high-speed supernatant. The pellet was resuspended in a resuspension buffer to the same volume of the cytosolic fraction. Equal volumes of all fractions were analyzed by SDS-PAGE and immunoblotting to allow interpretation of protein enrichment in cytosolic or membrane fractions with respect to the total lysate.</p></sec><sec id="s4-15"><title>Statistical analysis</title><p>All data in this study are presented as the mean ± standard error of the mean (SEM) and were obtained from <italic>N</italic> independent experiments with a total sample number of <italic>n</italic> (e.g. number of images, videos, synapses, etc.) as annotated in the Figure legends. For analysis of protein levels in STED microscopy and synaptic structures in EM, statistical differences between groups were calculated considering <italic>n</italic>, while in all other experiments, statistical differences were calculated between independent experiments <italic>N</italic> (In pHluorin/CypHer assays, at least 20 responding boutons/video were analyzed). For n&gt;100 or N&gt;5, data were tested for Gaussian distribution following D’Agostino-Pearson tests to determine parametric versus non-parametric statistical testing. The statistical significance between the two groups was evaluated with either two-tailed unpaired student’s t-tests for normally distributed data or two-tailed unpaired Mann-Whitney tests, if data did not follow Gaussian distribution. In experiments that necessitated normalization (to 100 or 1) before analysis, one-sample t-tests or one-sample Wilcoxon rank tests were performed for normal and non-normal distributed data, respectively. The statistical significance between more than two experimental groups of normally distributed data was analyzed by one-way ANOVA, followed by a Tukey’s post hoc test, while Kruskal-Wallis tests with post hoc Dunn’s multiple comparison test were used when datasets did not follow Gaussian distribution.</p><p>Corresponding statistical tests are indicated in the Figure and significance levels are annotated as asterisks (*p&lt;0.05, **p&lt;0.01, ***p&lt;0.001, and ****p&lt;0.0001). Differences that are not significant are not stated or indicated as ns (p&gt;0.05). Statistical data evaluation was performed using GraphPad Prism 9.5.1 (733) and all calculated p-values are annotated in corresponding numerical source data files. All Figures were assembled using Affinity Designer (version 1.10.6.1665).</p></sec><sec id="s4-16"><title>Contact for reagent and resource sharing</title><p>Further information and requests for resources and reagents should be directed to and will be fulfilled by the corresponding contact V.H. (Haucke@fmp-berlin.de).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Investigation, Visualization, Methodology, Writing – original draft</p></fn><fn fn-type="con" id="con2"><p>Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Resources, Methodology</p></fn><fn fn-type="con" id="con4"><p>Investigation, Visualization</p></fn><fn fn-type="con" id="con5"><p>Resources, Supervision, Methodology</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Supervision, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Resources, Supervision, Funding acquisition, Validation, Visualization, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>All animal experiments were reviewed and approved by the ethics committee of the Landesamt für Gesundheit und Soziales (LAGeSo) Berlin or the Committee on the Ethics of Animal Experiments of Columbia University and conducted according to the committees' guidelines (LAGeSo) or the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health (for mDia1 KO mice).</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-92755-mdarchecklist1-v1.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>List of oligonucleotides used in this study.</title></caption><media xlink:href="elife-92755-supp1-v1.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files; source data files have been provided.</p></sec><ack id="ack"><title>Acknowledgements</title><p>We are indebted to Sabine Hahn, Delia Löwe, and Silke Zillmann for expert technical assistance with the preparation of neuronal cultures. We further wish to thank Dr. Martin Lehmann (FMP, Berlin), Hannah Gelhaus, and Gresy Bregu (both FU Berlin) for aid with STED imaging, Dr. Dmytro Puchkov (FMP Imaging Core Facility) for supervising electron microscopy analysis, and Heike Stephanowitz and Prof. Fan Liu (FMP Core Facility Proteomics) for proteomic analyses. Supported by grants from the Deutsche Forschungsgemeinschaft (SFB958/TP A01) to VH.</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anes</surname><given-names>E</given-names></name><name><surname>Kühnel</surname><given-names>MP</given-names></name><name><surname>Bos</surname><given-names>E</given-names></name><name><surname>Moniz-Pereira</surname><given-names>J</given-names></name><name><surname>Habermann</surname><given-names>A</given-names></name><name><surname>Griffiths</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Selected lipids activate phagosome actin assembly and maturation resulting in killing of pathogenic mycobacteria</article-title><source>Nature Cell Biology</source><volume>5</volume><fpage>793</fpage><lpage>802</lpage><pub-id pub-id-type="doi">10.1038/ncb1036</pub-id><pub-id pub-id-type="pmid">12942085</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bingham</surname><given-names>D</given-names></name><name><surname>Jakobs</surname><given-names>CE</given-names></name><name><surname>Wernert</surname><given-names>F</given-names></name><name><surname>Boroni-Rueda</surname><given-names>F</given-names></name><name><surname>Jullien</surname><given-names>N</given-names></name><name><surname>Schentarra</surname><given-names>EM</given-names></name><name><surname>Friedl</surname><given-names>K</given-names></name><name><surname>Da Costa Moura</surname><given-names>J</given-names></name><name><surname>van Bommel</surname><given-names>DM</given-names></name><name><surname>Caillol</surname><given-names>G</given-names></name><name><surname>Ogawa</surname><given-names>Y</given-names></name><name><surname>Papandréou</surname><given-names>MJ</given-names></name><name><surname>Leterrier</surname><given-names>C</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Presynapses contain distinct actin nanostructures</article-title><source>The Journal of Cell Biology</source><volume>222</volume><elocation-id>e202208110</elocation-id><pub-id pub-id-type="doi">10.1083/jcb.202208110</pub-id><pub-id pub-id-type="pmid">37578754</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bleckert</surname><given-names>A</given-names></name><name><surname>Photowala</surname><given-names>H</given-names></name><name><surname>Alford</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Dual pools of actin at presynaptic terminals</article-title><source>Journal of Neurophysiology</source><volume>107</volume><fpage>3479</fpage><lpage>3492</lpage><pub-id pub-id-type="doi">10.1152/jn.00789.2011</pub-id><pub-id pub-id-type="pmid">22457456</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bloom</surname><given-names>O</given-names></name><name><surname>Evergren</surname><given-names>E</given-names></name><name><surname>Tomilin</surname><given-names>N</given-names></name><name><surname>Kjaerulff</surname><given-names>O</given-names></name><name><surname>Löw</surname><given-names>P</given-names></name><name><surname>Brodin</surname><given-names>L</given-names></name><name><surname>Pieribone</surname><given-names>VA</given-names></name><name><surname>Greengard</surname><given-names>P</given-names></name><name><surname>Shupliakov</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Colocalization of synapsin and actin during synaptic vesicle recycling</article-title><source>The Journal of Cell Biology</source><volume>161</volume><fpage>737</fpage><lpage>747</lpage><pub-id pub-id-type="doi">10.1083/jcb.200212140</pub-id><pub-id pub-id-type="pmid">12756235</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolz</surname><given-names>S</given-names></name><name><surname>Kaempf</surname><given-names>N</given-names></name><name><surname>Puchkov</surname><given-names>D</given-names></name><name><surname>Krauss</surname><given-names>M</given-names></name><name><surname>Russo</surname><given-names>G</given-names></name><name><surname>Soykan</surname><given-names>T</given-names></name><name><surname>Schmied</surname><given-names>C</given-names></name><name><surname>Lehmann</surname><given-names>M</given-names></name><name><surname>Müller</surname><given-names>R</given-names></name><name><surname>Schultz</surname><given-names>C</given-names></name><name><surname>Perrais</surname><given-names>D</given-names></name><name><surname>Maritzen</surname><given-names>T</given-names></name><name><surname>Haucke</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Synaptotagmin 1-triggered lipid signaling facilitates coupling of exo- and endocytosis</article-title><source>Neuron</source><volume>111</volume><fpage>3765</fpage><lpage>3774</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2023.08.016</pub-id><pub-id pub-id-type="pmid">37738980</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borst</surname><given-names>JGG</given-names></name><name><surname>Soria van Hoeve</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The calyx of Held synapse: from model synapse to auditory relay</article-title><source>Annual Review of Physiology</source><volume>74</volume><fpage>199</fpage><lpage>224</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-020911-153236</pub-id><pub-id pub-id-type="pmid">22035348</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boucrot</surname><given-names>E</given-names></name><name><surname>Ferreira</surname><given-names>APA</given-names></name><name><surname>Almeida-Souza</surname><given-names>L</given-names></name><name><surname>Debard</surname><given-names>S</given-names></name><name><surname>Vallis</surname><given-names>Y</given-names></name><name><surname>Howard</surname><given-names>G</given-names></name><name><surname>Bertot</surname><given-names>L</given-names></name><name><surname>Sauvonnet</surname><given-names>N</given-names></name><name><surname>McMahon</surname><given-names>HT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Endophilin marks and controls a clathrin-independent endocytic pathway</article-title><source>Nature</source><volume>517</volume><fpage>460</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1038/nature14067</pub-id><pub-id pub-id-type="pmid">25517094</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boulant</surname><given-names>S</given-names></name><name><surname>Kural</surname><given-names>C</given-names></name><name><surname>Zeeh</surname><given-names>JC</given-names></name><name><surname>Ubelmann</surname><given-names>F</given-names></name><name><surname>Kirchhausen</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Actin dynamics counteract membrane tension during clathrin-mediated endocytosis</article-title><source>Nature Cell Biology</source><volume>13</volume><fpage>1124</fpage><lpage>1131</lpage><pub-id pub-id-type="doi">10.1038/ncb2307</pub-id><pub-id pub-id-type="pmid">21841790</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanaday</surname><given-names>NL</given-names></name><name><surname>Kavalali</surname><given-names>ET</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Optical detection of three modes of endocytosis at hippocampal synapses</article-title><source>eLife</source><volume>7</volume><elocation-id>e36097</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.36097</pub-id><pub-id pub-id-type="pmid">29683423</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanaday</surname><given-names>NL</given-names></name><name><surname>Cousin</surname><given-names>MA</given-names></name><name><surname>Milosevic</surname><given-names>I</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Morgan</surname><given-names>JR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>The synaptic vesicle cycle revisited: New insights into the modes and mechanisms</article-title><source>The Journal of Neuroscience</source><volume>39</volume><fpage>8209</fpage><lpage>8216</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1158-19.2019</pub-id><pub-id pub-id-type="pmid">31619489</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chandrasekar</surname><given-names>I</given-names></name><name><surname>Huettner</surname><given-names>JE</given-names></name><name><surname>Turney</surname><given-names>SG</given-names></name><name><surname>Bridgman</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Myosin II regulates activity dependent compensatory endocytosis at central synapses</article-title><source>The Journal of Neuroscience</source><volume>33</volume><fpage>16131</fpage><lpage>16145</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2229-13.2013</pub-id><pub-id pub-id-type="pmid">24107946</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chauhan</surname><given-names>BK</given-names></name><name><surname>Lou</surname><given-names>M</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Lang</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Balanced Rac1 and RhoA activities regulate cell shape and drive invagination morphogenesis in epithelia</article-title><source>PNAS</source><volume>108</volume><fpage>18289</fpage><lpage>18294</lpage><pub-id pub-id-type="doi">10.1073/pnas.1108993108</pub-id><pub-id pub-id-type="pmid">22021442</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Phase separation at the synapse</article-title><source>Nature Neuroscience</source><volume>23</volume><fpage>301</fpage><lpage>310</lpage><pub-id pub-id-type="doi">10.1038/s41593-019-0579-9</pub-id><pub-id pub-id-type="pmid">32015539</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cingolani</surname><given-names>LA</given-names></name><name><surname>Goda</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Actin in action: the interplay between the actin cytoskeleton and synaptic efficacy</article-title><source>Nature Reviews. Neuroscience</source><volume>9</volume><fpage>344</fpage><lpage>356</lpage><pub-id pub-id-type="doi">10.1038/nrn2373</pub-id><pub-id pub-id-type="pmid">18425089</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clayton</surname><given-names>EL</given-names></name><name><surname>Cousin</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The molecular physiology of activity-dependent bulk endocytosis of synaptic vesicles</article-title><source>Journal of Neurochemistry</source><volume>111</volume><fpage>901</fpage><lpage>914</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06384.x</pub-id><pub-id pub-id-type="pmid">19765184</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colgan</surname><given-names>LA</given-names></name><name><surname>Yasuda</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Plasticity of dendritic spines: subcompartmentalization of signaling</article-title><source>Annual Review of Physiology</source><volume>76</volume><fpage>365</fpage><lpage>385</lpage><pub-id pub-id-type="doi">10.1146/annurev-physiol-021113-170400</pub-id><pub-id pub-id-type="pmid">24215443</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dani</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Bergan</surname><given-names>J</given-names></name><name><surname>Dulac</surname><given-names>C</given-names></name><name><surname>Zhuang</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Superresolution imaging of chemical synapses in the brain</article-title><source>Neuron</source><volume>68</volume><fpage>843</fpage><lpage>856</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2010.11.021</pub-id><pub-id pub-id-type="pmid">21144999</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daou</surname><given-names>P</given-names></name><name><surname>Hasan</surname><given-names>S</given-names></name><name><surname>Breitsprecher</surname><given-names>D</given-names></name><name><surname>Baudelet</surname><given-names>E</given-names></name><name><surname>Camoin</surname><given-names>L</given-names></name><name><surname>Audebert</surname><given-names>S</given-names></name><name><surname>Goode</surname><given-names>BL</given-names></name><name><surname>Badache</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Essential and nonredundant roles for <italic>Diaphanous formins</italic> in cortical microtubule capture and directed cell migration</article-title><source>Molecular Biology of the Cell</source><volume>25</volume><fpage>658</fpage><lpage>668</lpage><pub-id pub-id-type="doi">10.1091/mbc.E13-08-0482</pub-id><pub-id pub-id-type="pmid">24403606</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deguchi</surname><given-names>Y</given-names></name><name><surname>Harada</surname><given-names>M</given-names></name><name><surname>Shinohara</surname><given-names>R</given-names></name><name><surname>Lazarus</surname><given-names>M</given-names></name><name><surname>Cherasse</surname><given-names>Y</given-names></name><name><surname>Urade</surname><given-names>Y</given-names></name><name><surname>Yamada</surname><given-names>D</given-names></name><name><surname>Sekiguchi</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>D</given-names></name><name><surname>Furuyashiki</surname><given-names>T</given-names></name><name><surname>Narumiya</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mdia and rock mediate actin-dependent presynaptic remodeling regulating synaptic efficacy and anxiety</article-title><source>Cell Reports</source><volume>17</volume><fpage>2405</fpage><lpage>2417</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.10.088</pub-id><pub-id pub-id-type="pmid">27880913</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Del Signore</surname><given-names>SJ</given-names></name><name><surname>Kelley</surname><given-names>CF</given-names></name><name><surname>Messelaar</surname><given-names>EM</given-names></name><name><surname>Lemos</surname><given-names>T</given-names></name><name><surname>Marchan</surname><given-names>MF</given-names></name><name><surname>Ermanoska</surname><given-names>B</given-names></name><name><surname>Mund</surname><given-names>M</given-names></name><name><surname>Fai</surname><given-names>TG</given-names></name><name><surname>Kaksonen</surname><given-names>M</given-names></name><name><surname>Rodal</surname><given-names>AA</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>An autoinhibitory clamp of actin assembly constrains and directs synaptic endocytosis</article-title><source>eLife</source><volume>10</volume><elocation-id>e69597</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.69597</pub-id><pub-id pub-id-type="pmid">34324418</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delvendahl</surname><given-names>I</given-names></name><name><surname>Vyleta</surname><given-names>NP</given-names></name><name><surname>von Gersdorff</surname><given-names>H</given-names></name><name><surname>Hallermann</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Fast, temperature-sensitive and clathrin-independent endocytosis at central synapses</article-title><source>Neuron</source><volume>90</volume><fpage>492</fpage><lpage>498</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.03.013</pub-id><pub-id pub-id-type="pmid">27146271</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="confproc"><person-group person-group-type="author"><name><surname>Eisenmann</surname><given-names>KM</given-names></name><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Wallar</surname><given-names>BJ</given-names></name><name><surname>Alberts</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Rho GTPase-formin pairs in cytoskeletal remodelling</article-title><conf-name>Novartis Foundation Symposium</conf-name><fpage>206</fpage><lpage>218</lpage><pub-id pub-id-type="doi">10.1002/047001766x.ch16</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Engqvist-Goldstein</surname><given-names>AEY</given-names></name><name><surname>Drubin</surname><given-names>DG</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Actin assembly and endocytosis: from yeast to mammals</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>19</volume><fpage>287</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1146/annurev.cellbio.19.111401.093127</pub-id><pub-id pub-id-type="pmid">14570572</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>SM</given-names></name><name><surname>Brasnjo</surname><given-names>G</given-names></name><name><surname>Hayashi</surname><given-names>M</given-names></name><name><surname>Wölfel</surname><given-names>M</given-names></name><name><surname>Collesi</surname><given-names>C</given-names></name><name><surname>Giovedi</surname><given-names>S</given-names></name><name><surname>Raimondi</surname><given-names>A</given-names></name><name><surname>Gong</surname><given-names>LW</given-names></name><name><surname>Ariel</surname><given-names>P</given-names></name><name><surname>Paradise</surname><given-names>S</given-names></name><name><surname>O’toole</surname><given-names>E</given-names></name><name><surname>Flavell</surname><given-names>R</given-names></name><name><surname>Cremona</surname><given-names>O</given-names></name><name><surname>Miesenböck</surname><given-names>G</given-names></name><name><surname>Ryan</surname><given-names>TA</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>A selective activity-dependent requirement for dynamin 1 in synaptic vesicle endocytosis</article-title><source>Science</source><volume>316</volume><fpage>570</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1126/science.1140621</pub-id><pub-id pub-id-type="pmid">17463283</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>SM</given-names></name><name><surname>Raimondi</surname><given-names>A</given-names></name><name><surname>Paradise</surname><given-names>S</given-names></name><name><surname>Shen</surname><given-names>H</given-names></name><name><surname>Mesaki</surname><given-names>K</given-names></name><name><surname>Ferguson</surname><given-names>A</given-names></name><name><surname>Destaing</surname><given-names>O</given-names></name><name><surname>Ko</surname><given-names>G</given-names></name><name><surname>Takasaki</surname><given-names>J</given-names></name><name><surname>Cremona</surname><given-names>O</given-names></name><name><surname>O’ Toole</surname><given-names>E</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Coordinated actions of actin and BAR proteins upstream of dynamin at endocytic clathrin-coated pits</article-title><source>Developmental Cell</source><volume>17</volume><fpage>811</fpage><lpage>822</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2009.11.005</pub-id><pub-id pub-id-type="pmid">20059951</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gan</surname><given-names>Q</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Synaptic vesicle endocytosis in different model systems</article-title><source>Frontiers in Cellular Neuroscience</source><volume>12</volume><elocation-id>171</elocation-id><pub-id pub-id-type="doi">10.3389/fncel.2018.00171</pub-id><pub-id pub-id-type="pmid">30002619</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganguly</surname><given-names>A</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Ladt</surname><given-names>K</given-names></name><name><surname>Loi</surname><given-names>J</given-names></name><name><surname>Dargent</surname><given-names>B</given-names></name><name><surname>Leterrier</surname><given-names>C</given-names></name><name><surname>Roy</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A dynamic formin-dependent deep F-actin network in axons</article-title><source>The Journal of Cell Biology</source><volume>210</volume><fpage>401</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1083/jcb.201506110</pub-id><pub-id pub-id-type="pmid">26216902</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerth</surname><given-names>F</given-names></name><name><surname>Jäpel</surname><given-names>M</given-names></name><name><surname>Pechstein</surname><given-names>A</given-names></name><name><surname>Kochlamazashvili</surname><given-names>G</given-names></name><name><surname>Lehmann</surname><given-names>M</given-names></name><name><surname>Puchkov</surname><given-names>D</given-names></name><name><surname>Onofri</surname><given-names>F</given-names></name><name><surname>Benfenati</surname><given-names>F</given-names></name><name><surname>Nikonenko</surname><given-names>AG</given-names></name><name><surname>Fredrich</surname><given-names>K</given-names></name><name><surname>Shupliakov</surname><given-names>O</given-names></name><name><surname>Maritzen</surname><given-names>T</given-names></name><name><surname>Freund</surname><given-names>C</given-names></name><name><surname>Haucke</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Intersectin associates with synapsin and regulates its nanoscale localization and function</article-title><source>PNAS</source><volume>114</volume><fpage>12057</fpage><lpage>12062</lpage><pub-id pub-id-type="doi">10.1073/pnas.1715341114</pub-id><pub-id pub-id-type="pmid">29078407</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonschior</surname><given-names>H</given-names></name><name><surname>Schmied</surname><given-names>C</given-names></name><name><surname>Van der Veen</surname><given-names>RE</given-names></name><name><surname>Eichhorst</surname><given-names>J</given-names></name><name><surname>Himmerkus</surname><given-names>N</given-names></name><name><surname>Piontek</surname><given-names>J</given-names></name><name><surname>Günzel</surname><given-names>D</given-names></name><name><surname>Bleich</surname><given-names>M</given-names></name><name><surname>Furuse</surname><given-names>M</given-names></name><name><surname>Haucke</surname><given-names>V</given-names></name><name><surname>Lehmann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Nanoscale segregation of channel and barrier claudins enables paracellular ion flux</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>4985</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-32533-4</pub-id><pub-id pub-id-type="pmid">36008380</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goode</surname><given-names>BL</given-names></name><name><surname>Eck</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Mechanism and function of formins in the control of actin assembly</article-title><source>Annual Review of Biochemistry</source><volume>76</volume><fpage>593</fpage><lpage>627</lpage><pub-id pub-id-type="doi">10.1146/annurev.biochem.75.103004.142647</pub-id><pub-id pub-id-type="pmid">17373907</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gormal</surname><given-names>R</given-names></name><name><surname>Valmas</surname><given-names>N</given-names></name><name><surname>Fath</surname><given-names>T</given-names></name><name><surname>Meunier</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A role for tropomyosins in activity-dependent bulk endocytosis?</article-title><source>Molecular and Cellular Neurosciences</source><volume>84</volume><fpage>112</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.mcn.2017.04.003</pub-id><pub-id pub-id-type="pmid">28545680</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>C</given-names></name><name><surname>Chang</surname><given-names>J</given-names></name><name><surname>Shchedrina</surname><given-names>VA</given-names></name><name><surname>Pham</surname><given-names>VA</given-names></name><name><surname>Hartwig</surname><given-names>JH</given-names></name><name><surname>Suphamungmee</surname><given-names>W</given-names></name><name><surname>Lehman</surname><given-names>W</given-names></name><name><surname>Hyman</surname><given-names>BT</given-names></name><name><surname>Bacskai</surname><given-names>BJ</given-names></name><name><surname>Sever</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Regulation of dynamin oligomerization in cells: the role of dynamin-actin interactions and its GTPase activity</article-title><source>Traffic</source><volume>15</volume><fpage>819</fpage><lpage>838</lpage><pub-id pub-id-type="doi">10.1111/tra.12178</pub-id><pub-id pub-id-type="pmid">24891099</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higashi</surname><given-names>T</given-names></name><name><surname>Ikeda</surname><given-names>T</given-names></name><name><surname>Shirakawa</surname><given-names>R</given-names></name><name><surname>Kondo</surname><given-names>H</given-names></name><name><surname>Kawato</surname><given-names>M</given-names></name><name><surname>Horiguchi</surname><given-names>M</given-names></name><name><surname>Okuda</surname><given-names>T</given-names></name><name><surname>Okawa</surname><given-names>K</given-names></name><name><surname>Fukai</surname><given-names>S</given-names></name><name><surname>Nureki</surname><given-names>O</given-names></name><name><surname>Kita</surname><given-names>T</given-names></name><name><surname>Horiuchi</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Biochemical characterization of the Rho GTPase-regulated actin assembly by diaphanous-related formins, mDia1 and Daam1, in platelets</article-title><source>The Journal of Biological Chemistry</source><volume>283</volume><fpage>8746</fpage><lpage>8755</lpage><pub-id pub-id-type="doi">10.1074/jbc.M707839200</pub-id><pub-id pub-id-type="pmid">18218625</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higashida</surname><given-names>C</given-names></name><name><surname>Suetsugu</surname><given-names>S</given-names></name><name><surname>Tsuji</surname><given-names>T</given-names></name><name><surname>Monypenny</surname><given-names>J</given-names></name><name><surname>Narumiya</surname><given-names>S</given-names></name><name><surname>Watanabe</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>G-actin regulates rapid induction of actin nucleation by mDia1 to restore cellular actin polymers</article-title><source>Journal of Cell Science</source><volume>121</volume><fpage>3403</fpage><lpage>3412</lpage><pub-id pub-id-type="doi">10.1242/jcs.030940</pub-id><pub-id pub-id-type="pmid">18827014</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hodge</surname><given-names>RG</given-names></name><name><surname>Ridley</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Regulating Rho GTPases and their regulators</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>17</volume><fpage>496</fpage><lpage>510</lpage><pub-id pub-id-type="doi">10.1038/nrm.2016.67</pub-id><pub-id pub-id-type="pmid">27301673</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hori</surname><given-names>T</given-names></name><name><surname>Eguchi</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>HY</given-names></name><name><surname>Miyasaka</surname><given-names>T</given-names></name><name><surname>Guillaud</surname><given-names>L</given-names></name><name><surname>Taoufiq</surname><given-names>Z</given-names></name><name><surname>Mahapatra</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>H</given-names></name><name><surname>Takei</surname><given-names>K</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Microtubule assembly by tau impairs endocytosis and neurotransmission via dynamin sequestration in Alzheimer’s disease synapse model</article-title><source>eLife</source><volume>11</volume><elocation-id>e73542</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.73542</pub-id><pub-id pub-id-type="pmid">35471147</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hua</surname><given-names>Y</given-names></name><name><surname>Sinha</surname><given-names>R</given-names></name><name><surname>Thiel</surname><given-names>CS</given-names></name><name><surname>Schmidt</surname><given-names>R</given-names></name><name><surname>Hüve</surname><given-names>J</given-names></name><name><surname>Martens</surname><given-names>H</given-names></name><name><surname>Hell</surname><given-names>SW</given-names></name><name><surname>Egner</surname><given-names>A</given-names></name><name><surname>Klingauf</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A readily retrievable pool of synaptic vesicles</article-title><source>Nature Neuroscience</source><volume>14</volume><fpage>833</fpage><lpage>839</lpage><pub-id pub-id-type="doi">10.1038/nn.2838</pub-id><pub-id pub-id-type="pmid">21666673</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imoto</surname><given-names>Y</given-names></name><name><surname>Raychaudhuri</surname><given-names>S</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Fenske</surname><given-names>P</given-names></name><name><surname>Sandoval</surname><given-names>E</given-names></name><name><surname>Itoh</surname><given-names>K</given-names></name><name><surname>Blumrich</surname><given-names>EM</given-names></name><name><surname>Matsubayashi</surname><given-names>HT</given-names></name><name><surname>Mamer</surname><given-names>L</given-names></name><name><surname>Zarebidaki</surname><given-names>F</given-names></name><name><surname>Söhl-Kielczynski</surname><given-names>B</given-names></name><name><surname>Trimbuch</surname><given-names>T</given-names></name><name><surname>Nayak</surname><given-names>S</given-names></name><name><surname>Iwasa</surname><given-names>JH</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>B</given-names></name><name><surname>Ha</surname><given-names>T</given-names></name><name><surname>Inoue</surname><given-names>T</given-names></name><name><surname>Jorgensen</surname><given-names>EM</given-names></name><name><surname>Cousin</surname><given-names>MA</given-names></name><name><surname>Rosenmund</surname><given-names>C</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Dynamin is primed at endocytic sites for ultrafast endocytosis</article-title><source>Neuron</source><volume>110</volume><fpage>2815</fpage><lpage>2835</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2022.06.010</pub-id><pub-id pub-id-type="pmid">35809574</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keine</surname><given-names>C</given-names></name><name><surname>Al-Yaari</surname><given-names>M</given-names></name><name><surname>Radulovic</surname><given-names>T</given-names></name><name><surname>Thomas</surname><given-names>CI</given-names></name><name><surname>Valino Ramos</surname><given-names>P</given-names></name><name><surname>Guerrero-Given</surname><given-names>D</given-names></name><name><surname>Ranjan</surname><given-names>M</given-names></name><name><surname>Taschenberger</surname><given-names>H</given-names></name><name><surname>Kamasawa</surname><given-names>N</given-names></name><name><surname>Young</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Presynaptic Rac1 controls synaptic strength through the regulation of synaptic vesicle priming</article-title><source>eLife</source><volume>11</volume><elocation-id>e81505</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.81505</pub-id><pub-id pub-id-type="pmid">36214784</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kessels</surname><given-names>MM</given-names></name><name><surname>Qualmann</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Syndapin oligomers interconnect the machineries for endocytic vesicle formation and actin polymerization</article-title><source>The Journal of Biological Chemistry</source><volume>281</volume><fpage>13285</fpage><lpage>13299</lpage><pub-id pub-id-type="doi">10.1074/jbc.M510226200</pub-id><pub-id pub-id-type="pmid">16540475</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitzing</surname><given-names>TM</given-names></name><name><surname>Sahadevan</surname><given-names>AS</given-names></name><name><surname>Brandt</surname><given-names>DT</given-names></name><name><surname>Knieling</surname><given-names>H</given-names></name><name><surname>Hannemann</surname><given-names>S</given-names></name><name><surname>Fackler</surname><given-names>OT</given-names></name><name><surname>Grosshans</surname><given-names>J</given-names></name><name><surname>Grosse</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Positive feedback between Dia1, LARG, and RhoA regulates cell morphology and invasion</article-title><source>Genes &amp; Development</source><volume>21</volume><fpage>1478</fpage><lpage>1483</lpage><pub-id pub-id-type="doi">10.1101/gad.424807</pub-id><pub-id pub-id-type="pmid">17575049</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kononenko</surname><given-names>NL</given-names></name><name><surname>Puchkov</surname><given-names>D</given-names></name><name><surname>Classen</surname><given-names>GA</given-names></name><name><surname>Walter</surname><given-names>AM</given-names></name><name><surname>Pechstein</surname><given-names>A</given-names></name><name><surname>Sawade</surname><given-names>L</given-names></name><name><surname>Kaempf</surname><given-names>N</given-names></name><name><surname>Trimbuch</surname><given-names>T</given-names></name><name><surname>Lorenz</surname><given-names>D</given-names></name><name><surname>Rosenmund</surname><given-names>C</given-names></name><name><surname>Maritzen</surname><given-names>T</given-names></name><name><surname>Haucke</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Clathrin/AP-2 mediate synaptic vesicle reformation from endosome-like vacuoles but are not essential for membrane retrieval at central synapses</article-title><source>Neuron</source><volume>82</volume><fpage>981</fpage><lpage>988</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.05.007</pub-id><pub-id pub-id-type="pmid">24908483</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kononenko</surname><given-names>NL</given-names></name><name><surname>Haucke</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Molecular mechanisms of presynaptic membrane retrieval and synaptic vesicle reformation</article-title><source>Neuron</source><volume>85</volume><fpage>484</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2014.12.016</pub-id><pub-id pub-id-type="pmid">25654254</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>SK</given-names></name><name><surname>Sando</surname><given-names>R</given-names></name><name><surname>Lewis</surname><given-names>TL</given-names></name><name><surname>Hirabayashi</surname><given-names>Y</given-names></name><name><surname>Maximov</surname><given-names>A</given-names></name><name><surname>Polleux</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>LKB1 Regulates Mitochondria-Dependent Presynaptic Calcium Clearance and Neurotransmitter Release Properties at Excitatory Synapses along Cortical Axons</article-title><source>PLOS Biology</source><volume>14</volume><elocation-id>e1002516</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1002516</pub-id><pub-id pub-id-type="pmid">27429220</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lash</surname><given-names>LL</given-names></name><name><surname>Wallar</surname><given-names>BJ</given-names></name><name><surname>Turner</surname><given-names>JD</given-names></name><name><surname>Vroegop</surname><given-names>SM</given-names></name><name><surname>Kilkuskie</surname><given-names>RE</given-names></name><name><surname>Kitchen-Goosen</surname><given-names>SM</given-names></name><name><surname>Xu</surname><given-names>HE</given-names></name><name><surname>Alberts</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Small-molecule intramimics of formin autoinhibition: a new strategy to target the cytoskeletal remodeling machinery in cancer cells</article-title><source>Cancer Research</source><volume>73</volume><fpage>6793</fpage><lpage>6803</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-13-1593</pub-id><pub-id pub-id-type="pmid">24242070</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawson</surname><given-names>CD</given-names></name><name><surname>Ridley</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Rho GTPase signaling complexes in cell migration and invasion</article-title><source>The Journal of Cell Biology</source><volume>217</volume><fpage>447</fpage><lpage>457</lpage><pub-id pub-id-type="doi">10.1083/jcb.201612069</pub-id><pub-id pub-id-type="pmid">29233866</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López-Hernández</surname><given-names>T</given-names></name><name><surname>Takenaka</surname><given-names>KI</given-names></name><name><surname>Mori</surname><given-names>Y</given-names></name><name><surname>Kongpracha</surname><given-names>P</given-names></name><name><surname>Nagamori</surname><given-names>S</given-names></name><name><surname>Haucke</surname><given-names>V</given-names></name><name><surname>Takamori</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Clathrin-independent endocytic retrieval of SV proteins mediated by the clathrin adaptor AP-2 at mammalian central synapses</article-title><source>eLife</source><volume>11</volume><elocation-id>e71198</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.71198</pub-id><pub-id pub-id-type="pmid">35014951</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macia</surname><given-names>E</given-names></name><name><surname>Ehrlich</surname><given-names>M</given-names></name><name><surname>Massol</surname><given-names>R</given-names></name><name><surname>Boucrot</surname><given-names>E</given-names></name><name><surname>Brunner</surname><given-names>C</given-names></name><name><surname>Kirchhausen</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Dynasore, a cell-permeable inhibitor of dynamin</article-title><source>Developmental Cell</source><volume>10</volume><fpage>839</fpage><lpage>850</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2006.04.002</pub-id><pub-id pub-id-type="pmid">16740485</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marston</surname><given-names>DJ</given-names></name><name><surname>Dickinson</surname><given-names>S</given-names></name><name><surname>Nobes</surname><given-names>CD</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Rac-dependent trans-endocytosis of ephrinBs regulates Eph-ephrin contact repulsion</article-title><source>Nature Cell Biology</source><volume>5</volume><fpage>879</fpage><lpage>888</lpage><pub-id pub-id-type="doi">10.1038/ncb1044</pub-id><pub-id pub-id-type="pmid">12973357</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McMahon</surname><given-names>HT</given-names></name><name><surname>Boucrot</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Molecular mechanism and physiological functions of clathrin-mediated endocytosis</article-title><source>Nature Reviews. Molecular Cell Biology</source><volume>12</volume><fpage>517</fpage><lpage>533</lpage><pub-id pub-id-type="doi">10.1038/nrm3151</pub-id><pub-id pub-id-type="pmid">21779028</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mellor</surname><given-names>H</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>PRK1 is targeted to endosomes by the small GTPase, RhoB</article-title><source>J Biol Chem</source><volume>273</volume><fpage>4811</fpage><lpage>4814</lpage></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merrifield</surname><given-names>CJ</given-names></name><name><surname>Perrais</surname><given-names>D</given-names></name><name><surname>Zenisek</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Coupling between clathrin-coated-pit invagination, cortactin recruitment, and membrane scission observed in live cells</article-title><source>Cell</source><volume>121</volume><fpage>593</fpage><lpage>606</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2005.03.015</pub-id><pub-id pub-id-type="pmid">15907472</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miesenböck</surname><given-names>G</given-names></name><name><surname>De Angelis</surname><given-names>DA</given-names></name><name><surname>Rothman</surname><given-names>JE</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins</article-title><source>Nature</source><volume>394</volume><fpage>192</fpage><lpage>195</lpage><pub-id pub-id-type="doi">10.1038/28190</pub-id><pub-id pub-id-type="pmid">9671304</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Müller</surname><given-names>PM</given-names></name><name><surname>Rademacher</surname><given-names>J</given-names></name><name><surname>Bagshaw</surname><given-names>RD</given-names></name><name><surname>Wortmann</surname><given-names>C</given-names></name><name><surname>Barth</surname><given-names>C</given-names></name><name><surname>van Unen</surname><given-names>J</given-names></name><name><surname>Alp</surname><given-names>KM</given-names></name><name><surname>Giudice</surname><given-names>G</given-names></name><name><surname>Eccles</surname><given-names>RL</given-names></name><name><surname>Heinrich</surname><given-names>LE</given-names></name><name><surname>Pascual-Vargas</surname><given-names>P</given-names></name><name><surname>Sanchez-Castro</surname><given-names>M</given-names></name><name><surname>Brandenburg</surname><given-names>L</given-names></name><name><surname>Mbamalu</surname><given-names>G</given-names></name><name><surname>Tucholska</surname><given-names>M</given-names></name><name><surname>Spatt</surname><given-names>L</given-names></name><name><surname>Czajkowski</surname><given-names>MT</given-names></name><name><surname>Welke</surname><given-names>RW</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Nguyen</surname><given-names>V</given-names></name><name><surname>Rrustemi</surname><given-names>T</given-names></name><name><surname>Trnka</surname><given-names>P</given-names></name><name><surname>Freitag</surname><given-names>K</given-names></name><name><surname>Larsen</surname><given-names>B</given-names></name><name><surname>Popp</surname><given-names>O</given-names></name><name><surname>Mertins</surname><given-names>P</given-names></name><name><surname>Gingras</surname><given-names>AC</given-names></name><name><surname>Roth</surname><given-names>FP</given-names></name><name><surname>Colwill</surname><given-names>K</given-names></name><name><surname>Bakal</surname><given-names>C</given-names></name><name><surname>Pertz</surname><given-names>O</given-names></name><name><surname>Pawson</surname><given-names>T</given-names></name><name><surname>Petsalaki</surname><given-names>E</given-names></name><name><surname>Rocks</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Systems analysis of RhoGEF and RhoGAP regulatory proteins reveals spatially organized RAC1 signalling from integrin adhesions</article-title><source>Nature Cell Biology</source><volume>22</volume><fpage>498</fpage><lpage>511</lpage><pub-id pub-id-type="doi">10.1038/s41556-020-0488-x</pub-id><pub-id pub-id-type="pmid">32203420</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogunmowo</surname><given-names>TH</given-names></name><name><surname>Jing</surname><given-names>H</given-names></name><name><surname>Raychaudhuri</surname><given-names>S</given-names></name><name><surname>Kusick</surname><given-names>GF</given-names></name><name><surname>Imoto</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Itoh</surname><given-names>K</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Jafri</surname><given-names>H</given-names></name><name><surname>Dalva</surname><given-names>MB</given-names></name><name><surname>Chapman</surname><given-names>ER</given-names></name><name><surname>Ha</surname><given-names>T</given-names></name><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Membrane compression by synaptic vesicle exocytosis triggers ultrafast endocytosis</article-title><source>Nature Communications</source><volume>14</volume><elocation-id>2888</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-023-38595-2</pub-id><pub-id pub-id-type="pmid">37210439</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Neil</surname><given-names>SD</given-names></name><name><surname>Rácz</surname><given-names>B</given-names></name><name><surname>Brown</surname><given-names>WE</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Soderblom</surname><given-names>EJ</given-names></name><name><surname>Yasuda</surname><given-names>R</given-names></name><name><surname>Soderling</surname><given-names>SH</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Action potential-coupled Rho GTPase signaling drives presynaptic plasticity</article-title><source>eLife</source><volume>10</volume><elocation-id>e63756</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.63756</pub-id><pub-id pub-id-type="pmid">34269176</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Otomo</surname><given-names>T</given-names></name><name><surname>Otomo</surname><given-names>C</given-names></name><name><surname>Tomchick</surname><given-names>DR</given-names></name><name><surname>Machius</surname><given-names>M</given-names></name><name><surname>Rosen</surname><given-names>MK</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Structural basis of Rho GTPase-mediated activation of the formin mDia1</article-title><source>Molecular Cell</source><volume>18</volume><fpage>273</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2005.04.002</pub-id><pub-id pub-id-type="pmid">15866170</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Wallar</surname><given-names>BJ</given-names></name><name><surname>Flanders</surname><given-names>A</given-names></name><name><surname>Swiatek</surname><given-names>PJ</given-names></name><name><surname>Alberts</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Disruption of the Diaphanous-related formin Drf1 gene encoding mDia1 reveals a role for Drf3 as an effector for Cdc42</article-title><source>Current Biology</source><volume>13</volume><fpage>534</fpage><lpage>545</lpage><pub-id pub-id-type="doi">10.1016/s0960-9822(03)00170-2</pub-id><pub-id pub-id-type="pmid">12676083</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>J</given-names></name><name><surname>Kitchen</surname><given-names>SM</given-names></name><name><surname>West</surname><given-names>RA</given-names></name><name><surname>Sigler</surname><given-names>R</given-names></name><name><surname>Eisenmann</surname><given-names>KM</given-names></name><name><surname>Alberts</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Myeloproliferative defects following targeting of the Drf1 gene encoding the mammalian diaphanous related formin mDia1</article-title><source>Cancer Research</source><volume>67</volume><fpage>7565</fpage><lpage>7571</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-07-1467</pub-id><pub-id pub-id-type="pmid">17699759</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>GE</given-names></name><name><surname>Wilson</surname><given-names>SR</given-names></name><name><surname>Weiner</surname><given-names>OD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A pharmacological cocktail for arresting actin dynamics in living cells</article-title><source>Molecular Biology of the Cell</source><volume>22</volume><fpage>3986</fpage><lpage>3994</lpage><pub-id pub-id-type="doi">10.1091/mbc.E11-04-0379</pub-id><pub-id pub-id-type="pmid">21880897</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Piriya Ananda Babu</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>HY</given-names></name><name><surname>Eguchi</surname><given-names>K</given-names></name><name><surname>Guillaud</surname><given-names>L</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Microtubule and actin differentially regulate synaptic vesicle cycling to maintain high-frequency neurotransmission</article-title><source>The Journal of Neuroscience</source><volume>40</volume><fpage>131</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1571-19.2019</pub-id><pub-id pub-id-type="pmid">31767677</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raimondi</surname><given-names>A</given-names></name><name><surname>Ferguson</surname><given-names>SM</given-names></name><name><surname>Lou</surname><given-names>X</given-names></name><name><surname>Armbruster</surname><given-names>M</given-names></name><name><surname>Paradise</surname><given-names>S</given-names></name><name><surname>Giovedi</surname><given-names>S</given-names></name><name><surname>Messa</surname><given-names>M</given-names></name><name><surname>Kono</surname><given-names>N</given-names></name><name><surname>Takasaki</surname><given-names>J</given-names></name><name><surname>Cappello</surname><given-names>V</given-names></name><name><surname>O’Toole</surname><given-names>E</given-names></name><name><surname>Ryan</surname><given-names>TA</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Overlapping role of dynamin isoforms in synaptic vesicle endocytosis</article-title><source>Neuron</source><volume>70</volume><fpage>1100</fpage><lpage>1114</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2011.04.031</pub-id><pub-id pub-id-type="pmid">21689597</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramalingam</surname><given-names>N</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Breitsprecher</surname><given-names>D</given-names></name><name><surname>Lappalainen</surname><given-names>P</given-names></name><name><surname>Faix</surname><given-names>J</given-names></name><name><surname>Schleicher</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Phospholipids regulate localization and activity of mDia1 formin</article-title><source>European Journal of Cell Biology</source><volume>89</volume><fpage>723</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1016/j.ejcb.2010.06.001</pub-id><pub-id pub-id-type="pmid">20619927</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reddy-Alla</surname><given-names>S</given-names></name><name><surname>Schmitt</surname><given-names>B</given-names></name><name><surname>Birkenfeld</surname><given-names>J</given-names></name><name><surname>Eulenburg</surname><given-names>V</given-names></name><name><surname>Dutertre</surname><given-names>S</given-names></name><name><surname>Böhringer</surname><given-names>C</given-names></name><name><surname>Götz</surname><given-names>M</given-names></name><name><surname>Betz</surname><given-names>H</given-names></name><name><surname>Papadopoulos</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>PH-domain-driven targeting of collybistin but not Cdc42 activation is required for synaptic gephyrin clustering</article-title><source>The European Journal of Neuroscience</source><volume>31</volume><fpage>1173</fpage><lpage>1184</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2010.07149.x</pub-id><pub-id pub-id-type="pmid">20345913</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renard</surname><given-names>HF</given-names></name><name><surname>Simunovic</surname><given-names>M</given-names></name><name><surname>Lemière</surname><given-names>J</given-names></name><name><surname>Boucrot</surname><given-names>E</given-names></name><name><surname>Garcia-Castillo</surname><given-names>MD</given-names></name><name><surname>Arumugam</surname><given-names>S</given-names></name><name><surname>Chambon</surname><given-names>V</given-names></name><name><surname>Lamaze</surname><given-names>C</given-names></name><name><surname>Wunder</surname><given-names>C</given-names></name><name><surname>Kenworthy</surname><given-names>AK</given-names></name><name><surname>Schmidt</surname><given-names>AA</given-names></name><name><surname>McMahon</surname><given-names>HT</given-names></name><name><surname>Sykes</surname><given-names>C</given-names></name><name><surname>Bassereau</surname><given-names>P</given-names></name><name><surname>Johannes</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Endophilin-A2 functions in membrane scission in clathrin-independent endocytosis</article-title><source>Nature</source><volume>517</volume><fpage>493</fpage><lpage>496</lpage><pub-id pub-id-type="doi">10.1038/nature14064</pub-id><pub-id pub-id-type="pmid">25517096</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname><given-names>DA</given-names></name><name><surname>Rizzoli</surname><given-names>SO</given-names></name><name><surname>Betz</surname><given-names>WJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Effects of wortmannin and latrunculin A on slow endocytosis at the frog neuromuscular junction</article-title><source>The Journal of Physiology</source><volume>557</volume><fpage>77</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2004.062158</pub-id><pub-id pub-id-type="pmid">15004214</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ritter</surname><given-names>B</given-names></name><name><surname>Ferguson</surname><given-names>SM</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name><name><surname>McPherson</surname><given-names>PS</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>A lentiviral system for efficient knockdown of proteins in neuronal cultures [version 1; referees: 2 approved]</article-title><source>MNI Open Research</source><volume>1</volume><elocation-id>12766.1</elocation-id><pub-id pub-id-type="doi">10.12688/mniopenres.12766.1</pub-id><pub-id pub-id-type="pmid">29355247</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roux</surname><given-names>A</given-names></name><name><surname>Uyhazi</surname><given-names>K</given-names></name><name><surname>Frost</surname><given-names>A</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>GTP-dependent twisting of dynamin implicates constriction and tension in membrane fission</article-title><source>Nature</source><volume>441</volume><fpage>528</fpage><lpage>531</lpage><pub-id pub-id-type="doi">10.1038/nature04718</pub-id><pub-id pub-id-type="pmid">16648839</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saffarian</surname><given-names>S</given-names></name><name><surname>Cocucci</surname><given-names>E</given-names></name><name><surname>Kirchhausen</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Distinct dynamics of endocytic clathrin-coated pits and coated plaques</article-title><source>PLOS Biology</source><volume>7</volume><elocation-id>e1000191</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.1000191</pub-id><pub-id pub-id-type="pmid">19809571</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saheki</surname><given-names>Y</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Synaptic vesicle endocytosis</article-title><source>Cold Spring Harbor Perspectives in Biology</source><volume>4</volume><elocation-id>a005645</elocation-id><pub-id pub-id-type="doi">10.1101/cshperspect.a005645</pub-id><pub-id pub-id-type="pmid">22763746</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakaba</surname><given-names>T</given-names></name><name><surname>Neher</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Involvement of actin polymerization in vesicle recruitment at the calyx of Held synapse</article-title><source>The Journal of Neuroscience</source><volume>23</volume><fpage>837</fpage><lpage>846</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-03-00837.2003</pub-id><pub-id pub-id-type="pmid">12574412</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakaba</surname><given-names>T</given-names></name><name><surname>Kononenko</surname><given-names>NL</given-names></name><name><surname>Bacetic</surname><given-names>J</given-names></name><name><surname>Pechstein</surname><given-names>A</given-names></name><name><surname>Schmoranzer</surname><given-names>J</given-names></name><name><surname>Yao</surname><given-names>L</given-names></name><name><surname>Barth</surname><given-names>H</given-names></name><name><surname>Shupliakov</surname><given-names>O</given-names></name><name><surname>Kobler</surname><given-names>O</given-names></name><name><surname>Aktories</surname><given-names>K</given-names></name><name><surname>Haucke</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Fast neurotransmitter release regulated by the endocytic scaffold intersectin</article-title><source>PNAS</source><volume>110</volume><fpage>8266</fpage><lpage>8271</lpage><pub-id pub-id-type="doi">10.1073/pnas.1219234110</pub-id><pub-id pub-id-type="pmid">23633571</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sankaranarayanan</surname><given-names>S</given-names></name><name><surname>Atluri</surname><given-names>PP</given-names></name><name><surname>Ryan</surname><given-names>TA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Actin has a molecular scaffolding, not propulsive, role in presynaptic function</article-title><source>Nature Neuroscience</source><volume>6</volume><fpage>127</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1038/nn1002</pub-id><pub-id pub-id-type="pmid">12536209</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmied</surname><given-names>C</given-names></name><name><surname>Soykan</surname><given-names>T</given-names></name><name><surname>Bolz</surname><given-names>S</given-names></name><name><surname>Haucke</surname><given-names>V</given-names></name><name><surname>Lehmann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Synactj: easy-to-use automated analysis of synaptic activity</article-title><source>Frontiers in Computer Science</source><volume>3</volume><elocation-id>7837</elocation-id><pub-id pub-id-type="doi">10.3389/fcomp.2021.777837</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shinohara</surname><given-names>R</given-names></name><name><surname>Thumkeo</surname><given-names>D</given-names></name><name><surname>Kamijo</surname><given-names>H</given-names></name><name><surname>Kaneko</surname><given-names>N</given-names></name><name><surname>Sawamoto</surname><given-names>K</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Takebayashi</surname><given-names>H</given-names></name><name><surname>Kiyonari</surname><given-names>H</given-names></name><name><surname>Ishizaki</surname><given-names>T</given-names></name><name><surname>Furuyashiki</surname><given-names>T</given-names></name><name><surname>Narumiya</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A role for mDia, A Rho-regulated actin nucleator, in tangential migration of interneuron precursors</article-title><source>Nature Neuroscience</source><volume>15</volume><fpage>373</fpage><lpage>380</lpage><pub-id pub-id-type="doi">10.1038/nn.3020</pub-id><pub-id pub-id-type="pmid">22246438</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shupliakov</surname><given-names>O</given-names></name><name><surname>Bloom</surname><given-names>O</given-names></name><name><surname>Gustafsson</surname><given-names>JS</given-names></name><name><surname>Kjaerulff</surname><given-names>O</given-names></name><name><surname>Low</surname><given-names>P</given-names></name><name><surname>Tomilin</surname><given-names>N</given-names></name><name><surname>Pieribone</surname><given-names>VA</given-names></name><name><surname>Greengard</surname><given-names>P</given-names></name><name><surname>Brodin</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Impaired recycling of synaptic vesicles after acute perturbation of the presynaptic actin cytoskeleton</article-title><source>PNAS</source><volume>99</volume><fpage>14476</fpage><lpage>14481</lpage><pub-id pub-id-type="doi">10.1073/pnas.212381799</pub-id><pub-id pub-id-type="pmid">12381791</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soykan</surname><given-names>T</given-names></name><name><surname>Maritzen</surname><given-names>T</given-names></name><name><surname>Haucke</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Modes and mechanisms of synaptic vesicle recycling</article-title><source>Current Opinion in Neurobiology</source><volume>39</volume><fpage>17</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1016/j.conb.2016.03.005</pub-id><pub-id pub-id-type="pmid">27016897</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soykan</surname><given-names>T</given-names></name><name><surname>Kaempf</surname><given-names>N</given-names></name><name><surname>Sakaba</surname><given-names>T</given-names></name><name><surname>Vollweiter</surname><given-names>D</given-names></name><name><surname>Goerdeler</surname><given-names>F</given-names></name><name><surname>Puchkov</surname><given-names>D</given-names></name><name><surname>Kononenko</surname><given-names>NL</given-names></name><name><surname>Haucke</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Synaptic vesicle endocytosis occurs on multiple timescales and is mediated by formin-dependent actin assembly</article-title><source>Neuron</source><volume>93</volume><fpage>854</fpage><lpage>866</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.02.011</pub-id><pub-id pub-id-type="pmid">28231467</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Voll</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>pHluorin_Roi_Selector</data-title><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/DennisVoll/pHluorin_ROI_selector/">https://github.com/DennisVoll/pHluorin_ROI_selector/</ext-link></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Rost</surname><given-names>BR</given-names></name><name><surname>Camacho-Pérez</surname><given-names>M</given-names></name><name><surname>Davis</surname><given-names>MW</given-names></name><name><surname>Söhl-Kielczynski</surname><given-names>B</given-names></name><name><surname>Rosenmund</surname><given-names>C</given-names></name><name><surname>Jorgensen</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Ultrafast endocytosis at mouse hippocampal synapses</article-title><source>Nature</source><volume>504</volume><fpage>242</fpage><lpage>247</lpage><pub-id pub-id-type="doi">10.1038/nature12809</pub-id><pub-id pub-id-type="pmid">24305055</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Trimbuch</surname><given-names>T</given-names></name><name><surname>Camacho-Pérez</surname><given-names>M</given-names></name><name><surname>Rost</surname><given-names>BR</given-names></name><name><surname>Brokowski</surname><given-names>B</given-names></name><name><surname>Söhl-Kielczynski</surname><given-names>B</given-names></name><name><surname>Felies</surname><given-names>A</given-names></name><name><surname>Davis</surname><given-names>MW</given-names></name><name><surname>Rosenmund</surname><given-names>C</given-names></name><name><surname>Jorgensen</surname><given-names>EM</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Clathrin regenerates synaptic vesicles from endosomes</article-title><source>Nature</source><volume>515</volume><fpage>228</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1038/nature13846</pub-id><pub-id pub-id-type="pmid">25296249</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>S</given-names></name><name><surname>Boucrot</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Fast and ultrafast endocytosis</article-title><source>Current Opinion in Cell Biology</source><volume>47</volume><fpage>64</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2017.02.013</pub-id><pub-id pub-id-type="pmid">28391090</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Willems</surname><given-names>J</given-names></name><name><surname>de Jong</surname><given-names>APH</given-names></name><name><surname>Scheefhals</surname><given-names>N</given-names></name><name><surname>Mertens</surname><given-names>E</given-names></name><name><surname>Catsburg</surname><given-names>LAE</given-names></name><name><surname>Poorthuis</surname><given-names>RB</given-names></name><name><surname>de Winter</surname><given-names>F</given-names></name><name><surname>Verhaagen</surname><given-names>J</given-names></name><name><surname>Meye</surname><given-names>FJ</given-names></name><name><surname>MacGillavry</surname><given-names>HD</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Orange: a crispr/cas9-based genome editing toolbox for epitope tagging of endogenous proteins in neurons</article-title><source>PLOS Biology</source><volume>18</volume><elocation-id>e3000665</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pbio.3000665</pub-id><pub-id pub-id-type="pmid">32275651</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>O’Toole</surname><given-names>ET</given-names></name><name><surname>Girard</surname><given-names>M</given-names></name><name><surname>Ritter</surname><given-names>B</given-names></name><name><surname>Messa</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>McPherson</surname><given-names>PS</given-names></name><name><surname>Ferguson</surname><given-names>SM</given-names></name><name><surname>De Camilli</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A dynamin 1-, dynamin 3- and clathrin-independent pathway of synaptic vesicle recycling mediated by bulk endocytosis</article-title><source>eLife</source><volume>3</volume><elocation-id>e01621</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.01621</pub-id><pub-id pub-id-type="pmid">24963135</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>XS</given-names></name><name><surname>Lee</surname><given-names>SH</given-names></name><name><surname>Sheng</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Zhao</surname><given-names>WD</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Jin</surname><given-names>Y</given-names></name><name><surname>Charnay</surname><given-names>P</given-names></name><name><surname>Ervasti</surname><given-names>JM</given-names></name><name><surname>Wu</surname><given-names>LG</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Actin is crucial for all kinetically distinguishable forms of endocytosis at synapses</article-title><source>Neuron</source><volume>92</volume><fpage>1020</fpage><lpage>1035</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.10.014</pub-id><pub-id pub-id-type="pmid">27840001</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>LG</given-names></name><name><surname>Chan</surname><given-names>CY</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Multiple roles of actin in exo- and endocytosis</article-title><source>Frontiers in Synaptic Neuroscience</source><volume>14</volume><elocation-id>841704</elocation-id><pub-id pub-id-type="doi">10.3389/fnsyn.2022.841704</pub-id><pub-id pub-id-type="pmid">35308832</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Moseley</surname><given-names>JB</given-names></name><name><surname>Sagot</surname><given-names>I</given-names></name><name><surname>Poy</surname><given-names>F</given-names></name><name><surname>Pellman</surname><given-names>D</given-names></name><name><surname>Goode</surname><given-names>BL</given-names></name><name><surname>Eck</surname><given-names>MJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Crystal structures of a formin homology-2 domain reveal a tethered dimer architecture</article-title><source>Cell</source><volume>116</volume><fpage>711</fpage><lpage>723</lpage><pub-id pub-id-type="doi">10.1016/s0092-8674(04)00210-7</pub-id><pub-id pub-id-type="pmid">15006353</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>McInnes</surname><given-names>J</given-names></name><name><surname>Wierda</surname><given-names>K</given-names></name><name><surname>Holt</surname><given-names>M</given-names></name><name><surname>Herrmann</surname><given-names>AG</given-names></name><name><surname>Jackson</surname><given-names>RJ</given-names></name><name><surname>Wang</surname><given-names>Y-C</given-names></name><name><surname>Swerts</surname><given-names>J</given-names></name><name><surname>Beyens</surname><given-names>J</given-names></name><name><surname>Miskiewicz</surname><given-names>K</given-names></name><name><surname>Vilain</surname><given-names>S</given-names></name><name><surname>Dewachter</surname><given-names>I</given-names></name><name><surname>Moechars</surname><given-names>D</given-names></name><name><surname>De Strooper</surname><given-names>B</given-names></name><name><surname>Spires-Jones</surname><given-names>TL</given-names></name><name><surname>De Wit</surname><given-names>J</given-names></name><name><surname>Verstreken</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Tau association with synaptic vesicles causes presynaptic dysfunction</article-title><source>Nature Communications</source><volume>8</volume><elocation-id>15295</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms15295</pub-id><pub-id pub-id-type="pmid">28492240</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><table-wrap id="app1keyresource" position="anchor"><label>Appendix 1—key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">C57BL/6 N wild-type</td><td align="left" valign="bottom">Leibniz Research Institute for Molecular Pharmacology</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:IMSR_JAX:000664">IMSR_JAX:000664</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Genetic reagent (<italic>Mus musculus</italic>)</td><td align="left" valign="bottom">mDia1 KO</td><td align="left" valign="bottom">Bartolini Lab, Columbia University</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib58">Peng et al., 2003</xref>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/s0960-9822">https://doi.org/10.1016/s0960-9822</ext-link>(03)00170–2</td><td align="left" valign="bottom">Genetic knockout of Diaph1</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">HEK293T</td><td align="left" valign="bottom">American Type Culture Collection</td><td align="left" valign="bottom">Cat# CRL-3216; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:CVCL_0063">CVCL_0063</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">β-Actin (mouse monoclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# A5441; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_476744">AB_476744</ext-link></td><td align="left" valign="bottom">IB (1:5000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Bassoon (guinea pig monoclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">Cat# 141 318; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2927388">AB_2927388</ext-link></td><td align="left" valign="bottom">IC (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">CDC42 (rabbit polyclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab64533; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1310067">AB_1310067</ext-link></td><td align="left" valign="bottom">IB (1:1000); IC (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Dynamin1 (rabbit polyclonal)</td><td align="left" valign="bottom">Pietro D. Camilli</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib76">Shupliakov et al., 2002</xref>; DOI: 10.1126/science.276.5310.29</td><td align="left" valign="bottom">IB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">GFP (mouse monoclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# A-11120; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_221568">AB_221568</ext-link></td><td align="left" valign="bottom">IC (1:2500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Homer1 (mouse monoclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">Cat# 160 011; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2120992">AB_2120992</ext-link></td><td align="left" valign="bottom">IC (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Homer1 (rabbit polyclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">Cat# 160 003; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_887730">AB_887730</ext-link></td><td align="left" valign="bottom">IC (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">LAMP1 (rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 9091; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2687579">AB_2687579</ext-link></td><td align="left" valign="bottom">IB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">mDia1 (mouse monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 610848; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_398167">AB_398167</ext-link></td><td align="left" valign="bottom">IB (1:500); IP (2 µg)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">mDia1 (rabbit monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab129167; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_11143749">AB_11143749</ext-link></td><td align="left" valign="bottom">IC (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">mDia3 (rabbit polyclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# HPA005647; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_1078657">AB_1078657</ext-link></td><td align="left" valign="bottom">IB (1:1000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Myosin IIb (mouse monoclonal)</td><td align="left" valign="bottom">Abcam</td><td align="left" valign="bottom">Cat# ab684; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_305661">AB_305661</ext-link></td><td align="left" valign="bottom">IC (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Myosin IIb (rabbit polyclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 3404; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_126421">AB_126421</ext-link></td><td align="left" valign="bottom">IB (1:2000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Rac1 (mouse monoclonal)</td><td align="left" valign="bottom">BD Biosciences</td><td align="left" valign="bottom">Cat# 610650; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_397977">AB_397977</ext-link></td><td align="left" valign="bottom">IB (1:1000); IC (1:50)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">RFP (rabbit polyclonal)</td><td align="left" valign="bottom">Takara Bio</td><td align="left" valign="bottom">Cat# 632496; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10013483">AB_10013483</ext-link></td><td align="left" valign="bottom">IC (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">RhoA (rabbit monoclonal)</td><td align="left" valign="bottom">Cell Signaling Technology</td><td align="left" valign="bottom">Cat# 2117; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10693922">AB_10693922</ext-link></td><td align="left" valign="bottom">IB (1:1000); IC (1:100)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">α-Tubulin (mouse monoclonal)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# T9026; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_47759">AB_47759</ext-link></td><td align="left" valign="bottom">IB (1:5000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">IgG control (mouse monoclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# 31903; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10959891">AB_10959891</ext-link></td><td align="left" valign="bottom">IP (2 μg)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">vGAT-CypHer5E (rabbit polyclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">Cat# 131 103CpH; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2189809">AB_2189809</ext-link></td><td align="left" valign="bottom">Live-imaging (1:500)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse IgG Atto542 (donkey polyclonal)</td><td align="left" valign="bottom">Martin Lehmann</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib29">Gonschior et al., 2022</xref>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-022-32533-4">https://doi.org/10.1038/s41467-022-32533-4</ext-link></td><td align="left" valign="bottom">IC (1:400)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rabbit IgG Atto542 (donkey polyclonal)</td><td align="left" valign="bottom">Martin Lehmann</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib29">Gonschior et al., 2022</xref>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-022-32533-4">https://doi.org/10.1038/s41467-022-32533-4</ext-link></td><td align="left" valign="bottom">IC (1:400)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse Alexa Fluor 594 (goat polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# A-11032; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534091">AB_2534091</ext-link></td><td align="left" valign="bottom">IC (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rabbit Alexa Fluor 594 (goat polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# A-11037; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2534095">AB_2534095</ext-link></td><td align="left" valign="bottom">IC (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-guinea pig Atto647N (camelid monoclonal)</td><td align="left" valign="bottom">Synaptic Systems</td><td align="left" valign="bottom">Cat# N0602-At647N-S; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2744576">AB_2744576</ext-link></td><td align="left" valign="bottom">IC (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse Alexa Fluor 647 (goat polyclonal)</td><td align="left" valign="bottom">Thermo Fisher Scientific</td><td align="left" valign="bottom">Cat# A-21235; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2535804">AB_2535804</ext-link></td><td align="left" valign="bottom">IC (1:200)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse IRDye 680RD (goat polyclonal)</td><td align="left" valign="bottom">LI-COR Biosciences</td><td align="left" valign="bottom">Cat# 925–68070; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2651128">AB_2651128</ext-link></td><td align="left" valign="bottom">IB (1:10000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rabbit IRDye 680RD (goat polyclonal)</td><td align="left" valign="bottom">LI-COR Biosciences</td><td align="left" valign="bottom">Cat# 926–68071; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_10956166">AB_10956166</ext-link></td><td align="left" valign="bottom">IB (1:10000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-mouse IgG, IRDye 800CW (goat polyclonal)</td><td align="left" valign="bottom">LI-COR Biosciences</td><td align="left" valign="bottom">Cat# 926–32210; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_621842">AB_621842</ext-link></td><td align="left" valign="bottom">IB (1:10000)</td></tr><tr><td align="left" valign="bottom">Antibody</td><td align="left" valign="bottom">Anti-rabbit IgG, IRDye 800CW (goat polyclonal)</td><td align="left" valign="bottom">LI-COR Biosciences</td><td align="left" valign="bottom">Cat# 926–32211; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_621843">AB_621843</ext-link></td><td align="left" valign="bottom">IB (1:10000)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Phalloidin-Alexa Fluor 594</td><td align="left" valign="bottom">AAT Bioquest</td><td align="left" valign="bottom">Cat# ABD-23158</td><td align="left" valign="bottom">IC (1:1000)</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Synaptophysin-pHluorin</td><td align="left" valign="bottom">Leon Lagnado</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib29">Gonschior et al., 2022</xref>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41467-022-32533-4">https://doi.org/10.1038/s41467-022-32533-4</ext-link></td><td align="left" valign="bottom">Expresses rat Synaptophysin-2xpHluorin (inserted between Asn<sub>183</sub> – Thr<sub>184</sub>) under a CMV promotor</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">vGlut1-pHluorin</td><td align="left" valign="bottom">Volker Haucke</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib5">Bolz et al., 2023</xref>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.neuron.2023.08.016">https://doi.org/10.1016/j.neuron.2023.08.016</ext-link></td><td align="left" valign="bottom">Expresses rat vGlut1-pHluorin (inserted between Gly<sub>99</sub> – Gly<sub>100</sub>) under a hSyn1 promotor; lentiviral plasmid</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">mCherry</td><td align="left" valign="bottom">Clontech</td><td align="left" valign="bottom">Cat# 632523</td><td align="left" valign="bottom">Expresses mCherry under a CMV promotor</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">mDia1-WT-mCherry</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">-</td><td align="left" valign="bottom">Expresses mouse mDia1-WT-mCherry under a CMV promotor</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">mDia1-ΔN -mCherry</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">-</td><td align="left" valign="bottom">Expresses truncation (first 60 AA) variant of mouse mDia1-mCherry under a CMV promotor</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">mDia1-WT-SNAP</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">-</td><td align="left" valign="bottom">Expresses mouse mDia1-WT-SNAP under a hSyn1 promotor; lentiviral plasmid</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">mDia1-K994A-SNAP</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">-</td><td align="left" valign="bottom">Expresses K994A variant of mDia1-SNAP under a hSyn1 promotor; lentiviral plasmid</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Dynamin1-WT-SNAP</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">-</td><td align="left" valign="bottom">Expresses mouse Dynamin1-WT-SNAP under a hSyn1 promotor; lentiviral plasmid</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Dynamin1-K44A-SNAP</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">-</td><td align="left" valign="bottom">Expresses K44A variant of mouse Dynamin1-SNAP under a hSyn1 promotor; lentiviral plasmid</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">vGlut1-mCherry</td><td align="left" valign="bottom">Franck Polleux</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib44">Kwon et al., 2016</xref>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pbio.1002516">https://doi.org/10.1371/journal.pbio.1002516</ext-link></td><td align="left" valign="bottom">Expresses rat vGlut1-mCherry under a CAG promotor</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Rac1-CA</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">Cat# 12983; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_12983">Addgene_12983</ext-link></td><td align="left" valign="bottom">Expresses Q61L variant of human myc-Rac1 under a CMV promotor</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">Rac1-DN</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">Cat# 12984; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_12984">Addgene_12984</ext-link></td><td align="left" valign="bottom">Expresses T17N variant of human myc-Rac1 under a CMV promotor</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">RhoA-WT</td><td align="left" valign="bottom">Theofilos Papadopoulos</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib64">Reddy-Alla et al., 2010</xref>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1460-9568.2010.07149.x">https://doi.org/10.1111/j.1460-9568.2010.07149.x</ext-link></td><td align="left" valign="bottom">Expresses human 3xHA-RhoA-WT under a CMV promotor</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">RhoA-DN</td><td align="left" valign="bottom">Theofilos Papadopoulos</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib64">Reddy-Alla et al., 2010</xref>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1460-9568.2010.07149.x">https://doi.org/10.1111/j.1460-9568.2010.07149.x</ext-link></td><td align="left" valign="bottom">Expresses T19N variant of human 3xHA-RhoA under a CMV promotor</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">RhoB-WT</td><td align="left" valign="bottom">Harry Mellor</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib51">Mellor, 1998</xref>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.273.9.4811">https://doi.org/10.1074/jbc.273.9.4811</ext-link></td><td align="left" valign="bottom">Expresses human myc-RhoB-WT under a CMV promotor</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">RhoB-DN</td><td align="left" valign="bottom">Harry Mellor</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib51">Mellor, 1998</xref>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1074/jbc.273.9.4811">https://doi.org/10.1074/jbc.273.9.4811</ext-link></td><td align="left" valign="bottom">Expresses T19N variant of human myc-RhoB under a CMV promotor</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">shCTR (transfected)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# SHC016</td><td align="left" valign="bottom">No murine targets</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">shmDia1 (transfected)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# TRCN0000108685</td><td align="left" valign="bottom">Targets 3'UTR of NM_007858</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">shRhoA (transfected)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# TRCN0000302388</td><td align="left" valign="bottom">Targets CDS of NM_016802</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">shRhoB (transfected)</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# TRCN0000294874</td><td align="left" valign="bottom">Targets CDS of NM_007483</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">shCTRmiR</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">-</td><td align="left" valign="bottom">Expresses rat Synaptophysin-2xpHluorin under a CMV promotor and shRNA embedded into a microRNA (shRNAmiR) with no murine targets</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">shmDia1miR</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">-</td><td align="left" valign="bottom">Expresses rat Synaptophysin-2xpHluorin under a CMV promotor and shRNAmiR against the CDS of mouse Diaph1 (mDia1)</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">shCTR (transduced)</td><td align="left" valign="bottom">Christian Rosenmund</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib81">Watanabe et al., 2014</xref>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/nature13846">https://doi.org/10.1038/nature13846</ext-link></td><td align="left" valign="bottom">Expresses NLS-RFP or BFP under a hSyn1 promotor and shRNA against no murine target (msClathrin scrambled) under a U6 promotor</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">shmDia1 (transduced)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">-</td><td align="left" valign="bottom">Expresses NLS-RFP or BFP under a hSyn1 promotor and shRNA against the 3'UTR of mouse Diaph1 (mDia1) under a U6 promotor</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">shmDia3 (transduced)</td><td align="left" valign="bottom">This study</td><td align="left" valign="bottom">-</td><td align="left" valign="bottom">Expresses NLS-RFP or BFP under a hSyn1 promotor and shRNA against the CDS of mouse Diaph2 (mDia3) under a U6 promotor</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">MD2.G</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">Cat# 12259; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_12259">Addgene_12259</ext-link></td><td align="left" valign="bottom">Expresses lentiviral VSV-G envelope protein</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">psPAX2</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">Cat# 12260; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_12260">Addgene_12260</ext-link></td><td align="left" valign="bottom">Expresses lentiviral packaging protein</td></tr><tr><td align="left" valign="bottom">Recombinant DNA reagent</td><td align="left" valign="bottom">pOrange GFP-β-Actin KI</td><td align="left" valign="bottom">Addgene</td><td align="left" valign="bottom">Cat#131479; RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:Addgene_131479">Addgene_131479</ext-link></td><td align="left" valign="bottom">gRNA and GFP donor for endogenous N-terminal tagging of β-Actin (amino acid position: D2) by targeting Actb</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Dynasore</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# D7693</td><td align="left" valign="bottom">80 μM 10 min</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">EHT 1864</td><td align="left" valign="bottom">MedChemExpress</td><td align="left" valign="bottom">Cat# HY-16659</td><td align="left" valign="bottom">10 μM acute (CypHer); 2 h (IC/EM)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">IMM-01</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# SML1064</td><td align="left" valign="bottom">10 μM acute</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Jasplakinolide</td><td align="left" valign="bottom">Sigma-Aldrich</td><td align="left" valign="bottom">Cat# J4580</td><td align="left" valign="bottom">8 μM acute (JLY); 1 μM 30 min</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Latrunculin A</td><td align="left" valign="bottom">Cayman Chemical</td><td align="left" valign="bottom">Cat# CAY10684</td><td align="left" valign="bottom">5 µM acute (JLY)</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">ML141</td><td align="left" valign="bottom">MedChemExpress</td><td align="left" valign="bottom">Cat# HY-12755</td><td align="left" valign="bottom">10 µM acute</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Rhosin</td><td align="left" valign="bottom">MedChemExpress</td><td align="left" valign="bottom">Cat# HY-12646</td><td align="left" valign="bottom">10 µM 2 h</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Tetrodotoxin</td><td align="left" valign="bottom">Carl Roth</td><td align="left" valign="bottom">Cat# 6973.1</td><td align="left" valign="bottom">1 µM 36 h</td></tr><tr><td align="left" valign="bottom">Chemical compound, drug</td><td align="left" valign="bottom">Y-27632</td><td align="left" valign="bottom">Tocris</td><td align="left" valign="bottom">Cat# 1254</td><td align="left" valign="bottom">1 µM acute (JLY)</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Rhotekin-Rho binding domain (RBD) beads</td><td align="left" valign="bottom">Cytoskeleton Inc</td><td align="left" valign="bottom">Cat# RT02</td><td align="left" valign="bottom">60 μg</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">PAK-p21 binding domain (PBD) beads</td><td align="left" valign="bottom">Cytoskeleton Inc</td><td align="left" valign="bottom">Cat# PAK02</td><td align="left" valign="bottom">20 μg</td></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">ProFection Mammalian Transfection System – Calcium Phosphate</td><td align="left" valign="bottom">Promega</td><td align="left" valign="bottom">Cat# E1200</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Gibson Master Mix</td><td align="left" valign="bottom">New England Biolabs Inc</td><td align="left" valign="bottom">Cat# E2611L</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Q5 site-directed mutagenesis kit</td><td align="left" valign="bottom">New England Biolabs Inc</td><td align="left" valign="bottom">Cat# E0552S</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Fiji</td><td align="left" valign="bottom">NIH</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002285">SCR_002285</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Prism</td><td align="left" valign="bottom">GraphPad</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_002798">SCR_002798</ext-link></td><td align="left" valign="bottom">Version 9.5.1.</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Image Lab Software</td><td align="left" valign="bottom">Bio-Rad</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_014210">SCR_014210</ext-link></td><td align="left" valign="bottom">Version 6.0.1</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Image Studio Lite</td><td align="left" valign="bottom">LI-COR Biosciences</td><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_013715">SCR_013715</ext-link></td><td align="left" valign="bottom">Version 5.2.5</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">pHluorin ROI sector</td><td align="left" valign="bottom">Github</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/DennisVoll/pHluorin_ROI_selector/">https://github.com/DennisVoll/pHluorin_ROI_selector/</ext-link>; <xref ref-type="bibr" rid="bib79">Voll, 2020</xref></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">SynActJ</td><td align="left" valign="bottom">Martin Lehmann</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib74">Schmied et al., 2021</xref>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcomp.2021.777837">https://doi.org/10.3389/fcomp.2021.777837</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Macro_plot_lineprofile_multicolor</td><td align="left" valign="bottom">Kees Straatman</td><td align="left" valign="bottom"><xref ref-type="bibr" rid="bib28">Gerth et al., 2017</xref>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.str.2019.03.020">https://doi.org/10.1016/j.str.2019.03.020</ext-link></td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">MaxQuant</td><td align="left" valign="bottom">Jürgen Cox</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.maxquant.org/maxquant/">https://www.maxquant.org/maxquant/</ext-link></td><td align="left" valign="bottom">Version 1.6.1.0</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">Perseus</td><td align="left" valign="bottom">Jürgen Cox</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://www.maxquant.org/perseus/">https://www.maxquant.org/perseus/</ext-link></td><td align="left" valign="bottom">Version 1.6.7.0</td></tr><tr><td align="left" valign="bottom">Sequence-based reagent</td><td align="left" valign="bottom">see <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92755.3.sa0</article-id><title-group><article-title>eLife assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Dötsch</surname><given-names>Volker</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Goethe University</institution><country>Germany</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Convincing</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Important</kwd></kwd-group></front-stub><body><p>This manuscript provides <bold>convincing</bold> evidence for the involvement of membrane actin, and its regulatory proteins, mDia1/3, RhoA, and Rac1 in the mechanism of synaptic vesicle re-uptake (endocytosis). These <bold>important</bold> data fill a gap in the understanding of how the regulation of actin dynamics and endocytosis are linked. The manuscript will be of interest to all scientists working on cellular trafficking and membrane remodeling.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92755.3.sa1</article-id><title-group><article-title>Reviewer 1 Public Review:</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The authors set out to clarify the molecular mechanism of endocytosis (re-uptake) of synaptic vesicle (SV) membrane in the presynaptic terminal following release. They have examined the role of presynaptic actin, and of the actin regulatory proteins diaphanous-related formins ( mDia1/3), and Rho and Rac GTPases in controlling the endocytosis. They successfully show that presynaptic membrane-associated actin is required for normal SV endocytosis in the presynaptic terminal, and that the rate of endocytosis is increased by activation of mDia1/3. They show that RhoA activity and Rac1 activity act in a partially redundant and synergistic fashion together with mDia1/3 to regulate the rate of SV endocytosis. The work adds substantially to our understanding of the molecular mechanisms of SV endocytosis in the presynaptic terminal.</p><p>Strengths:</p><p>The authors use state-of-the-art optical recording of presynaptic endocytosis in primary hippocampal neurons, combined with well-executed genetic and pharmacological perturbations to document effects of alteration of actin polymerization on the rate of SV endocytosis. They show that removal of the short amino-terminal portion of mDia1 that associates with the membrane interrupts the association of mDia1 with membrane actin in the presynaptic terminal. They then use a wide variety of controlled perturbations, including genetic modification of the amount of mDia1/3 by knock-down and knockout, combined with inhibition of activity of RhoA and Rac1 by pharmacological agents, to document the quantitative importance of each agent, and their synergistic relationship in regulation of endocytosis.</p><p>The analysis is augmented by ultrastructural analyses that demonstrate the quantitative changes in numbers of synaptic vesicles and in uncoated membrane invaginations that are predicted by the optical recordings.</p><p>The manuscript is well-written and the data are clearly explained. Statistical analysis of the data is strengthened by the very large number of data points analyzed for each experiment.</p><p>Weaknesses:</p><p>There are no major weaknesses.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92755.3.sa2</article-id><title-group><article-title>Reviewer 2 Public Review:</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>This manuscript expands previous work from the Haucke group which demonstrated the role of formins in synaptic vesicle endocytosis. The techniques used to address the research question are state-of-the-art. As stated above there is a significant advance in knowledge, with particular respect to Rho/Rac signalling.</p><p>Strengths:</p><p>The major strength of the work was to reveal new information regarding the control of both presynaptic actin dynamics and synaptic vesicle endocytosis via Rho/Rac cascades. In addition, there was further mechanistic insight regarding the specific function of mDia1/3. The methods used were state-of-the-art.</p><p>Weaknesses:</p><p>There are no major weaknesses.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.92755.3.sa3</article-id><title-group><article-title>Author Response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Oevel</surname><given-names>Kristine</given-names></name><role specific-use="author">Author</role><aff><institution>Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Hohensee</surname><given-names>Svea</given-names></name><role specific-use="author">Author</role><aff><institution>Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Atul</given-names></name><role specific-use="author">Author</role><aff><institution>Columbia University Medical Center</institution><addr-line><named-content content-type="city">New York City</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Rosas-Brugada</surname><given-names>Irving</given-names></name><role specific-use="author">Author</role><aff><institution>Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Bartolini</surname><given-names>Francesca</given-names></name><role specific-use="author">Author</role><aff><institution>Columbia University</institution><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff></contrib><contrib contrib-type="author"><name><surname>Soykan</surname><given-names>Tolga</given-names></name><role specific-use="author">Author</role><aff><institution>Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff></contrib><contrib contrib-type="author"><name><surname>Haucke</surname><given-names>Volker</given-names></name><role specific-use="author">Author</role><aff><institution>Leibniz-Forschungsinstitut für Molekulare Pharmakologie</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Public reviews</bold></p><p><bold>Reviewer 1 (Public Review):</bold></p><p>Summary:</p><p>The authors set out to clarify the molecular mechanism of endocytosis (re-uptake) of synaptic vesicle (SV) membrane in the presynaptic terminal following release. They have examined the role of presynaptic actin, and of the actin regulatory proteins diaphanous-related formins (mDia1/3), and Rho and Rac GTPases in controlling the endocytosis. They successfully show that presynaptic membrane-associated actin is required for normal SV endocytosis in the presynaptic terminal and that the rate of endocytosis is increased by activation of mDia1/3. They show that RhoA activity and Rac1 activity act in a partially redundant and synergistic fashion together with mDia1/3 to regulate the rate of SV endocytosis. The work adds substantially to our understanding of the molecular mechanisms of SV endocytosis in the presynaptic terminal.</p><p>Strengths:</p><p>The authors use state-of-the-art optical recording of presynaptic endocytosis in primary hippocampal neurons, combined with well-executed genetic and pharmacological perturbations to document effects of alteration of actin polymerization on the rate of SV endocytosis. They show that removal of the short amino-terminal portion of mDia1 that associates with the membrane interrupts the association of mDia1 with membrane actin in the presynaptic terminal. They then use a wide variety of controlled perturbations, including genetic modification of the amount of mDia1/3 by knock-down and knockout, combined with inhibition of activity of RhoA and Rac1 by pharmacological agents, to document the quantitative importance of each agent and their synergistic relationship in regulation of endocytosis.</p><p>The analysis is augmented by ultrastructural analyses that demonstrate the quantitative changes in numbers of synaptic vesicles and in uncoated membrane invaginations that are predicted by the optical recordings.</p><p>The manuscript is well-written and the data are clearly explained. Statistical analysis of the data is strengthened by the very large number of data points analyzed for each experiment.</p><p>Weaknesses:</p><p>There are no major weaknesses. The optical images as first presented are small and it is recommended that the authors provide larger, higher-resolution images.</p></disp-quote><p>Response: We thank the referee for these highly positive remarks. In response, we now provide larger, high-resolution images as requested.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer 2 (Public Review):</bold></p><p>Summary:</p><p>This manuscript expands on previous work from the Haucke group which demonstrated the role of formins in synaptic vesicle endocytosis. The techniques used to address the research question are state-of-the-art. As stated above there is a significant advance in knowledge, with particular respect to Rho/Rac signalling.</p><p>Strengths:</p><p>The major strength of the work was to reveal new information regarding the control of both presynaptic actin dynamics and synaptic vesicle endocytosis via Rho/Rac cascades. In addition, there was further mechanistic insight regarding the specific function of mDia1/3. The methods used were state-of-the-art.</p><p>Weaknesses:</p><p>There are a number of instances where the conclusions drawn are not supported by the submitted data, or further work is required to confirm these conclusions.</p></disp-quote><p>Response: We thank the referee for his/her thorough reading of the manuscript and the thoughtful comments and questions. We have conducted additional experiments and made textual change to our manuscript to address these points and to further strengthen the conclusions as detailed in our response to the recommendations for authors.</p><disp-quote content-type="editor-comment"><p><bold>Recommendations for the authors</bold></p><p><bold>Reviewer 1 (Recommendations For The Authors):</bold></p><p>Most of the figures contain images that are too small to be easily interpreted because the resolution is degraded when they are enlarged in the PDF file. The authors should redesign the figures so that the letters marking each panel are smaller, and the size of each data panel is much larger (at least twice as large with increased resolution). There is, at present, a great deal of white space in most of the figures that should be reduced to make room for larger, higher-resolution images. Larger fonts should be used for annotations of the images so that they are easier to read. The data appears to be very high quality, but it is presented at a size and resolution that don't do it justice.</p></disp-quote><p>Response: We thank the referee for his/ her helpful comments. In response to the referee’s comment, we have carefully re-arranged all figures and now provide larger, high-resolution images.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer 2 (Recommendations For The Authors):</bold></p><p>Major points</p><p>(1) Figure 1 - While there is a rationale for employing a cocktail of drugs to interfere with actin dynamics, it would be highly informative to determine the effect of these modulators in isolation. This is important, since in their previous publication (Soykan et al Neuron 2017 93:854) the authors demonstrated that latrunculin had no effect, while jasplakinolide accelerated endocytosis of originating purely from Y-27362 and ROCK kinase inhibition, rather than destabilisation/stabilisation of actin. It will be key to dissect this by examining the effect on endocytosis of both (1) a cocktail of latrunculin/jasplakinolide and (2) Y-27362 alone.</p></disp-quote><p>Response: We thank the referee for highlighting this interesting point. We have now experimentally addressed the effect of latrunculin (L), jasplakinolide (J) and the ROCK inhibitor Y-27362 (Y) either alone or in combination on the kinetics of synaptic vesicle (SV) endocytosis(new Fig. 1-Supplement 1C,D). We now demonstrate that application of the ROCK inhibitor Y-27362 or the combination of latrunculin (L) and jasplakinolide (J) have no effect on Syph-pH endocytosis. Combined use of jasplakinolide (J) and the ROCK inhibitor Y-27362 (Y) has a small phenotype. In contrast, a mix of all three inhibitors (JYL) potently impairs endocytosis kinetics at hippocampal synapses. These data demonstrate that actin dynamics are required for SV endocytosis, while ROCK inhibition alone does not appear to impair endocytosis kinetics. We note that our data are in line with a study by Ann Saal et al (2020) who reported a lack of effect of ROCK inhibition on the kinetics of Synaptotagmin1-CypHer retrieval.</p><disp-quote content-type="editor-comment"><p>(2) Figure 1 - There are clear effects on the retrieval of pHluorin reporters and also endogenous vGAT in the presence of disruptors of actin function. However, there was no assessment of the impact of these interventions on either neurotransmitter release or SV fusion (with the exception of 1 condition with one stimulus train (Fig S1D), and the effect of Rac modulation in Fig S6F). As quoted by the authors, previous studies using knockout of beta- or gamma-actin have shown a profound effect on these parameters in hippocampal neurons, which has the potential to impact the speed and extent of compensatory endocytosis. The authors will already have this data from the use of the two reporters (pHluorn and GAT-cypHer), and it is important to include this to allow interpretation of the effect on endocytosis observed.</p></disp-quote><p>Response: We agree with the referee that this is an important point that we have tackled experimentally using vGAT-CypHer and synapto-pHluorin responses as measures. In the new Fig. 1-Supplement 1, Fig. 5- Supplement 1, and Fig.6 -Supplement 1 of our revised manuscript, we show that SV exocytosis is largely unaffected by any of the applied manipulations of actin function.</p><p>Specifically, we have added surface normalized data as a surrogate measure for exocytosis for the following:</p><list list-type="bullet"><list-item><p>JLY treatment monitored by Syph-pH (Figure 1-Supplement 1A) and vGAT-CypHer (Figure 1-Supplement 1B),</p></list-item><list-item><p>shCTR/shmDia1 (transfected) assayed via Syph-pH (Figure 1-Supplement 1G),</p></list-item><list-item><p>shCTR/shmDia1/shmDia1+3 assayed via vGLUT1-pH (40AP: Figure 1-Supplement 1J; 80AP: Figure 1-Supplement 1L),</p></list-item><list-item><p>shCTR/shmDia1+3 (transduced) assayed by vGAT-CypHer (Figure 1-Supplement 1M),</p></list-item><list-item><p>IMM treatment monitored by vGLUT1-pH (Figure 1-Supplement 1O),</p></list-item><list-item><p>RhoA/B WT/DN overexpression monitored by Syph-pH (Figure 5-Supplement 1B),</p></list-item><list-item><p>shCTR/shRhoA+B (transfected) monitored via Syph-pH (Figure 5-Supplement 1D),</p></list-item><list-item><p>shCTR/shmDia1+3 +/- EHT 1864 (Rac Inhibitor) assayed by vGAT-CypHer (Figure 6-Supplement 1D),</p></list-item><list-item><p>shCTR/shmDia1+3 +/- Rac1-CA/DN assayed by Syph-pH (Figure 6-Supplement 1F).</p></list-item></list><p>The lack of effect of these manipulations on exocytic SV fusion is thus distinct from the effects of complete abrogation of actin expression in beta- or gamma-actin knockout studies reported by the LingGang Wu laboratory (Neuron 2016) as the referee also noted.</p><disp-quote content-type="editor-comment"><p>(3) Figure 3H, 3K, 4C, 4F - It is unclear how the values on the Y-axis were calculated. Regardless, to confirm that there is a specific increase in presynaptic mDia1/actin, the equivalent values for Homer/mDia1 should be presented (with Basson/Homer as a negative control). Without this, it is difficult to argue for a specific enrichment of mDia1/actin at the presynapse. The CRISPR experiments help with this interpretation (Fig 4G-I), however, inclusion of the Homer/mDia1 STED data would strengthen it greatly.</p></disp-quote><p>Response: We apologize if the description has been unclear. We essentially have followed the same type of analysis as recently described by Bolz et al (2023). In brief, the rationale for quantifying presynaptic protein levels of interests is as follows: The presynaptic area was defined by the normalized distribution curve of Bassoon, i.e. area between 151.37 and -37.84 nm as marked by purple shading with a cutoff set where Bassoon and Homer1 distributions overlap (-37.84 nm) as shown in Figure 3Supplement 1H (pasted below). The individual synaptic line profiles, e.g. of mDia1 were integrated to yield presynaptic between 151.37 and -37.84 nm (purple in the graph) vs. postsynaptic levels from - 56.76 to -245.97 nm (green shaded area). new Figure 3-Supplement 1H-J</p><fig id="sa3fig1" position="float"><label>Author response image 1.</label><caption><title>Based on this analysis postsynaptic mDia1 levels were also elevated upon Dynasore treatment (new Figure 3-Supplement 1I).</title><p>In spite of this and consistent with the fact that the majority of mDia1 is localized at the presynapse, we found that postsynaptic F-actin levels were unchanged in mDia1/3depleted neurons (p = 0.0966; One sample t-test) (new Figure 4-Supplement 1E,F).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92755-sa3-fig1-v1.tif"/></fig><fig id="sa3fig2" position="float"><label>Author response image 2.</label><caption><title>Moreover, we also conducted further analysis with respect to possible effects of Dynasore on synaptic architecture in general.</title><p>Neither presynaptic Bassoon nor postsynaptic Homer1 levels were significantly altered by Dynasore treatment (new Figure 3–Supplement 1J).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-92755-sa3-fig2-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>(4) Figure 4J - The rescue of the pHlourin response by jasplakinolide is difficult to interpret when considering previous work from the same authors. In their 2017 publication (Soykan et al Neuron 2017 93:854), they revealed that the drug accelerated the pHluorin response, whereas now they demonstrate no effect in the control condition. If the drug does accelerate endocytosis, then it may be working via a different mechanism to restore endocytosis in mDia1/3 knockdown neurons.</p></disp-quote><p>Response: The referee is correct. The very mild acceleration of endocytosis in the presence of jasplakinolide can be observed using synaptophysin-pHluorin as a reporter under moderate mediumfrequency stimulation at 10Hz for 5 s (i.e. 50 APs). In the present dataset using a different pHluorin reporter (i.e. vGLUT1-pHluorin) that tends to yield faster endocytic responses (as noted before by the Ryan lab) and using a high frequency stimulus (20Hz) we fail to observe a significant effect. While this cannot be excluded, we would be reluctant to conclude that these differences indicate distinct mechanisms of jasplakinolide action. Alternatively, actin may be of particular importance under conditions of high-frequency stimulation.</p><disp-quote content-type="editor-comment"><p>In this regard, the conclusions from the pHluorin experiment would be greatly strengthened by demonstrating that jasplakinolide corrects the reduction of presynaptic actin in mDia1/3 knockdown synapses observed in figures 4E-I.</p></disp-quote><p>Response: As demonstrated in Figure 4-Supplement 1G and in support of a common mechanism of action, we find that application of jasplakinolide rescues reduced presynaptic actin levels in mDia1/3depleted neurons. The respective data for presynaptic actin (normalized to shCTR + DMSO set to 100) are: shCTR + DMSO = 100 ± 6.3; shmDia1+3 + DMSO = 47.7 ± 4.3; shCTR + Jasp = 150.6 ± 11.9; shmDia1+3 + Jasp = 94.3 ± 11.5.These data are now also quoted in the revised manuscript text.</p><disp-quote content-type="editor-comment"><p>Minor points</p><p>(1) There is no rationale provided regarding why different stimulation protocols are sometimes used in the pHluorin/cypHer experiments. In most cases it is 200 APs (40 Hz), however, in some cases, it is 40 APs or 80 APs. Can the authors explain why they used these different protocols?</p></disp-quote><p>Response: The referee noted this correctly. This in part reflects the history of the project, in which initial datasets were acquired using 200 AP trains using pHluorin reporters. To probe whether the phenotypic effects induced by actin perturbations, were robust over different stimulation paradigms and optical reporters, additional data using either 40 or 80 AP trains as well as experiments capitalizing on vGLUT1 or endogenous vGAT monitiored by pH-sensitive cypHer-labeled antibodies were conducted. We hope the referee agrees that these additional data add to the general importance of our study.</p><disp-quote content-type="editor-comment"><p>(2) Figure 2 - The reduction in SV density in mDia1/3 knockdown neurons correlates with the results in Figures 1 and 7. However, a functional consequence of this reduction (change in size of RRP or neurotransmitter release, as stated above) would have increased the impact of these experiments.</p></disp-quote><p>Response: We agree with the referee and will address this interesting possibility using electrophysiolgical recordings in future studies.</p><disp-quote content-type="editor-comment"><p>(3) It appears the experimental n in Figure 2 is profiles, rather than experiments. This should be clarified, especially since there is no reference to how many times the experiments in Fig2E-G were performed.</p></disp-quote><p>Response: This point has been clarified in the revised figure legend.</p><disp-quote content-type="editor-comment"><p>(4) Figure 6 - The authors state that inhibition of Rac function either via a dominant negative mutant or an inhibitor increases the inhibition of endocytosis via knockdown of mDia1/3. However, both interventions inhibit endocytosis themselves in the control condition. It would be informative to see the full statistical analysis of this data since there does not appear to be a significant additive effect when comparing Rac inhibition with the additional knockdown of mDia1/3.</p></disp-quote><p>Response: In our revised manuscript, we now provide the full statistical analysis in the revised Source Data Table for Figures 6G,H. We observe that Rac1-DN expression indeed further aggravates phenotypes elicited by depletion of mDia1+3, but not vice versa. We have modified the corresponding section in the results section of our revised manuscript accordingly.</p><disp-quote content-type="editor-comment"><p>(5) Figure 7 - The increase in endosomes in mDia1/3 knockdown neurons is consistent with previous studies examining pharmacological inhibition of formins (Soykan et al Neuron 2017 93:854). However, it is noted that these structures were absent in the images shown in Figure 2. Similar to the previous point in figure 6, a full reporting of the significance of different conditions is important here, since it appears that the only difference between EHT1864 and its co-incubation with mDia1/3 knockdown neurons is in the number of ELVs (Fig 7H).</p></disp-quote><p>Response: Similar to the example EM images shown in Figure 7, enlarged endocytic structures are also observed in shmDia1+3 depleted synapses shown in Figure 2. However, ELVs and membrane invaginations were not color-coded as the focus in figure 2 is on the reduction of the SV pool. To better illustrate this, we have chosen a more representative example of this phenotype in revised Figure 2.</p><p>Moreover, we now provide the full statistical analysis of EM phenotypes in the revised Source Data Table for Figure 7. We find that Rac1 inhibition indeed significantly aggravates the effects of mDia1+3 loss with respect to the accumulation of membrane invaginations, while the effect on ELVs remains insignificant. However, accumulation of ELVs in the presence of the Rac1 inhibitor EHT1864 is further aggravated upon depletion of mDia1+3. We have modified the corresponding section in the results section of our revised manuscript accordingly.</p><p>We speculate that Rac1 may thus predominantly act at the plasma membrane, whereas mDia1/3 may serve additional functions in SV reformation at the level of ELVs. Clearly, further studies would be needed to test this idea in the future.</p></body></sub-article></article>